Full year results release
VITAL HEALTHCARE PROPERTY TRUST
Managed by NorthWest Healthcare
Properties Management Limited
vhpt.co.nz
MARKET RELEASE
Managed by NorthWest Healthcare
Pr operties Management Ltd
11 August 2022
Strong earnings growth driven by high-quality property portfolio
Despite increasing volatility in stock markets around the world, healthcare property
remains a strong defensive asset class offering stable and transparent rental income
cashflows to investors with potential for further growth, says Australasia’s leading specialist
owner of healthcare real estate.
NorthWest Healthcare Properties Management Limited (NorthWest), the manager of Vital
Healthcare Property Trust (Vital), released its results for the 12 months ended 30 June 2022
(FY22) today. The result included confirmation of 9.625 cents per unit (cpu) distributions for
the year; 8.5% above FY21.
NorthWest said the increase in distributions was underpinned by strong growth in earnings
and recent asset acquisitions and development activity.
Fund Manager Aaron Hockly said Vital's Board and Management expect to deliver
further growth in earnings and distributions and has today provided FY23 distribution
guidance of 9.75cpu.
“Over FY22 Vital committed to undertake an additional $146 million of new
developments including the expansion of Ormiston Hospital in Auckland, Grace Hospital
in Tauranga and further additions to Wakefield Hospital in Wellington and Playford Health
Hub in Adelaide. Newly committed developments replenish Vital's development pipeline
following the recent completion of a A$97 million development and expansion of
Epworth Eastern Hospital in Melbourne and a new day surgery adjoining Royston Hospital
in Hastings which was officially opened earlier this month. Vital currently has 10
developments underway across Australia and New Zealand for a total projected cost of
$293.2m providing a forecast blended yield of 5.8%
1
.,” said Mr Hockly.
As part of its $1.8 billion pipeline of potential developments across Australia and New
Zealand, Vital is planning further development at its healthcare precinct in Remuera
where it owns Ascot Hospital and Ascot Central.
In addition to the above, Vital has $169 million of ambulatory care fund-through
2
developments underway in Australia comprising a A$54.4 million development for
Genesis Care (stage 1 of Campbelltown, Sydney) and a newly announced A$98.6m
fund-through development for Nexus in Hobart.
1
Forecast assumes developments are fully let on current expectations of future market terms.
2
These are developments where Vital is funding a development rather than acting as developer.
VITAL HEALTHCARE PROPERTY TRUST
Managed by NorthWest Healthcare Properties Management L
vhpt.co.nz
Page 2 of 3
Vital undertook $382
3
million of property acquisitions in FY22 including its first South Island
assets, purchasing sites in central Christchurch and Queenstown. Both sites housed
existing healthcare operators and offered future development potential, Mr Hockly said.
Mr Hockly noted NorthWest's focus on maintaining a consistently low average building
age within Vital as a means to minimise maintenance capital expenditure and to ensure
Vital’s properties meet current and future needs of healthcare operators and patients.
“Vital’s $3.3 billion property portfolio is high quality and high acuity, with a current
weighted average lease expiry of 17.6 years – the longest of any property group on the
NZX,” said Mr Hockly.
Net property income increased by 12.2% over FY22 reflecting the contributions from
rental growth, acquisitions and developments. Like-for-like, same property rental growth
using a constant currency was 2.8% for FY22. With ~80% of Vital's leases linked to CPI in
some way, Vital also retained high occupancy at 98.8% (30 June 2021: 99.2%).
During the past year, Vital and NorthWest both issued their first Sustainability Reports.
NorthWest has subsequently appointed three "Sustainability Champions" to its Australasian
business, part of its commitment to achieving net zero emissions across all its operations
and platforms, including Vital, by 2050.
FY22 Results at a glance
FY22 FY21 Change
Property Portfolio $3.3 billion $2.6 billion 26.7%
Occupancy (by income) 98.8% 99.2% -
AFFO $67.8 million $57.5 million 18.0%
AFFO per unit (cpu) 11.92 11.54 3.3%
NTA per unit ($pu) 3.34 2.89 15.3%
Balance sheet gearing 30.0% 35.0% -
Weighted average cost of debt 3.73% 3.32% -
Weighted average debt maturity 3.9 years 2.5 years -
Distributions (cpu) 9.625 8.88 8.5%
Over the 10 years ended 30 June 2022, Vital has delivered a total return
4
of 13.2% per
annum outperforming the NZX REIT index by 4.2% per annum and the NZX50 by 0.9% per
annum
5
.
Over the five years ending 30 June 2023, Vital expects to record a compound annual
growth rate for distributions of 2.3% per annum.
Vital's balance sheet gearing was reduced to a conservative 30.0% at 30 June 2022 (30
June 2021: 35.0%) and has no debt expiring until October 2023.
– ENDS –
3
Excludes transaction costs and includes Kawarau Park Health Precinct, Queenstown which settled in
July 2022.
4
Unit price change plus distributions.
5
Source: Forsyth Barr
VITAL HEALTHCARE PROPERTY TRUST
Managed by NorthWest Healthcare Properties Management L
vhpt.co.nz
Page 3 of 3
ENQUIRIES
Aaron Hockly
Fund Manager, Vital Healthcare Property Trust
Tel 09 973 7301, Email aaron.hockly@nwhreit.com
Michael Groth
Chief Financial Officer, NorthWest Healthcare Properties Management Limited
Tel +61 409 936 104, Email michael.groth@nwhreit.com
About Vital (NZX code VHP):
Vital Healthcare Property Trust is an NZX-listed fund that invests in high-quality healthcare
properties in New Zealand and Australia including private hospitals (~80% of portfolio
value), out-patient facilities (~16% of portfolio value) and aged care (~4% of portfolio
value)
6
.
Vital is the only specialist listed landlord of healthcare property in Australasia and
currently has a portfolio valued at over $3.3 billion
3
.
Vital is managed by NorthWest Healthcare Properties Management Limited, a subsidiary
of Toronto Stock Exchange listed NorthWest Healthcare Properties REIT, a global owner
and manager of healthcare property.
For more information, visit our website: www.vhpt.co.nz
Disclaimer:
This announcement has been prepared by NorthWest Healthcare Properties Management
Limited (the "Manager") as manager of the Vital Healthcare Property Trust (the "Trust"). The
details in this announcement provide general information only. It is not intended as
investment, legal, tax or financial advice or recommendation to any person and must not
be relied on as such. You should obtain independent professional advice prior to making
any decision relating to your investment or financial needs.
All references to $ are to New Zealand dollars unless otherwise indicated.
This announcement may contain forward-looking statements. Forward-looking statements
can include words such as “expect”, “intend”, “plan”, “believe”, “continue” or similar
words in connection with discussions of future operating or financial performance or
conditions. The forward-looking statements are based on management's and directors’
current expectations and assumptions regarding the Trust’s business, assets and
performance and other future conditions, circumstances and results. As with any
projection or forecast, forward-looking statements are inherently susceptible to uncertainty
and to any changes in circumstances. The Trust’s actual results may vary materially from
those expressed or implied in the forward-looking statements. The Manager, the Trust, and
its or their directors, employees and/or shareholders have no liability whatsoever to any
person for any loss arising from this announcement or any information supplied in
connection with it. The Manager and the Trust are under no obligation to update this
announcement or the information contained in it after it has been released. Past
performance is no indication of future performance.
6
All figures as at 30 June 2022.
---
Annual Report
2022
HEALTHY PROPERTIES
DELIVER HEALTHY RETURNS
Kawarau Park Health Precinct,
Queenstown
Investing in healthcare
infrastructure in New
Zealand and Australia
2
|
VITAL HEALTHCARE PROPERTY TRUST
FY22 HIGHLIGHTS
Contents
About Vital and NorthWest 4
Overview of Vital
6
Key events over FY22 10
Short, medium and longer term
progression 12
Manager’s report 14
Asset allocation 20
Australian portfolio overview 22
New Zealand portfolio overview
24
5 largest assets and asset groupings 26
Developments 32
Acquisitions 36
Sustainability 44
Our Board 76
Our executive team 78
Corporate governance 80
Financial statements 88
Independent auditor’s report 132
Unit Holder statistics 135
Vital’s structure 136
Directory 139
9. 625cpu11 . 9 2cpu
8.5% ABOVE FY21
3.3% ABOVE FY21
$287m
1
DISTRIBUTIONSAFFOACQUISITIONS TO SUPPORT
FUTURE GROWTH
1
Excluding transaction costs
ANNUAL REPORT
|
3
To be Australia and
New Zealand’s leading listed
healthcare property fund.
Deliver stable and growing total Unit
Holder returns, including an attractive
risk-adjusted income distribution, majority
sourced from healthcare real estate.
VisionMission
NZX listed property trust which owns ~$3.3 billion of
healthcare property in New Zealand and Australia.
4
|
VITAL HEALTHCARE PROPERTY TRUST
NorthWest Healthcare
Properties REIT
TSX listed owner and manager of NZ$12.4 billion
of healthcare property across four continents.
Hard work, integrity, collaboration, drive,
flexibility, team work, fun and results.
Be the leading global diversified
healthcare real estate company.
Provide best in-class real estate
solutions to the healthcare
industry and deliver exceptional
shareholder value to investors.
EXCELLENCE
Delivering exceptional
outcomes
INTEGRITY
Doing what’s
right
PARTNERSHIP
Succeeding
together
We value
VisionMission
Values
NorthWest (Australia and New Zealand)
is the manager of Vital, with over 60
professionals in the region. We have
offices in Auckland, Melbourne, Sydney
and the Gold Coast.
ANNUAL REPORT
|
5
1
Number of properties include Kawarau Park Health Precinct, Queenstown, but excludes strategic assets. All other figures exclude Kawarau Park Health Precinct, Queenstown.
As at 30 June 2022
Overview of Vital
1
Vital is the only specialist healthcare landlord on the NZX.
~$3.3bn
47 PROPERTIES
(AUS & NZ)
~$2.4bn
31 PROPERTIES
(AUS)
~$0.9bn
1 6 PROPERTIES
(NZ)
6
|
VITAL HEALTHCARE PROPERTY TRUST
Vital Portfolio by Geography
AUSTRALIA
72%
NEW ZEALAND
28%
WESTERN
AUSTRALIA
NORTHERN
TERRITORY
SOUTH
AUSTRALIA
NEW SOUTH
WALES
TASMANIA
VICTORIA
QUEENSLAND
4
3
6
6
12
14
2
ANNUAL REPORT
|
7
Acute Hospitals 53%
Ambulatory Care 16%
Specialty Hospitals
(mental health & rehabilitation) 27%
Aged Care 4%
53%
27%
16 %
4%
H
O
S
P
I
T
A
L
8
0
%
O
T
H
E
R
2
0
%
19 %
16 %
22%
15 %9%
4%
3%
3%
3%
2%
4%
Healthe Care Surgical 16%
Norfolk Southern Cross Limited 4%
Evolution Healthcare 9%
Epworth 15%
Hall & Prior 4%
Bolton Clarke 3%
Sportsmed 3%
Mercy Ascot 3%
Ramsay 2%
Other 22%
Aurora Healthcare 19%
TENANT DIVERSIFICATION
% of Rent
SUB-SECTOR DIVERSIFICATION
% of Value
8
|
VITAL HEALTHCARE PROPERTY TRUST
1
Income producing properties only
2
Average building age = the later of the date of construction or last significant capital works
$123m
11.1
years
AVERAGE BUILDING AGE
2
98.8%
PORTFOLIO OCCUPANCY
FY22 PROPERTY INCOME
17.6 years
WEIGHTED AVERAGE
LEASE EXPIRY (WALE)
4.58%
WEIGHTED AVERAGE CAP RATE
1
(AUS 4.54%, NZ 4.70%)
ANNUAL REPORT
|
9
Key events over FY22
• FY22 AFFO and distribution
guidance announced 11.8cpu
and 9.5cpu respectively
• Acquisition of Hutt Valley
Health Hub, Wellington
for $46.5m announced
AUGUST 2021
• 2.375cpu distribution paid
• 2.375cpu distribution paid
• Practical completion of
Stage 1 of Wakefield
Hospital, Wellington for a
total cost of ~$50.8m
SEPTEMBER 2021
DECEMBER 2021
JULY 2021
2021
• $27.8m raised via a Unit Purchase Plan
from existing retail holders at $2.85 per unit
• Completion of Stage 1 of Playford
Health Hub, Adelaide for ~A$20m
• Commencement of $6.3m Royston
Stage 2, $31.7m Grace Hospital and
$6.3m Bowen Hospital developments
• MoU signed with Calvary Health
Care to operate a ~A$93m hospital
(Stage 3 of Playford Health Hub)
NOVEMBER 2021
• A$315m debt refinance to
extend debt capacity by A$65m
and extend debt tenor
• Acquisition of Tennyson Centre,
Adelaide for A$92.75m
• $115m placement primarily to existing
institutional holders at $2.90 per unit
• Commencement of $91.5m Wakefield
Stage 2 with demolition of existing building
• Terms agreed for $74m of new and
extended brownfield developments
across five of Evolution Healthcare’s
facilities in New Zealand
OCTOBER 2021
10
|
VITAL HEALTHCARE PROPERTY TRUST
• Appointment of Angela Bull as an additional Independent Director
• Acquisition of 68 Saint Asaph St, Christchurch for $50.7m
• Acquisition of Kawarau Park Health Precinct, Queenstown for
~$95m (settled July 2022)
• Acquisition and expansion of Endoscopy Auckland announced
for $43.8m (acquisition cost plus estimated development spend)
• Announcement of expansion of Ormiston Hospital, Auckland
for ~$40m (includes land already owned by Vital)
APRIL 2022
• 2.4375cpu distribution paid
• Practical completion of
A$97m Epworth Eastern
East Wing Tower
• A$39.3m Playford Health
Hub Stage 2 commenced with
demolition of existing building
• A$350 debt refinance
completed, increasing facility
limits by A$150m and weighted
average term to maturity by
1.1 years to 4.4 years
• $200m in new equity raised
through an entitlement
offer at $2.95 per unit
• Acquisition of a vacant aged
care facility in Mt Eliza, Victoria
for ~$A12m to be re-purposed
as a private hospital
• Ormiston Hospital ~$40m
expansion commenced
• 2.4375cpu distribution paid
• Retirement of Andrew Evans
as an Independent Director
after 15 years on the board
• Acquisition of 80 Ascot
Ave, Remuera for $16m
• Agreement to undertake a
~A$98m development of a new
private hospital and ambulatory
care facility in Hobart, Tasmania
MARCH 2022
2022
MAY 2022JUNE 2022
• Acquisition of land for expansion of The Hills
Clinic in Sydney for ~A$50.0m (includes
land cost and estimated construction costs)
• Announcement of acquisition of multi-stage
development site in south-west Sydney for
A$76.6m (includes acquisition costs, Stage
1 construction costs and tenant incentive)
• Upgrade to annualised AFFO and distribution
guidance to at least 11.9cpu and 9.75cpu
FEBRUARY 2022
ANNUAL REPORT
|
11
Short, medium and
longer term progression
1
Portfolio enhanced through acquisitions, development and disposals to:
(1) increase diversity of assets and tenants, (2) reduce age of building and
(3) maintain long WALE. This helps to reduce income risk for Vital’s Unit Holders.
Portfolio enhancements support target of growing
AFFO and distributions by 2–3% per unit per annum.
1
All figures are as 30 June at the end of the financial year listed other than Net Property Income, AFFO and Distributions which are for the financial year.
2
Average building age = the later of the date of construction or the last significant capital works
3
Includes $214.9m of committed development spend remaining and ~$1.8bn of developments being considered. Development timing and therefore spend expected to be over
a staged and lengthy period (at least 10 years)
489%
growth (FY12-FY22)
Maintenance of
market leading WALE
Younger buildings
reduce maintenance
capex requirements
156%
increase (FY12 - FY22)
Enhance earnings
and valuation growth
and support portfolio
development
Concentration
risk reduced
Diversity of assets reduces
risk and enhances earnings
F Y 12F Y 19FY22
Total property
value
~$0.57bn
(AUS: 71%, NZ: 29%)
~$1.93bn
(AUS: 76%, NZ: 24%)
$3.34bn
(AUS: 72%, NZ: 28%)
WALE11.9 years18.1 years17.6 years
Average
Building Age
2
Data not availabile13.5 years11.1 years
Net Property
Income (annual)
$48m$98m$123m
Development
pipeline
~$60m$279m$2.1bn
3
Largest single
tenant exposure
40%49%19 %
Sector split
Hospital: 88%
Ambulatory care: 12%
Aged care 0%
Hospital: 83%
Ambulatory care: 14%
Aged care 3%
Hospital: 80%
Ambulatory care: 16%
Aged care 4%
Weighted average
cap rate
9.30%5.61%4.58%
Reduction demonstrates: (1)
quality of assets and tenants;
and (2) value added by leasing
and development undertaken
12
|
VITAL HEALTHCARE PROPERTY TRUST
Balance sheet strengthened during FY22 through raising $379m
of new equity and extending debt whilst supporting portfolio
growth as a means to grow AFFO and distributions.
4
Net Distributable Income per unit (AFFO not reported)
Significantly
expanded
No debt expiring until
October 2023
49%
growth (FY12-FY22)
25%
growth (FY12-FY22)
241%
growth (FY12-FY22)
F Y 12F Y 19FY22
Balance sheet
gearing
42.3%35.3%30.0%
Average debt
maturity
3.8 years2.2 years3.9 years
NTA per unit
$0.98$2.31$3.34
AFFO per unit (cpu)
8.0c
4
9.9c11 . 9 2 c
Distributions
per unit (cpu)
7.7c8.75c9.625c
ANNUAL REPORT
|
13
Manager’s report
Vital recorded growth in earnings, distributions
to Unit Holders and assets during FY22 as
NorthWest’s management continued to
demonstrably benefit Unit Holders.
14
|
VITAL HEALTHCARE PROPERTY TRUST
Tēnā koutou,
NorthWest Healthcare Properties Management
Limited (NorthWest), the Manager of Vital Healthcare
Property Trust (Vital), is pleased to report Vital’s
results for the year ended 30 June 2022 (FY22).
Despite a more uncertain economic
environment and rising debt costs, NorthWest
has continued to deliver earnings and
distribution growth for Vital's Unit Holders
whilst also continuing to enhance the property
portfolio and embed sustainability into all
parts of NorthWest and Vital.
FY22 highlights included:
• 3.3% increase in AFFO per unit from 11.54
cents per unit (cpu) to 11.92 cpu.
• 8.5% increase in distributions per unit from 8.88 cpu to
9.625 cpu on a prudent 81% AFFO pay-out ratio.
• 15.3% increase in net tangible assets (NTA)
per unit from $2.89 to $3.34.
• $287m of property acquisitions (before costs)
and $15m of disposals undertaken.
• $100m of capital expenditure undertaken comprising $86m
for developments, ~$12m for value-add works and ~$2m
for maintenance and tenant incentive related works.
• Commencement of $240m of new developments
including Ormiston Hospital expansion in Auckland
and Stage 2 of both Wakefield Hospital in Wellington
and Playford Health Hub in Adelaide.
• Replenishment of potential development pipeline to provide
future earnings and valuation upside for Unit Holders.
• Release of inaugural Sustainability Reports for both
Vital and NorthWest as well as participation in both
the Carbon Disclosure Project (CDP) and the Global
Real Estate Sustainability Benchmark (GRESB). Results
are due to be publicly released later in 2022.
• $379m (before costs) of equity raised primarily via a
$143m placement and UPP in late 2021 and a $200m
entitlement offer in early 2022. Equity was raised to
support the acquisitions and developments referred to
above and to keep balance sheet gearing below 35%.
• Appointment of Angela Bull as an Independent
Director, replacing long-term director Andrew Evans,
completing a two-year process of Board renewal.
ANNUAL REPORT
|
15
Our commitment to sustainability
During FY22, Vital released its first Sustainability Report
(part of its Annual Report released in August 2021) and
NorthWest released its first Sustainability Report (available
here). These reports, which include measurable targets,
demonstrate our commitment to sustainability and are
considered the first key steps in our sustainability journey.
FY22 sustainability highlights include:
• Establishment of global and regional sustainability teams
and governance structures in NorthWest including
the appointment of three dedicated sustainability
resources in Australia and New Zealand to champion
sustainability initiatives in this region including for Vital:
• Clare Solomon – Vice President
Sustainability and Development.
• Tony Gill – National Engineering and Operations Manager.
•Liz Ingram – Sustainability Associate.
• Commitment by NorthWest covering all of its
operations and platforms including Vital to achieve
net zero emissions by 2050. We are now focused on
establishing baseline emissions with a view to establishing
science-based interim 2030 reduction targets.
• Materiality workshops and stakeholder engagement
meetings held with key Vital Unit Holders,
employees, debt providers and tenants.
• Alignment of NorthWest and Vital’s commitments and
targets with United Nations Sustainability Goals and the
Global Real Estate Sustainability Benchmark (GRESB).
• Establishment of ESG working groups with key
tenants including Epworth Healthcare in Australia
and Evolution Healthcare in New Zealand.
• Participation in both GRESB and the Carbon Disclosure
Project (CDP) with results released later in 2022.
Please refer to pages 44-75 of this Annual Report
for Vital’s detailed Sustainability Report.
We will build on these achievements as well
as our targets and goals over time.
Portfolio overview
Vital’s ~$3.3 billion property portfolio remains high
quality, high acuity with a long WALE and limited
upcoming expiries (on average 1.7% of the portfolio's
rent expires per annum over the next 10 years).
Vital’s weighted average lease expiry (WALE) was 17.6 years
at 30 June 2022 compared to 18.7 years at 30 June 2021.
The average building age has been maintained at a
young 11.1 years consistent with the Manager's strategy to
maintain or lower this key metric as a means of maintaining
relatively low capital expenditure and ensure Vital's
assets continue to meet tenant / patient demand.
Net property income
Net property income increased by 12.8% from FY21 (excluding
foreign exchange impacts), reflecting contributions from the
structured rent reviews within the portfolio, developments and
acquisitions. After adjusting for foreign exchange, net property
income increased by12.2%.
~80% of Vital's rent is linked to CPI. 77% of this having a weighted
average annual limit of ~3.7% with the balance being uncapped.
This structure provides Vital's Unit Holders with some protection in
periods of elevated inflation.
Like-for-like net property income increased by 2.8% over FY22
on a same currency basis.
Acquisitions
Further details of the $287m
1
of acquisitions during FY22 plus
other acquisitions to the date of this report are included on
pages 36-43 of this report.
Divestments
$15m of divestments undertaken at a premium to previous
book value due to the disposal of surplus development land.
Developments
In addition to asset enhancing and maintenance capital
expenditure, Vital had ~$293m of development projects underway
in New Zealand and Australia with ~$215m remaining to spend.
In addition, $169m of fund-through
2
developments have been
committed to.
Further details of specific developments are
available on pages 32-35 of this report.
Financial results
Cash from operations available to Unit Holders, measured by
AFFO, increased 18.0% to $67.8m. AFFO per unit was 11.92c;
a 3.3% increase from FY21.
Expenses were $66.2m, 13.0% higher than FY21
notwithstanding a 27.7% increase in assets.
Vital’s NTA per unit increased by 15.3% to $3.34 primarily due to
$244.2m of property revaluation gains. These revaluation gains
included ~$10m in development margins and ~$100m due to
rental increases and leasing.
Capital management
During the year Vital’s debt facilities were increased by ~A$215m
along with a renegotiation of facilities expiring early in FY23.
The next debt facility expiries now occur late 2023. Vital has a
weighted average debt maturity at 30 June 2022 of 3.9 years,
and management continues to investigate measures to extend
Vital's debt tenor. Vital’s all-in weighted average cost of debt
at 30 June 2022 was 3.73% (30 June 2020: 3.32%) now
beginning to reflect a challenging cost of debt environment.
$379m (before costs) of equity was raised primarily
via a $142.8m placement and UPP in late 2021 and a
$200m entitlement offer in early 2022. Equity was raised
to support the acquisitions and developments referred to
above and to keep balance sheet gearing below 35%.
The debt to total assets ratio was 30.0% at 30 June 2022
2
Developments where Vital is funding through the development
rather than acting as developer.
1
Excluding acquisition costs
16
|
VITAL HEALTHCARE PROPERTY TRUST
18.0%
INCREASE IN AFFO
(CASH IN EARNINGS)
15.3%
INCREASE IN NTA
PER UNIT
12.8%
INCREASE IN NET
PROPERTY INCOME
3.3%
INCREASE IN AFFO
PER UNIT
ANNUAL REPORT
|
17
support and non-discretionary spending. As noted
above, we have added to Vital's development
capacity through strategic acquisitions.
Our plan for the short
to medium term is:
• Renew Vital’s 5-year portfolio strategy noting
that we have achieved many of the targets
of the previous strategy ahead of time and
to reflect changed market conditions.
• The above strategy will help us continue to grow
earnings and distributions for Unit Holders whilst
maintaining a prudent pay-out ratio of ~80%.
• Focus on the current and potential development
pipeline in New Zealand and Australia to
provide new and upgraded health facilities
for communities across our region.
• Maintain Vital’s debt maturity profile and
consider further diversifying sources of debt
to support returns for Vital's Unit Holders.
• Continue to enhance and upgrade our
sustainability programme, as part of
NorthWest’s wider programme, to play
our part in protecting and enhancing the
environment, the communities in which we
operate and the stakeholders we serve.
Nā māua noa, nā
(30 June 2021: 35.0%). Vital currently has
approximately A$302m of headroom under its
debt facilities and considers that enough headroom
is available to facilitate the development
pipeline reported in this Annual Report.
Board renewal
In April 2022, Angela Bull was appointed as
an Independent Director and member of the
Audit Committee to replace Andrew Evans who
retired from these roles on 30 June 2022.
Angela is currently Chief Executive of Tramco Group,
a New Zealand owned property investment company
which specialises in large scale land holdings,
notably the Viaduct Harbour precinct in Auckland and
Wairakei Estate in the Waikato. She holds a Bachelor
of Laws and a Bachelor of Arts (Political Science)
and practised property and environmental law prior
to her executive career. Angela held a number of
senior positions over a 10-year period with Foodstuffs,
most recently being General Manager Property
Development for Foodstuffs North Island. Angela is an
independent director of the Real Estate Institute of New
Zealand, realestate.co.nz, Foodstuffs South Island Ltd
and Foodstuffs NZ Ltd. She is located in Auckland,
New Zealand.
Andrew had been on the Board of
Vital’s manager since 2007.
The replacement of Andrew with Angela maintains
key existing attributes of the Board including majority
independent directors, geographic balance (two
directors in each of New Zealand and Australia and
one director in Canada) and an appropriate skills mix.
FY23 guidance
1
TThe Board and management are pleased to
provide FY23 distribution guidance of 9.75 cpu
(payable quarterly); 1.3% above FY22 whilst
maintaining a prudent ~80% payout ratio.
Outlook
Despite recent heightened market volatility,
healthcare property remains a defensive asset
class, underpinned by a high level of government
Graham Stuart
Independent Chair
11 August 2022
NorthWest Healthcare Properties Management Limited, the Manager of Vital Healthcare Property Trust
Aaron Hockly
Fund Manager
As Australasia’s leading listed
owner of high quality, high acuity
healthcare real estate, supported
by NorthWest’s unmatched
development and management
expertise, Vital remains well
positioned to take advantage
of opportunities in this sector.
1
Refer to disclaimer on back page of this report for limitations to this guidance.
18
|
VITAL HEALTHCARE PROPERTY TRUST
Financial summary
Portfolio metrics
All figures are in New Zealand dollars (NZD) unless otherwise stated
All figures are in New Zealand dollars (NZD) unless otherwise stated
1
AFFO for FY18 has been restated to include the notional impact of the 1 July 2018 introduction of attributed FIF tax rule changes
1
Excludes properties held for development
2
Additions include Tennyson Centre, Playford Health Hub - Retail and Carpark, 120 Thames Street, Hutt Valley Health
Hub, 68 Saint Asaph St, Endoscopy Auckland, and disposal of Gold Coast Surgery Centre. Excludes post 30 June 2022
acquisition of Kawarua Park Health Precinct, Queenstown
2 018
$000s
2 019
$000s
2020
$000s
2021
$000s
2022
$000s
Financial Performance
Net property income90,65997,683100,147109,66312 3 , 018
Revaluation gain/(loss) on investment properties85,461103,55645,703235,383244,239
AFFO and distributions
Adjusted Funds From Operations (AFFO)
1
47,07443,89747,21157,457 6 7, 8 2 4
AFFO (cpu)10.84 9.90 10.4511 . 5 411 . 9 2
Cash distribution to Unit Holders (cpu)8.508 . 758 . 758.889.63
Financial Position
Total assets1,786,8281,9 31, 5432,105,2182,662,5603,399,834
Borrowings6 7 0 ,12 4734,211813 , 515929,3001,018,777
Total equity9 8 7, 9 7 61,029,7451, 078 ,9791,503,4512,165,876
Debt to total assets ratio (%)38.735.338.735.030.0
Net tangible assets ($ per unit)2.262.312.382.893.34
2 0182 019202020212022
Investment properties ($m)1, 7311,8362,086 2,6343,339
Number of investment properties
1
4242444146
2
Occupancy (%)99.399.499.499.298.8
Weighted average lease term to expiry (years)18.218 .118 .118 . 717. 6
12 month lease expiry (% of income)1.81. 71.41. 71. 7
ANNUAL REPORT
|
19
Asset allocation
Vital invests in health ecosystems in New Zealand and Australia. Our
precinct strategy will help create new opportunities for Vital to build out
assets in health-related precincts where public, private, education, aged
care and research uses are closely agglomerated and interrelated.
TARGET PORTFOLIO WEIGHTINGS
1
Healthcare precinct = area or hub for healthcare delivery typically including at least two of a public hospital, major private hospital, health teaching facility or health research facility
2
The initial focus for this sub-sector will be New Zealand. Hospitals and aged care are the priority for Vital's growth in Australia at least in the near-term
Comprises
Public, private, speciality, rehabilitation
and mental health hospitals
Comprises
Administration, diagnostic services and specialist
consulting, primary care out-patient facilities
Targeting
Government supported or high private health
insurance catchments with growing populations
Targeting
Facilities located in a healthcare precinct
1
and/
or from where healthcare is delivered
HOSPITALSOUT-PATIENT/AMBULATORY CARE
Target portfolio weighting
50 - 70%
(30 June 2022: 80%)
Target portfolio weighting
10 - 20%
(30 June 2022: 16%)
20
|
VITAL HEALTHCARE PROPERTY TRUST
Comprises
Residential aged care facilities
(excluding retirement facilities)
Comprises
Biotechnology, pharmaceutical, biomedical, university,
health education and other research facilities
Targeting
High quality operators with substantial balance sheets
and <45% rent/EBITDAR and high-quality infrastructure
Targeting
Specialised facilities and/or facilities
located in a healthcare precinct
1
AGED CARELIFE SCIENCES/RESEARCH
Target portfolio weighting
10 - 20%
(30 June 2022: 4%)
Target portfolio weighting
5 - 15%
(30 June 2022: 0%)
2
Investments are targeted to provide earnings growth
from a diversified and defensive asset base.
ANNUAL REPORT
|
21
Australian portfolio
overview
• Abbotsford Private Hospital
• Hamersley Aged Care
• Marian Centre
• Rockingham Aged Care
• Sportsmed Hospital, Clinic
and Consulting
• Tennyson Centre
• Playford Health Hub
• 120 Thames Street
• Ekera Medical Centre
• Epworth Camberwell
• Epworth Eastern Hospital
• Epworth Rehabilitation
• South Eastern Private Hospital
WESTERN
AUSTRALIA
SOUTH
AUSTRALIA
NEW SOUTH
WALES
VICTORIA
QUEENSLAND
WESTERN AUSTRALIASOUTH AUSTRALIAVICTORIA
4
3
6
6
12
~$2.4bn
31
1
PROPERTIES (AUS)
1
Income Producing Property (excludes strategic assets)
22
|
VITAL HEALTHCARE PROPERTY TRUST
PRIVATE HOSPITALS
AMBULATORY CARE
AGED CARE
• 17 hospitals (acute and specialty –
mental health, rehabilitation)
• 4 hospital operators
• 80% of AUS portfolio value; 79% of AUS rent
• WALE: 19.1 years
• Baycrest Aged Care
• Belmont Private Hospital
• Eden Rehabilitation
• Palm Beach Currumbin Clinic
• Tantula Rise Aged Care
• The Southport Private Hospital
• Clover Lea Aged Care
• Darlington Aged Care
• Fairfield Aged Care
• Grafton Aged Care
• Hirondelle Private Hospital
• Hurstville Private Hospital
• Lingard Day Centre
• Lingard Private Hospital
• Maitland Private Hospital
• Mons Road Medical Centre
• The Hills Clinic
• Toronto Private Hospital
• 6 assets, multiple tenants
• 14% of AUS portfolio value; 12% of AUS rent
• WALE: 7.0 years
•8 facilities
•2 operators
• 6% of AUS portfolio value; 9% of AUS rent
•WALE: 14.0 years
QUEENSLAND
NEW SOUTH WALES
ANNUAL REPORT
|
23
New Zealand portfolio
overview
1
• Apollo Health and Wellness Centre
• Ascot Carpark (Right of Use)
• Ascot Central
• Ascot Hospital
• Boulott Hospital
• Bowen Hospital
• Endoscopy Auckland
• Grace Hospital
• Hutt Valley Health Hub
• Kensington Hospital
• Napier Health Centre
• Ormiston Hospital
• Royston Hospital
• Wakefield Hospital
NORTH ISLAND
14
2
1
Number of properties include Kawarau Park Health Precinct, Queenstown, but excludes strategic assets. All other figures exclude Kawarau Park Health Precinct, Queenstown.
~$0.9bn
16 PROPERTIES (NZ)
24
|
VITAL HEALTHCARE PROPERTY TRUST
PRIVATE HOSPITALS
AMBULATORY CARE
•9 hospitals (all acute)
•6 hospital operators
• 75% of NZ portfolio value; 75% of NZ rent
•WALE: 21.6 years
• 6 assets, multiple tenants
• 25% of NZ portfolio value; 25% of NZ rent
• WALE: 9.9 years
• Kawarau Park Health Precinct
• 68 Saint Asaph St
SOUTH ISLAND
ANNUAL REPORT
|
25
5 largest assets and
asset groupings
Valued at $1.32bn and representing 40% of Vital’s total portfolio, the
five largest assets or asset groupings (i.e. adjoining assets or assets which
form part of the same healthcare precinct) span Melbourne, Newcastle,
Auckland, Brisbane and Wellington and a diverse range of tenants.
They represent a core part of Vital’s value and earnings. Development
has recently occurred or is planned to occur at each of these sites.
It is anticipated that this list will evolve over time primarily through
developments. Notably Vital’s recent acquisition in Campbelltown,
Sydney is expected to end up being one of Vital’s largest assets through
the delivery of a multi-staged development over several years.
26
|
VITAL HEALTHCARE PROPERTY TRUST
Comprising three income producing assets plus 5,500 square
metres of development land, this is Vital’s largest asset concentration
and forms part of the Box Hill Health and Education Precinct which
includes Box Hill Public Hospital and Box Hill (tertiary training)
Institute approximately 14 kilometres from Melbourne’s CBD.
These assets have been acquired, developed and improved
over time reflecting Vital’s two decade relationship
with Epworth (Victoria’s largest private healthcare
operator and Vital’s third largest tenant by income).
The largest of the three income producing assets, Epworth
Eastern Hospital, is valued at A$406m comprising 286
inpatient beds, 14 operating theatres, three endoscopy
suites and six floors of specialist medical consulting including
radiotherapy, medical imaging and pathology. A 14 storey
redevelopment of this hospital was completed in early 2022.
The development land at 17-23 Nelson Road is expected
to have a value if fully developed in excess of A$350m.
Epworth Eastern Precinct, Melbourne, VIC
A$482m
VALUE
ASSETS
Epworth Eastern Hospital, 17-23
Nelson Rd (development land), Ekera
Medical Centre & 120 Thames St
PATIENT BEDSLAND AREA
NLA
270~15,000sqm
~35,000sqm
PROXIMITY TO
PUBLIC HOSPITAL
% OF VITAL'S
PORTFOLIO
YEAR ACQUIRED
BY VITAL
150m
16.0%1999
ANNUAL REPORT
|
27
Comprising two income producing assets, this is Vital’s second
largest asset concentration and is fully leased to Healthe Care
Surgical (Vital’s second largest tenant by income). The assets are
~4 kilometres from Newcastle’s CBD.
Lingard Private Hospital is a 123-bed
acute medical and surgical hospital
which has recently been expanded and
redeveloped and is valued at A$203m.
Due to demand at the hospital, a new
day surgery unit was completed in mid-
2020 including four day theatres and two
endoscopy suites which is valued at A$43m.
Lingard Private Hospital Precinct, Newcastle, NSW
A$256m
VALUE
ASSETS
Lingard Private Hospital, Lingard
Day Centre and 27 Hopkins
Street (development land)
LAND AREANLA
~15,000sqm14 0
11,500sqm
PROXIMITY TO
PUBLIC HOSPITAL
% OF VITAL'S
PORTFOLIO
YEAR ACQUIRED
BY VITAL
3.6km
8.5%
2 010
PATIENT BEDS
28
|
VITAL HEALTHCARE PROPERTY TRUST
Ascot Hospital was developed in 1999 and was Vital’s first significant
hospital development. Over the last 23 years, Vital has developed
the adjoining Ascot Central (specialist centre) and recently acquired
3,415 square metres of land with a view to further expanding one
of New Zealand’s leading health precincts.
Ascot Hospital has 12 operating theatres,
88 inpatient beds and is valued at $140.5m.
It is operated by Mercy Ascot, New Zealand’s
second largest private hospital operator.
Ascot Central is valued at $44.8m and has
a range of medical and ancillary tenants
including Fertility Associates, New Zealand’s
leading provider of fertility services.
Ascot Hospital Precinct, Auckland, NZ
$209m
VALUE
ASSETS
Ascot Hospital, Ascot Central,
80 Ascot Ave (development
land) & Ascot Carpark
LAND AREANLA
~40,000sqm
88
~16,000sqm
PROXIMITY TO
PUBLIC HOSPITAL
% OF VITAL'S
PORTFOLIO
YEAR ACQUIRED
BY VITAL
5.6km
6.3%
1999
PATIENT BEDS
ANNUAL REPORT
|
29
Belmont Private Hospital is a 150-bed general mental health hospital
approximately 12 kilometres from Brisbane’s CBD. It is the largest mental
health hospital in Queensland and offers a range of specialist acute
mental health services catering for both inpatient and day patients.
The facility is currently under development to add an additional
35 beds, 13 consulting suites and 70 car parks. This $23m
development is expected to be complete in late-2022.
Belmont Private Hospital, Brisbane, QLD
A$146m
VALUEASSETS
Belmont Private
Hospital
LAND AREANLA
~43,000sqm
~8,700sqm
PROXIMITY TO
PUBLIC HOSPITAL
% OF VITAL'S
PORTFOLIO
YEAR ACQUIRED
BY VITAL
11.0km4.8%2 010
15 0
PATIENT BEDS
30
|
VITAL HEALTHCARE PROPERTY TRUST
Wakefield Hospital is the largest private hospital in the Wellington
region, located on a 2.2 hectare site, 5 kilometres south of
Wellington’s CBD and 850 metres from Wellington Regional Hospital.
Vital has committed to a full redevelopment of this
facility to provide a seismically resilient, modern
and functional facility including eight operating
theatres, 47 beds, a 3,000sqm medical consulting
building and over 260 carparks. The combined
value of the development works is approximately
$134m with Vital’s commitment at $112.8m and
the balance funded by Evolution Healthcare, New
Zealand’s third largest private hospital operator.
The first stage of this project involving the construction
of a new building housing medical specialist consulting
space, a full radiology unit, and new administration
and front of house area was completed in mid-2021.
Stage 2 is underway and is expected
to be completed in late 2024.
Wakefield Hospital, Wellington, NZ
$130m
VALUEASSETS
Wakefield
Hospital
LAND AREA
NLA
~20,000sqm
14,500sqm
PROXIMITY TO
PUBLIC HOSPITAL
% OF VITAL'S
PORTFOLIO
YEAR ACQUIRED
BY VITAL
850m
3.9%2 017
68
PATIENT BEDS
ANNUAL REPORT
|
31
Developments
Vital has 10 committed developments underway
at a total projected cost of $293m with $215m
remaining to spend. In addition, Vital has $169m
of fund-through developments underway and a
potential development pipeline of $1.8bn.
~ $2.1bn
COMMITTED AND POTENTIAL
DEVELOPMENT PIPELINE
1
During FY22 $86m was spent on developments including completion of Vital’s
largest single development Epworth Eastern. $148m was also converted from
potential developments into committed developments.
All values shown in $m
ABBOTSFORD PRIVATE HOSPITAL
PERTH
PLAYFORD HEALTH HUB STAGE 2
ADELAIDE
BELMONT PRIVATE HOSPITAL
BRISBANE
Development cost
A$18.6
Spend to date
A$14.0
Cost to complete
A$4.6
Forecast Net Return
6.1%
Forecast completion date
Late-22
Development cost
A$39.3
Spend to date
A$5.3
Cost to complete
A$34.0
Forecast Net Return
7.3%
Forecast completion date
Early-24
Development cost
A$22.6
Spend to date
A$10.4
Cost to complete
A$12.2
Forecast Net Return
5.8%
Forecast completion date
Late-22
2
Stabilised yield based on Genesis Care rent in Yr3
1
Excluding fund-through developments
Committed and fund-through developments
32
|
VITAL HEALTHCARE PROPERTY TRUST
In addition, $169m of the fund-through developments have been committed to
4
BOWEN HOSPITAL OT5
WELLINGTON
ORMISTON HOSPITAL STAGE 1
AUCKLAND
CAMPBELLTOWN STAGE 1
SYDNEY
TASMAN MEDICAL CENTRE
HOBART
ENDOSCOPY AUCKLAND
AUCKLAND
GRACE HOSPITAL STAGE 1
TAURANGA
BOULCOTT HOSPITAL
WELLINGTON
ROYSTON HOSPITAL STAGE 2
HASTINGS
Development cost
NZ$6.3
Spend to date
NZ$3.0
Cost to complete
NZ$3.3
Forecast Net Return
5.3%
Forecast completion date
Late-22
Development cost
NZ$37.9
Spend to date
NZ$5.1
Cost to complete
NZ$32.8
Forecast Net Return
5 .1 %
Forecast completion date
Mid-24
Development cost
A$54.4
Spend to date
A$6.1
Cost to complete
A$48.3
Forecast Net Return
4.3%
2
Forecast completion date
Early-24
Development cost
A$98.6
Spend to date
A$9.5
Cost to complete
A$89.1
Forecast Net Return
~4.5%
Forecast completion date
Late-24
WAKEFIELD HOSPITAL STAGE 2
WELLINGTON
Development cost
NZ$91.5
Spend to date
NZ$29.1
Cost to complete
NZ$62.4
Forecast Net Return
5.6%
Forecast completion date
Late-24
Development cost
NZ$22.6
Spend to date
NZ$0.3
Cost to complete
NZ$22.3
Forecast Net Return
5 .1 %
Forecast completion date
Late-23
Development cost
NZ$31.7
Spend to date
NZ$5.5
Cost to complete
NZ$26.2
Forecast Net Return
5.3%
Forecast completion date
Late-23
Development cost
NZ$7.7
Spend to date
NZ$0.0
Cost to complete
NZ$7.7
Forecast Net Return
6.2%
Forecast completion date
TBC
3
Development cost
NZ$6.3
Spend to date
NZ$2.4
Cost to complete
NZ$3.9
Forecast Net Return
5.3%
Forecast completion date
Late-22
3
Subject to receipt of final business case
4
Developments where Vital is funding through the development rather than acting as developer
ANNUAL REPORT
|
33
New and proposed developments
1
Stage 1 Medical Office Building Development Application
lodged in April 2022 and Stage 2 Mental Health
Development Application lodged in June 2022.
Early works have commenced on site at Ormiston
Hospital with Savory Construction to form on
grade carpark and associated infrastructure.
Trade pricing for main contract underway
with Savory engaged on an ECI basis.
The Ormiston Hospital
development's main contractor,
Savoury Construction has
registered the site with the
MATES in Construction
programme which aims to shape
and strengthen connections
on building sites and across
the construction industry to
raise awareness and support
those at risk of suicide.
By encouraging positive wellbeing
and supportive conversations
through on-site training, MATES field
officers who are trained in suicide
intervention, facilitate connections
for those at risk of suicide with the
appropriate professional support.
Development Application lodged in July 2022.
Detailed design phase commenced with procurement
strategy to be determined in late-2022.
Coomera
BRISBANE, QLD
Woolloongabba
SOUTH BRISBANE, QLD
Ormiston
AUCKLAND, NZ
Work is underway to convert ~$196m of strategic land holdings into
income producing properties (including the below).
1
All photos are artist's impressions
34
|
VITAL HEALTHCARE PROPERTY TRUST
Epworth Eastern
MELBOURNE, VIC
Having identified the opportunity within
the Box Hill Health and Education
Precinct to co-locate a public and
private hospital, Epworth Eastern Private
Hospital was constructed in 2005,
consisting of 208 beds, eight operating
theatres, associated radiology,
pathology and consulting suites.
Subsequent expansion of the Epworth Eastern
tower was announced in 2018 responding
to the precinct’s growth requirements.
The Epworth Eastern tower project consists of
14-storey building including five operating
theatres and 63 beds. Construction
was successfully completed throughout
COVID-19 lockdowns with practical
completion reached in March 2022.
The project had a total cost of A$97 million
bringing the total value of the Epworth
Eastern campus to over A$400 million.
Epworth have taken a head lease over all floors
to level 10 with the remaining levels 11-14 to be
leased to individual consulting surgeons.
Further investment and growth opportunities
have been recognised and provisioned
for via the acquisition of an adjacent land
total cost
A$97m
WALE
20.5 years
fully let blended yield
~5.8%
Grace Hospital
TAURANGA, NZ
In late 2020 Vital announced that
it had acquired Grace Hospital.
As part of the acquisition Vital and the
hospital operator (a joint venture between
Evolution Healthcare and Southern Cross
Healthcare) have been undertaking design
and planning to extend the existing facility.
Vital committed to funding masterplanned
works at Grace Hospital over five years from
settlement of the transaction. Stage 1 of the
masterplan works was to complete the fit
out of two cold shell theatres, taking the total
number of operational theatres to 11 and to
improve admission areas and patient flows.
This initial stage has been completed and
will officially open in mid July 2022.
Detailed planning and design for further stages
of Grace Hospital's expansion continue.
The project is forecast to increase the
value of the site by over 25%.
expected completion
Late 2023
project value
$31.7m
yield
5.3%
spend to date
$5.5m
Development case studies
parcel with potential for a 40,000sqm
mixed use development. Master
planning for this site has commenced.
completion
March 2022
ANNUAL REPORT
|
35
Acquisitions
During FY22, Vital acquired five income
producing healthcare properties in
Adelaide, Auckland, Christchurch,
Queenstown and Wellington; all with
significant development potential.
Vital has also acquired development sites in
Melbourne, Auckland, Hobart , and two in Sydney.
1
Includes post 30 June 2022 acquisition of Kawarau Park Health Precinct, Queenstown and excludes transaction costs
~$382m
1
OF ACQUISITIONS
UNDERTAKEN
36
|
VITAL HEALTHCARE PROPERTY TRUST
Kawarau Park Health Precinct
QUEENSTOWN, NZ
WALE underpinned by
hospital lease of 12 years
8.7 years
of leases (by income)
increase by the greater of
market and CPI (uncapped)
~40%
fully let blended yield
~4.5%
1
purchase price
$95m
Arvida Retirement and
Aged Care Facility
(under construction)
Queenstown
Airport
Childcare
Retail 2
Retail 1
Medical Centre
/ Pharmacy
Southern Cross
Hospital
Radiology
Centre of Medical
Excellence
Arvida Group
Country Club
Buildings to be on separate
titles which supports a higher
valuation than if combined
Kawarau Park Health Precinct
Tenants
A newly developed health precinct comprising six tenanted buildings
including Queenstown's only private hospital operated in a joint
venture between Southern Cross Healthcare and Central Lakes Trust.
The hospital includes three operating theatres and 13 inpatient rooms.
Other tenants include nationwide providers such as NZX-listed
Green Cross Health and Pacific Radiology (subsidiary of NZX-listed
Infratil), along with several surgical consulting rooms, childcare
and supporting retail and commercial uses.
Favourable demographics
The hospital is the only private hospital in Queenstown
and Central Otago and the precinct benefits from
Queenstown's favourable demographics.
Development potential
The precinct is situated on over 2.3ha of land and has additional
development potential of at least 2,000sqm of land.
1
Excludes development land of ~$4m
ANNUAL REPORT
|
37
Vital has acquired a 27.6 hectare
site in Campbelltown. The site is
well positioned within the rapidly
growing south-west Sydney
growth corridor and down the
road from the newly redeveloped
Campbelltown Public Hospital.
Campbelltown Health Precinct
will be delivered in stages.
Stage 1
A fund-through development with
GenesisCare to construct a state-
of-the-art Comprehensive Cancer
Centre (CCC) and wellness centre.
Construction for Stage 1 will
commence next week with
completion forecast for Q2 2024.
Stage 2 and 3
The remaining ~2-3 hectares offers a
valuable long term staged precinct
opportunity. Masterplanning for
the precinct is underway and
commercial discussions to anchor
Stage 2 are progressing.
The precinct will deliver a range of
services including mental health, day
surgery and other services such as
specialist consult suites, pharmacy,
psychology and allied services. It is
anticipated that a State Significant
Development Application (SSDA) will
be lodged for Stage 2 in 2023.
New healthcare precinct to be developed
CAMPBELLTOWN, NSW
Camden Rd
Hurley St
Cancer Cancer
CentreCentre
Mental Mental
HealthHealth
Health Health
FacilityFacility
Last large land holding
available in Campbelltown for
healthcare precinct development
38
|
VITAL HEALTHCARE PROPERTY TRUST
Artist’s Impression
Central
Health precinct
Located in the heart of Campbelltown,
~20kms south-west of Liverpool
Close to or in the broader health
precinct that includes Campbelltown
Hospital and Western Sydney
University Medical School
40,000sqm
of potential gross floor area
Up to
ANNUAL REPORT
|
39
Logan Hospital is undergoing a
$540 million expansion to deliver
688 beds by late 2022.
Vital have acquired 17 residential lots in
Meadowbrook co-located with Logan Hospital.
A DA was lodged in March 2022 for 18,347 square
meters of GFA for both public and private health
services to support the growing catchment.
In late June, Vital acquired 3,415 square
metres of vacant land adjoining Ascot
Hospital in Remuera, Auckland for $16m.
Work is underway to expand Vital’s footprint
comprising two existing buildings plus a car
park in this leading healthcare precinct.
Meadowbrook
80 Ascot Ave
QUEENSLAND
AUCKLAND, NZ
The public health services offered include general medical
and a broad range of surgical services including obstetrics,
paediatrics and psychiatry. The hospital is located in
South Brisbane and services a population of >340,000
within one of Queensland’s fastest growing areas.
40
|
VITAL HEALTHCARE PROPERTY TRUST
In July 2022, Vital agreed terms with Nexus
Hospitals to fund-through the development of a new,
purpose-built 8,747 square metre day hospital and
ambulatory care facility in Hobart, Tasmania.
The facility will be known as “Tasman Medical Centre”. Total
costs are expected to be ~A$98m including A$9.5m of land
which Vital acquired in early July 2022. Construction is expected
to complete by the end of 2024. Vital will receive a ~4.5 yield
both during construction and from practical completion.
New development fund-through planned;
Vital’s first asset in Hobart and its only exposure
to Tasmania. The WALE is expected to be 13.3
years from practical completion with annual
rent reviews a mixture of CPI (collar of 2.5%
and cap of 5%) and fixed rent reviews.
In May 2022, Vital acquired a former 60-bed aged
care facility ~7 kilometres from Frankston for ~A$12m.
A process is underway to redevelop this facility.
Tasman Medical Centre
Mt Eliza
HOBART, TAS
MORNINGTON PENINSULA, VIC
Tasman Medical Centre is 100% pre-leased from practical
completion to a mixture of Nexus (60% of rent) and a mix
of healthcare and ancillary tenants. The WALE is expected
to be 13.3 years from practical completion with annual rent
reviews a mixture of CPI (collar of 2.5% and a cap of 5%)
and fixed rent reviews (typically 2.5%). This fund-through is
Vital’s sole investment in Tasmania after previously selling a
small facility in Burnie, Northwest Tasmania in late 2020.
ANNUAL REPORT
|
41
In the second half of FY22, Vital settled its acquisition of the
Hutt Valley Health Hub, a purpose-built seismically resilient
medical office building and out-patient facility for $46.5m.
The existing Hutt Valley Health Hub was completed in late
2019 consistent with the Manager’s focus on developing
and acquiring new and recently constructed buildings.
The property adjoins Vital’s existing asset, Boulcott Hospital,
as well as the main public hospital for the region, Hutt
Hospital. The acquisition has increased Vital’s future expansion
land holding to ~3,200 square metres in the precinct to
meet both public and private healthcare demand.
In February 2022, Vital acquired 4,340
square metres of land in north-west Sydney,
approximately 28 kilometres from the CBD
and adjacent to an existing Vital asset, The
Hills Clinic. The Hills Clinic a specialist mental
health hospital 100% leased to Aurora
Healthcare Australia, Australia’s largest
specialty private mental health provider
with 1,000 beds across 16 facilities.
The acquired land is subject to a leasing pre-
commitment from Aurora enabling expansion
of the existing hospital with additional beds,
group rooms and other facilities. Total
development costs, inclusive of the land, are
expected to be ~$50m and will be rentalised
at an initial yield of ~5%. The expansion lease
is expected to have the same term as the
existing lease which has 25 years remaining
with rent growing annually in line with CPI
and market reviews every 10 years.
Hutt Valley Health Hub
The Hills Clinic
WELLINGTON, NZ
SYDNEY, NSW
42
|
VITAL HEALTHCARE PROPERTY TRUST
In late 2021, Vital acquired the
Tennyson Centre in Adelaide for
~A$93m providing an initial yield of
4.7%. The Tennyson Centre is one of
Adelaide’s leading “Cancer Centres
of Excellence”, comprising high
quality tenants who operate within
the identification, assessment and
treatment of cancer through oncology,
radiotherapy, imaging and consulting
services. Tenants include Nexus, Icon,
Sonic, GenesisCare and Dr Jones &
Partners. Since acquisition, the WALE has
been extended from 2.7 years to 4.5
years with further leasing anticipated.
The transaction included 1,920
square metres of adjoining land
for future development.
This large, modern ambulatory care (maternity) and life
sciences site is located 300 metres from Christchurch Hospital,
New Zealand’s second largest hospital. It was acquired
by Vital for $50.7 million in April 2022 on an initial yield
of ~5.1%. Existing tenants include the Canterbury District
Health Board and life sciences corporate Syft Technologies.
~30% of net lettable area is available for lease and subject
to a 24-month vendor rental underwrite. The building has
a WALE of 8.5 years (including the vendor underwrite).
The acquisition includes 1,600 square metres of
expansion land.
In June, Vital settled the acquisition of the majority of the
land and buildings at 148 Gillies Avenue and 22-24 Kipling
Avenue, Epsom
1
for $22.2 million providing an initial yield
of ~4.75%. Currently, the properties comprise an existing
endoscopy facility and residential units on ~4,000 square
metres of land. The hospital business is jointly owned
by Healthcare Holdings and Evolution Healthcare.
Terms have been agreed to utilise the vacant land at 22 Kipling
Ave and develop a new day surgery and endoscopy facility,
with the existing facility expanding surgery capacity for a total
development cost of ~$21.6 million increasing the property yield
to ~5.1%. The existing buildings have a 20 year WALE and the
new hospital will be pre-leased for 20 years from completion.
68 Saint Asaph StEndoscopy Auckland
The Tennyson
Centre
CHRISTCHURCH, NZAUCKLAND, NZ
ADELAIDE, SA
Gillies Property
Kipling Property
(site now predominantly
cleared for development)
The Tennyson
Centre
Development
Land
1
The balance of the development land remains subject to Overseas Investment Office approval
Skilled asset management has resulted in a
significant WALE extension and progression of
planned development.
ANNUAL REPORT
|
43
Sustainability
NorthWest is on a journey to connect more people
and places with enduring possibilities, rooted in a deep
commitment to a sustainable future. This journey includes
all of the investment platforms it manages including Vital.
NorthWest remains steadfast in our dedication
to drive value for every stakeholder, leading
with our focus on partnering with our tenants as
we work with them to achieve better outcomes
for their patients as sustainably as possible.
By formalising our sustainability commitment, we
will amplify our collective impact - empowering
the growing ambitions of our partners, enabling the
next generation of the workforce, and engaging
in the sustainable evolution of healthcare.
Vital’s sustainability
achievements
In August 2021, Vital released its first sustainability
report. Vital’s achievements against set
targets are on page 46 of this report.
44
|
VITAL HEALTHCARE PROPERTY TRUST
Ehara tāku toa I te toa takitahi,
engari he toa takitini.
My strength is not as an individual,
but as a collective.
Whakataukī
Māori proverb
ANNUAL REPORT
|
45
Vital’s FY22 sustainability targets
and achievements
Continue to improve diversity on
the Board and in Management
1
Women in management 48%.
Angela Bull appointed as Independent
Director to the Vital Board
Focus on mentoring and
career progression
20% of our staff have moved to
new roles or been promoted to the
next level role this year so far
Encourage greater
community involvement
Volunteering policy formalised
providing employees with
two days of paid time off
designated for volunteering
Continue existing
professional development
through the launch of LinkedIn
Learning 2022, in addition to
targeted and general employee
personal development, diversity
equity and inclusion training
provided to all employees,
and personal and professional
coaching through Careerbase
Participate in third-party
assessments through GRESB
and CDP
Vital has submitted to GRESB and CDP
with results expected in Q2 FY23
Improve our CDP score
Vital was one of 5 NZ participants
to improve their scores in 2021.
We are seeking to further improve
this in 2022 capturing initiatives
implemented over FY22
Deploy sustainability initiatives
with key stakeholders
including tenants
• Continued to foster the Strategic
ESG Alliance with Epworth
Healthcare facilitating active
collaboration, information-
sharing, and improved sustainable
outcomes at both the property
and operating levels
• Vital is a member of both the
Green Building Council of Australia
and the New Zealand Green
Building Council. We have pursued
registration of four active and pipeline
development projects including Stage
2 of Playford Health Hub in Adelaide
Continue to progress investigation
of additional solar installations
Vital has undertaken desktop
sustainability audits of all Vital assets
to better understand environmental
impacts and opportunities and has
now commenced level 2 audits for all
landlord-controlled assets. Sustainable
tenant fit-out and tenant sustainability
guides launched and currently
being piloted at nominated assets
Establish baseline
environmental reporting
Underway across energy,
water and waste
Meet distribution guidance
and AFFO target
Upgraded guidance met
Maintain prudent payout ratio
Maintained at ~80%
Continue charitable and
community support programmes
Vital has pledged to a three-year
scholarship programme for the Keystone
Trust in conjunction with the University
of Auckland, with applications
open as at the date of this report
Extend and diversify debt
Debt extended and debt
funders increased
PeoplePracticePlaces
1
As part of wider renewal/recruitment processes.
46
|
VITAL HEALTHCARE PROPERTY TRUST
Sustainability framework
In December 2021, NorthWest released its
first sustainability report covering all of its
operations including Vital which it manages.
As a result, Vital's sustainability framework
has now been updated to align with the
NorthWest framework as outlined below.
NORTHWEST'S
SUSTAINABILITY
FRAMEWORK
Healthy
planet
Deepening our
contribution to a
healthy planet
Inclusive
company
Building for our current
team members as well as
our future employees
• Sustainability governance and team • Sustainability integration into investment processes
• Sustainable financing • Green leases • Reporting and disclosures
Thriving
partners
Preparing lasting tenant spaces
for health and healing
Enablers
Strong
communities
Investing in the
communities we serve
ANNUAL REPORT
|
47
Vitals material matters and
stakeholder engagement
During FY22, management undertook material
matters workshops for key stakeholders.
These workshops were facilitated by an external
consultant, Proxima, and were designed to identify
the key risks for Vital as an entity across all areas of
sustainability. The workshops identified the following:
Low
Medium
Low
High
Critical
MediumCriticalHigh
Community
Health, Safety,
and Wellbeing
Carbon
Disclosures
and Energy
Management
Enabling
Quality Care at
Our Properties
Healthy Building
Certifications
and
Performance
Materials,
Design, & Processes
Fit for Healthcare
Tenancies &
Sustainability
Sustainability
Integration
into Corporate
Processes
Diversity, Equity,
and Inclusion
Employee
Experience
Tenant
Partnership
Experience
Corporate
Governance on
Sustainability
MATERIALITY TO VITAL
MATERIALITY TO STAKEHOLDERS
The above matrix was provided to Vital’s key internal
and external stakeholders to ensure there was
alignment and to elicit any additional discussion points
or focus areas. These stakeholders included:
• Key NorthWest executives notably NorthWest’s
President and Chief Administrative Officer
• Vital’s six largest institutional Unit Holders
• Representatives of retail Unit Holders notably the
CEO of the NZSA and brokers from Forsyth Barr
• Key tenants (New Zealand and Australia)
• Largest debt providers in New Zealand
48
|
VITAL HEALTHCARE PROPERTY TRUST
Tenant engagement and interaction
Tenant engagement survey
Formalising our commitment to provide consistent
interactions and partner to improve our facilities we will
be undertaking a tenant engagement survey with an
ambition to achieve top quartile performance on tenant
Net Promoter Score (NPS) relative to our peers.
Tenant engagement programme
We continue to support and educate our partners about the
benefits of sustainable practices, including during our new
development phases and retrofit activities and are working
with a number of our tenants to formalise ESG strategic
alliances to further enhance our facilities for quality care.
As a region we are supporting the global approach in establishing
working groups locally with our stakeholders. While this will be
driven by the broader business, we will be engaging directly
with our tenants for the sharing of our experiences in the
sustainability space and our journey and ambition to reduce
our carbon emissions in line with our net-zero commitments.
Towards the end of 2022, we aim to host a workshop
with our key tenants with guest speakers and activities
encouraging active engagement in our sustainability efforts.
Strategic tenant alliances and
tenant advisory boards
Vital have established strategic tenant alliances that allow for
the sharing of information and collaboration with our healthcare
partners to identify some of the key opportunities and challenges at
the intersection of healthcare and sustainability. In the Australia and
New Zealand region, NorthWest have entered an ESG alliance
agreement with Epworth Healthcare and Evolution Healthcare to
facilitate active collaboration, information-sharing, and improved
sustainable outcomes at both the property and operating levels.
The alliance’s steering committee’s roles are to identify
opportunities, establish and deliver against shared goals and
targets that are aligned with each organisation’s vision.
We recognise the challenge of establishing a baseline,
tracking and transparently reporting against Scope 3 GHG
emissions in the healthcare sector. Vital will prioritise our
efforts through these strategic alliances to tackle this challenge
in partnership with our healthcare tenant operators.
Vital will seek to further expand these strategic alliances moving
forward with an ambition to identify and address key sector
challenges in the future in partnership with our healthcare tenants.
We are looking to further prioritise and develop our ESG alliance
with Epworth Healthcare and Evolution Healthcare and explore
opportunities to scale up and implement similar ESG alliances
with other key operators such as Healthscope and HealtheCare.
Inaugural tenant forum
Fostering a network of healthcare experts to further deliver
differentiated value to our tenants, we will launch a series of
initiatives to connect our tenants and promote knowledge sharing
across the industry, leveraging our unique position at the intersection
of healthcare and sustainability. Through a multi-pronged
engagement approach, our tenants and other stakeholders can
participate and engage in ways that could offer mutual benefit
and positively impact the healthcare real estate sector as a whole.
Once pandemic complications clear, we plan to convene
select tenant partners on relevant topics in an inaugural forum,
establishing and formalising a network of healthcare experts.
This will further promote idea generation, best practices sharing,
and innovation across the healthcare industry. We will also
expand and formalise our global communication strategy
in order to activate and engage with the network experts.
Topics might include GHG emissions and renewable energy
procurement, energy, water and waste efficiency, community
development, and health and wellbeing initiatives.
Thriving partners
Vital recognises the importance of fostering and strengthening our
relationships with our healthcare tenant partners. Through providing
consistent interactions and prioritising improvements to our facilities
we seek to improve the user experience and provide infrastructure
that allows for our tenants to deliver improved patient outcomes.
ANNUAL REPORT
|
49
Optimising spaces for patient wellness
As the largest NZX-listed landlord of healthcare real estate in
Australia and New Zealand and with a development pipeline of
~NZ$2.1bn, our spaces are designed with our tenants and their
patients needs at the centre. Through intentional design we create
spaces for patient wellness by enhancing the indoor environment
and facilitating connections to the outdoors where possible.
All our properties undergo region-specific indoor air quality
assessments to ensure the facilities meet industry standards and
adopted guidelines (ie Green Star, WELL health and safety ratings).
This ensures that our spaces support quality environments for
patients and other building visitors; maintaining comfort through key
areas such as noise, temperature, humidity and most importantly
protecting against any potential indoor environmental hazards.
In 2022/23, Vital will continue to undertake air quality
testing with 100% of our managed and controlled
properties to be assessed against wellness dimensions,
including air quality and accessibility, with one-third of
these assessments to occur within the reporting year.
50
|
VITAL HEALTHCARE PROPERTY TRUST
During FY22, Vital and NorthWest joined the
New Zealand Green Building Council and
the Green Building Council of Australia.
Membership of these green building councils has provided a
range of benefits including sustainability training for all asset
managers, development managers, facilities managers and
the sustainability team across Australia and New Zealand
in June 2022 (Foundations in Greenstar Performance).
Also during FY22, Vital and NorthWest joined the Property Council
of Australia in addition to its long-standing membership as an
industry leader of the Property Council of New Zealand. NorthWest
employees are regular attendees at property council events in
Australia and New Zealand including the annual conference,
ESG training, market updates and women in property events.
Memberships and
industry leaderships
Women In Property Annual Lunch, NSW
ANNUAL REPORT
|
51
Intentional culture
NorthWest must attract, retain, and
support our talent to ensure sustainable
success in an equitable culture.
NorthWest aspires to create a workforce that reflects the
diverse communities in which it operates. This includes
Australia and New Zealand where Vital is managed.
Inclusive company
FY22 highlights include:
• Regional staff conference held in northern New South Wales.
• Appointment of Angela Bull as an additional Independent
Director on Vital's Board. Angela is a highly experienced
property executive and has served on several boards.
• Diversity Policy established in April to support our focus
on diversity and inclusion including gender equity.
• Parental Leave Policy which grants paid leave to a primary
carer following the birth or adoption of a child.
• Volunteerism Policy established offering all full-time and
part-time employees paid time off to further assist the
communities in which we operate with community and
charitable efforts.
• Regular team social activities for each regional office as well
as Property Council training sessions, sporting activities.
• A range of health and wellbeing benefits being provided for
staff including flu vaccines, executive level health check-ups,
fruit provided in all offices and flexible working arrangements.
Preparing lasting tenant spaces for health and healing.
As a global business, NorthWest creates an inclusive
environment that encourages all people to bring their unique
self and passion to work, allowing them to feel safe in doing so.
52
|
VITAL HEALTHCARE PROPERTY TRUST
Learning and development
Globally, NorthWest has launched access for all permanent
employees to LinkedIn Learning – an online learning experience
platform that offers engaging video content, typically instructional
in nature driving personalised suggestions based on topics of
interest across business, technology-related and professional
development delivered through experts in the field.
Following a successful pilot of Careerbase in 2021, NorthWest
rolled out the personalised learning and development platform
to all permanent and contract staff, including new staff once they
have completed probation. This offer to staff in A/NZ which
gave points to source vendors and activities to build knowledge
and skills aligned to identified personal development needs,
with uptake in courses with the Australian Property Council
to personality diagnostics and 1:1 coaching sessions.
Angela Bull was
appointed as replacement
Independent Director
ANNUAL REPORT
|
53
Cyber security
and upgrades
During the past 12 months,
NorthWest IT has undertaken
five significant initiatives to
harden our cyber security and
protect our digital assets.
The upgrades were in response to new
requirements from our cyber security
insurer and the general increase
in cyber threats from the global
pandemic and the war in Russia.
Firewall fleet upgrade
The upgrade gives us better visibility into
security threats across our offices, and
a more automated tool for ensuring that
all firewalls are up to date and correctly
configured to block cyber threats.
Upgrade to Veeam
We moved our primary backup
infrastructure to the highest-rated
platform in the industry to provide
more recovery options along with
easier and faster recovery options.
54
|
VITAL HEALTHCARE PROPERTY TRUST
Ransomware protection
To ensure a layer of impermeable
data protection against ransomware,
we added WASABI backup solution.
This solution is an immutable backup
store that would be incorruptible by
ransomware. It is a cloud solution and
a third layer of backup replication.
KnowBe4
Knowbe4 is a cyber security training and
testing platform. We use the software to
send out email phishing simulations to
help us identify which of our staff requires
cyber security training. We provide
onboarding cyber security training for
new employees and use Knowbe4 for
testing and quarterly training updates.
Our goal is to ensure that our employees
have the skills to help protect our
organisation against a cyber attack.
Duo MFA
We now use a best-in-class Multi-
Factor Authentication (MFA) platform
called DUO from Cisco for externally
facing services. MFA double checks
each user’s identity so cyber attackers
cannot use lost or compromised
passwords to access our network.
ANNUAL REPORT
|
55
56
|
VITAL HEALTHCARE PROPERTY TRUST
All-staff conference
Our team of healthcare real estate professionals
attended an A/NZ staff conference in Kingscliff,
NSW for three days of learning opportunities,
future-focused workshops and brainstorming,
beach walks and adrenalin pumping exercise,
plus thought-provoking addresses from
both internal and external speakers.
Innovation, ESG and a strong network of personal
relationships will continue to define how NorthWest
does business, underpinned by a dedicated and
capable team leading us into the future.
ANNUAL REPORT
|
57
Career progression
JOEL SMART
SENIOR ANALYST, INVESTMENT AND ASSET
MANAGEMENT, UK REAL ESTATE
LIZ INGRAM
SUSTAINABILITY ASSOCIATE
How many years have you been with NorthWest?
2.5 years. I joined the Auckland office in January 2020,
and transferred to the UK office in April this year.
What attracted you to NorthWest? The opportunity
to learn from great people within a global
company and work on an NZX listed fund.
Where are you located? London, UK.
What has the transition been like to a new country?
There’s been a bit more rain than the ‘summer’ I’m used to.
What has been the greatest aha moment? A small
clause in an agreement can have a big impact.
What has surprised you? That the fundamentals of real
estate are still similar across very different regions.
What has been the greatest challenge? Learning to
connect with people and build relationships remotely.
What are you thankful for? I’m thankful for the
opportunities I’ve been given to learn and to have job
security when moving to the other side of the world.
What would your advice be for someone looking
for a new opportunity or challenge? Speak up
and let others know what you’re looking for. People
are often willing to help if you reach out to them.
How many years have you been with
NorthWest? 2 years in October.
What attracted you to NorthWest? The team! Team culture
is really important to me because I am with my colleagues for
more hours in a day that I am with my own family. It doesn't
feel like work when you are with your friends all day.
Where are you located? Auckland, New Zealand.
What has the transition been like to your new role?
Eyeopening! I didn't realise how passionate I was or how
invigorated I am by the sustainability space until I made
the leap. Having encouragement from great mentors
within the team has also made the change easier.
What has been the greatest aha moment? Realising
how intertwined ESG is across every area of our
business. Also realising the privilege of being part a
team that can help facilitate initiatives that will have a
positive impact on our planet and future generations.
What has surprised you? The amount
of acronyms in the ESG space!!
What has been the greatest challenge?
Relinquishing the parts of my old role that I loved.
What are you thankful for? The opportunity to transition
to a completely different role with a global reach,
while maintaining relationships with the local team.
What would your advice be for someone looking
for a new opportunity or challenge? Take the leap
and do it! I have no regrets and love what I do.
There has been significant growth within the team,
with an increase in headcount from 45 in January to
61 in July 2022 across all areas; finance, corporate
support, development and asset management teams.
A focus of 2022 has been to identify and further support
enhanced development and growth opportunities including
promotions and new roles for those at NorthWest with further
potential. This included identifying talent for new roles, extending
the scope of roles or identifying opportunities for talent to work
in other global offices. 20% of our staff have moved to new
roles or been promoted to the next level role this year so far.
58
|
VITAL HEALTHCARE PROPERTY TRUST
GEORGIE HUXLEY
VICE PRESIDENT, LEASING
CLARE SOLOMON
VICE PRESIDENT, SUSTAINABILITY AND
DEVELOPMENT
How many years have you been with
NorthWest? 5 years at the end of this year.
What attracted you to NorthWest? The people! Even though
it was only a team of four at the time. I could tell it was a
great work environment, with people who genuinely cared,
both about their work but also about each other. We all still
work here today! I also felt huge alignment with the social
infrastructure nature of our properties and the sense that we are
giving back to the community through our product delivery.
Where are you located? Melbourne, Australia.
What has the transition been like leading a new function?
Change is always an adjustment. I was lucky in that I was
already doing quite a bit of strategic leasing as part of my
previous role – a quasi trial run of the new job! The most
challenging part is probably having to navigate priorities
as we have so many large scale projects on the go.
What has been the greatest aha moment? I’d be lying if
I didn’t acknowledge that each day brings a new learning.
With healthcare real estate, you are naturally entwined
with the success of your partner operators’ businesses. It’s
important to keep on top of pressures and challenges that
your operators may be facing, whether that be at a workforce
level, competition, technological or economic factors.
What has surprised you? Not exactly work related
but the standout of the last 2 years to me has been
the resilience of the healthcare sector, in particular
the front line workers. Just outstanding.
What has been the greatest challenge? Starting in a new
role and not being able to travel was quite difficult. I always
prefer to meet in person if possible as it’s a great way to get
to know people and understand them both professionally
and personally which is so important. Delivering Stage 1
of Playford Health Hub completely remotely and hitting
practical completion without having stepped foot onsite
during construction was a huge effort from the team.
What are you thankful for? The team. The leasing environment
can be very fast paced and a rollercoaster of emotions sometimes.
It’s the team that sits behind and alongside me that helps ride
the wave, support the vision and ultimately deliver the projects.
What would your advice be for someone looking
for a new opportunity or challenge? Say yes to the
challenges. Push yourself out of your comfort zone.
You never know how much you might enjoy it.
How many years have you been with
NorthWest? Just over 8 years.
What attracted you to NorthWest? Since commencing
my career in development I have been fortunate enough
to work in the health and aged care sector. It is an
incredibly rewarding sector to be in with opportunity
to deliver infrastructure that can directly impact and
improve patient outcomes and the health of the broader
community. NorthWest commitment, vision and ambition
in this sector is what attracted me initially to NorthWest.
Where are you located? Melbourne, Australia.
What has the transition been like to your new role? My
transition indirectly commenced prior to formalisation of
the appointment of my new role through my involvement
with the global team in the development of the NorthWest
Sustainability framework, strategy and commitments
released at the end of 2021. My involvement in this, under
the guidance of Boston Consulting Group has allowed me
to make a smooth transition into my new role, grounded
with enthusiasm to deliver against our ESG strategy.
What has been the greatest aha moment? To be
successful and drive change ESG must be integrated
into our core business strategy – every member of
every part of our business has a role to play!
What has been the greatest challenge? I don’t think I
have faced my greatest challenge in my new role – but
it is coming! Realising the opportunities where healthcare
and sustainability meet is both exciting and challenging
with a portfolio that is heavily reliant of combatting scope
three emissions in a challenged sector! This is an exciting
challenge that I look forward to partnering with our
tenant operators and industry experts moving forward!
What are you thankful for? The commitment NorthWest and
particularly the Global Leadership Team have to realising
the vision and ambition for the business and the critical role
ESG has to play in achieving this vision moving forward.
ANNUAL REPORT
|
59
Indigenous workgroup
and RAP initiative
New spaces for our growing team
Sydney office
We are proud to announce the opening of our Sydney
office at 285 George Street, Brookfield Place.
Designed by award-winning Hammond Studio, the interior of the Peapes
Building offers a contemporary and highly functional transformation
of a heritage building. The Sydney team selected the artwork together
from Artbank, including a highly notable Ginger Riley painting. Through
the partnership with Artbank, the office is providing direct support
to Australian contemporary artists and are promoting the value of
Australian contemporary art to our visitors as they join our space.
Together we create value though
people, place and community and this
extends to our first placemakers – the
First National people of Australia,
and Māori in New Zealand.
With this in mind an indigenous workgroup has
been created to lift our focus and commit our
good intention to improved actions in 2022.
We have committed to two priorities; deliver
online training for all our staff in A/NZ to
ensure a baseline understanding of indigenous
matters across Māori, Aboriginal and Torres
Strait Islander cultures and the development
of a Reconciliation Action Plan (RAP).
These two priorities, together with sponsorship
of our indigenous workgroup by our leadership
team help us to focus and start our journey
of reconciliation with the intention in the
medium term we will go deeper and focus
on improved outcomes in the health industry
as well as partners with other like minded
organisations to continue to advance and learn.
In April, the Auckland team joined Ngarimu
Blair of Ngati Whatua ki Tāmaki for an
insightful Walking Wānanga (guided walk)
to gain a deeper understanding of Tāmaki
Makaurau (Auckland) and Māori history.
Just as we engage our tenants, we engage our people to
ensure their needs are met and their voices are heard.
Our employees’ positive experiences as part of the NorthWest team
strengthen who we are as an organisation and the values that drive
us forward. With a need now more than ever to attract and retain top
talent, as well as creating space for the growing team across the A/NZ
region, Sydney and Auckland offices have moved into new offices.
60
|
VITAL HEALTHCARE PROPERTY TRUST
Auckland office
NorthWest opened a new Auckland office
in the Commercial Bay precinct at the
start of 2022 with the goal of creating
a collaborative space conducive to the
approach we bring to our stakeholders.
Chosen for its alignment with NorthWest’s ESG
strategy, the building boasts initiatives such as
worm farms, low energy fittings and group wellness
classes for tenant use. Designed with a focus on
sustainability, people and place the new office
appoints art curated purposefully with local New
Zealand artists, including works by Bill Hammond
to its both functional breakout spaces and open
plan areas used for celebrating NorthWest’s
successes. The office incorporates considered
design such as recycling the existing concrete slab,
grinding and polishing as needed and locally
sourced products and suppliers where possible.
ANNUAL REPORT
|
61
Strong communities
We are committed to enhancing the communities where we
operate by sharing our time, research and resources and
amplifying the healthcare objectives of our partners. Giving
back to our communities is ingrained in who we are and we
align our community investment efforts to those of our tenants.
62
|
VITAL HEALTHCARE PROPERTY TRUST
Building on our existing support
and sponsorship of the Keystone
New Zealand Property Education
Trust, Vital has committed to
a three year Key Scholarship
Partner programme through an
annual scholarship, mentoring
and support to a student from
the University of Auckland.
The Keystone Trust provides education
and career support for students with
financial and circumstantial needs who
are working towards a qualification in
the property and construction sectors.
Keystone Trust
NorthWest supports
five key international
days including
• International Womens Day
• World Health Day
• Earth Day
• World Mental Health Day
• Human Rights Day
ANNUAL REPORT
|
63
To strengthen the places where we operate, Vital and NorthWest partners
with our tenants and local communities through charitable giving, working
with organisations to improve the social determinants of health in our
communities and supporting our communities during times of crisis.
Charitable giving
and community
involvement
Contributed to form the NorthWest
REIT International Policy Network
Investing in healthcare research
At the NorthWest group level, one of our 2022
sustainability initiatives is to support research into
the response of healthcare systems in pandemics.
NorthWest has pledged a contribution of C$5m over five
years to form the NorthWest REIT International Policy Network.
As part of this initiative, the University of Toronto, will work
with its first partners, the University of Melbourne School of
Population and Global Health and the University of Sydney
School of Public Health, to examine pressing issues in health
policy and health systems in Canada and Australia.
“This gift will provide a strong foundation for
better healthcare systems here and around
the world. The NorthWest International Policy
Network will provide invaluable opportunities
to learn what works best to create sustainable
and high-performing healthcare systems.”
Adalsteinn Brown
Dean and Professor
at the University of Toronto
Dalla Lana School of Public Health
C$5m
64
|
VITAL HEALTHCARE PROPERTY TRUST
Donations totaling in excess of ~$60,000
1
were made to various charities and
community organisations over the course
of the year. Some of these include:
A$10,000 +
A$5,000 +
Donated to
St Vincent de Paul Society
Donated to Baby Give Back
A$7,230
Beyond Blue
A$8,900
Epworth Medical Foundation
NZ$15,000
Mercy Hospice Auckland
NZ$3,840
Mental Health Foundation of NZ
NZ$3,000
Starship Foundation
NZ$2,600
Te Kura Kaupapa
Māori o Hoani Waititi
QLD and NSW flood donations
Many individuals and communities were
affected by the devastating floods in New
South Wales and Queensland this year.
The damage and destruction that they faced
is unprecedented and recovery efforts will
take years of support and hard work.
NorthWest committed to supporting the flood-affected
communities and donated A$5,000 over and above
any by NorthWest staff donations which it also matched
dollar for dollar. We partnered with St. Vincent’s
Health Australia and Vinnies Australia to maximise
donations. St Vincent’s Health pledged to dollar match
any contributions made by their staff or the public via
the St. Vincent’s Health Australia Flood Appeal.
Baby Give Back
CEO and founder of Queensland charity
Baby Give Back, Carly Fradgley, addressed
the team at the A/NZ staff conference,
on the important work they do in the local
communities of south-east Queensland to
support vulnerable babies, children and
families by recycling essential children’s items.
The work Carly and her team do is a timely reminder of
the value in sustainable re-use, alongside the immense
impact sustainable re-use can have for people in need.
1
Figure does not include the C$5m donated to research in healthcare
ANNUAL REPORT
|
65
Asset management and
standing assets
As a leader in healthcare real estate, NorthWest
supports our tenants by collaborating with them on ways
to reduce the environmental impact of their operations
and continues to pilot and test innovative ideas at the
intersection of healthcare and sustainability.
Green Star training
All asset managers, property managers and development
managers have undertaken Green Star - Foundations
training demonstrating our commitment to improve our
capabilities and our approach to reducing the environmental
impact of our properties and development projects.
Green Star Performance
We have undertaken Green Star - Performance v1.2 (Energy
and water) ratings on across the Vital portfolio and are
exploring opportunities for Green Star certification on a
number of the landlord-controlled assets within the portfolio.
Healthy planet
Vital recognises the importance of minimising our impact on
the planet and are committed to further bringing sustainability
into the core of our business including our approach to asset
management, development and precincts.
Commitment to building audits
Following desktop audits for all assets, we have now
commenced level 1 and level 2 analysis providing detailed
energy calculations with the added financial analysis of
proposed energy measures for each site which will assist in
determining a targeted roadmap for delivering on sustainable
business initiatives at an individual property level.
Sustainable fitout guide
As a trusted partner to healthcare operators, we are working
with industry experts and collaborating with our tenants to
create a sector appropriate sustainability guideline. This
will provide a reference for our healthcare operators to
reduce and manage resources through sustainable materials,
processes, and design. This is currently being piloted
and will be extended to all tenants moving forward.
The tenant sustainability guide includes topics such as:
• connectivity to communities and public transportation
• fit-out/renovations recommendation as appropriate
• best practices for the management and reduction of energy
and water consumption as well as waste production
• additional building processes promoting
a healthy indoor environment
66
|
VITAL HEALTHCARE PROPERTY TRUST
Development
In line with this goal and our sustainability strategy, these
Ecologically Sustainable Development (ESD) guidelines have
been developed to ensure that all new developments and major
redevelopments have a consistent reference for embedding ESD
principles and initiatives into projects. The guidelines support
various scales of developments and provide a framework that
facilitates improved outcomes and opportunities for us to pursue
certified sustainability ratings aligned with industry leadership.
The following key ESD priorities are prioritised across all projects:
• Net-zero emissions: In line with international and national
commitments, net-zero emissions are a priority to mitigate the
impacts of climate change. All new projects must be net-zero
emissions ready and enable a transition to 100% renewable
energy powered buildings, with zero onsite fossil fuels.
• Embodied emissions and life cycle assessments:
Embodied carbon emissions are a significant driver
of increasing greenhouse gas (GHG) emissions and
reducing upfront carbon emissions is a key requirement
for all new building projects and redevelopments.
• Health and wellbeing: To improve health and wellbeing,
prioritise wellness factors and reduce environmental
impacts, sustainable and healthy designs and sustainably
procured building materials will be incorporated on all
projects where possible, including increased daylight,
improved fresh air provisions and sustainable materials.
• Climate resilience: All projects must be climate resilient
with climate change risks identified and design responses
incorporated that mitigate and adapt to a changing climate.
• Certified outcomes: To demonstrate leadership, ensure
transparency, and celebrate sustainability initiatives, all
major projects will achieve a certified rating. This includes
building and community certifications for major developments
and performance ratings for existing assets. The guidelines
incorporate a range of ESD requirements and best practice
provisions to embed ESD into developments and enable
a holistic approach for projects to improve environmental,
social and economic performance. The guidelines have
been structured to provide minimum ESD requirements
that all projects must incorporate and a number of flexible
pathways for projects to achieve a certified rating.
Renewable energy
We are currently exploring sustainability opportunities
within the Vital portfolio by undertaking detailed energy
audits to explore opportunities for installation of solar,
thermal storage, electrification, current equipment
efficiency calculations and other sustainable outcomes.
Stage 1 of this process includes assets within the portfolio
that are landlord-controlled, enabling us to formulate a
sustainability roadmap to carbon neutrality at an individual
asset level. Stage 2 expands this out to the remainder of the
portfolio, to assist providing our parnters with sustainable
opportunities, working together to become carbon neutral.
Vital have further partnered with Veolia to create an energy
dashboard for the purpose of automating the collection of data into
a centralised database. The system has been created to collect,
track, compare and report Vital’s emissions usage in real time.
In line with this approach, the following sites are currently
undergoing energy audits, and are part of our pilot
programme with the new hubgrade dashboard system:
• Tennyson Centre
• 120 Thames St
• Playford Health Hub
• Ormiston Hospital
• Mons Road Medical Centre
• Epworth Eastern Medical Centre
• Ekera Medical Centre
• Ascot Hospital
• Ascot Central
• Apollo Health and Wellness Centre
• Hutt Valley Health Hub
The hubgrade system is designed to capture utility data including
already installed solar energy, giving us the ability to accurately
report on our green energy production. We are currently in the
process of installing solar on a number of our assets to expand to
the production of green energy across our portfolio. Sites with solar
PV include the South Eastern Private Hospital, Maitland Private
Hospital, Tennyson Centre, Epworth Eastern Hospital, Lingard Day
Centre and Lingard Private Hospital, The Hills Clinic, Abbotsford
Private Hospital, Hurstville Private Hospital, Ekera Medical Centre,
Sportsmed (hospital, clinic and consulting suites), Palm Beach
Currumbin Clinics, Eden Rehabilitation and Belmont Private Hospital.
ANNUAL REPORT
|
67
Net-zero carbon
Understanding our climate risks
Certifications for
sustainable excellence
We recognise the growing need to do more for our planet and
are committed to achieving net-zero carbon emissions by 2050,
with a focus over the next 18 months on establishing a roadmap
for for a science-based interim 2030 reduction target.
Through the comprehensive energy audits currently underway, we can establish
a prioritisation roadmap to identify a variety of energy efficiency programmes
which will inform our strategy to reach our net-zero ambition by 2050.
Our efforts over the next 18 months include setting a short-term
emissions and 100% renewable energy target, and exploring
opportunities to phase out fossil fuels from our existing portfolio.
We understand that emissions from our partners and tenants (Scope
3 emissions) are a significant portion of our carbon footprint and and
we will continue to work with our tenants to improve energy and water
efficiencies and increase renewable energy procurement where possible.
ESD guidelines set out stringent requirements for all new
developments to permit net-zero carbon operation and minimise
upfront emissions from the design construction process.
Physical climate risks such as drought, wildfires, flooding, earthquakes
and rising sea levels have the potential to pose major threat to our
portfolio. By understanding and pre-empting these physical climate risks
across all our assets, we can ensure we have a resilient portfolio.
Through Measurabl, we have undertaken risk assessments of each
asset and are analysing the results to identify which buildings are
facing the greatest risk to help us recognise the impact climate change
will have across the portfolio. Following this analysis, we will establish
a framework of measures to take preventative action to ensure the
portfolio is resilient to climate change and our healthcare providers are
not impacted during a time of crisis when they are needed most.
Vital and NorthWest continue to pursue opportunities that enhance the
experience for our tenants and their patients, through the integration of
sustainability practices into our existing facilities and new developments.
In an explicit effort to demonstrate our commitment to sustainability as well as
ensure long-term value creation for our stakeholders, we will have undertaken
Green Star – Performance certifications across the Vital portfolio and will
review and identify opportunities for enhancements and retrofits to improve
certification levels. We are also exploring other certifications such as NABERS,
Energy Star and WELL, among others relevant to each property and location.
For our new developments, we integrate certification considerations into our
processes where applicable and have registered the below development
projects for Green Star – Design & As Built certifications: Coomera Health
Precinct, Logan Private Hospital and Playford Health Hub Medical Precinct.
68
|
VITAL HEALTHCARE PROPERTY TRUST
Seismic resilience
As part of the recent lease extension to the Hawkes Bay DHB, management
agreed to upgrade the seismic resilience of the Napier Health Centre
to >67%NBS in line with the government’s strategy to house their
workers in well performing buildings. In coordination with the DHB,
the build methodology proposed excludes excessive odour and noise
producing activities and ensures full and continual care is provided to
Hawkes Bay patients throughout the 10-month programme of works.
Design and procurement is now complete to improve the NBS rating
of the Apollo Health and Wellness Centre with work to progress
in Q1FY23. Work to create sliding structural connections between
levels 2 and 3 of the centre is isolated to the 4x stairwells on site and
will not impact our tenant’s ability to provide care to patients.
Vital has committed to carrying out seismic strengthening of 68 Saint
Asaph St to achieve a 100% IL3 rating, which is designed for a 1/1000
year event. This is in line with the DHB requirements for the seismic rating
of any buildings they occupy and will provide safety and continuity
for our healthcare tenants. The design works to achieve this rating are
underway with work expected to commence in the last quarter of 2022.
WAKEFIELD HOSPITAL
WELLINGTON
NAPIER HEALTH CENTRE
HAWKE'S BAY
APOLLO HEALTH & WELLNESS CENTRE
AUCKLAND
68 SAINT ASAPH STREET
CHRISTCHURCH
ANNUAL REPORT
|
69
Hutt Valley Health Hub, Wellington, NZ
CASE STUDY
Hutt Valley Health Hub is a near new, purpose built
medical office building located immediately adjacent to
Vital’s existing Boulcott Hospital and the region’s Public
Hospital – Hutt Hospital.
The safety of the staff and patients onsite
is of critical importance to Vital, and
we also understand the importance that
these community services can have in the
recovery of a seismic event. Hutt Valley
Health Hub was designed and constructed
to meet importance level 4 (IL4), which
is a very high level of seismic resilience,
almost 2x the minimum code requirements.
The building itself is located close to
several bus stops and within 10 minutes
walking distance of the Epuni train station.
Finalist in the 2022
Property Council Property
Industry Awards
70
|
VITAL HEALTHCARE PROPERTY TRUST
Kawarau Park, Queenstown, NZ
CASE STUDY
Natural
light
Insulation unbridged
warm roof
Thermally broken
window joinery
LVL framing
Optional natural
ventilation in ward rooms
Utilisied local labour
during construction
Predominantly native
and resilient planting
Local materials, NZ
manufactured products
The hospital operated by Southern Cross aims to create an
environment where wellness is at the foundation of the patient
experience. It has been designed to set a new benchmark for
energy use in New Zealand for both public and private hospitals.
The Hospital
Kawarau Park Precinct
Patients and visitors alike are immersed in sustainable
design in this facility. From high levels of insulation
throughout, maximised use of natural light and
the choice of natural ventilation in ward rooms
occupants receive the benefit of wellness-in-design
while simultaneously maintaining control standards
expected of a medical facility. Building system
technology addresses regulation of traditional
boiler usage in cooler months in favour of more
efficient heatpump systems to warm the facility,
in addition to control of daylight and CO2 to
ensure energy is only consumed where required.
Construction of a health precinct enables patients to attend to a set of
harmonised specialists in one location, minimising time spent traveling to
receive care. Each building within the Kawarau Park Health Hub features NZ
manufactured building products and utilised local labour in its construction.
The precinct grounds feature native planting and overall design reflects the
surroundings to minimise the visual impact of the site on the community.
Southern Cross Central Lakes Hospital designed
by Warren and Mahoney Architects is shortlisted
in the Southern Architecture Awards 2022
ANNUAL REPORT
|
71
Enablers
We must evolve our ways of working and ensure the integration
of sustainability throughout our operations, strategy and
decision-making to deliver on our sustainability commitments for
our healthcare tenants, Unit Holders and broader stakeholders.
72
|
VITAL HEALTHCARE PROPERTY TRUST
A sustainability governance model has been adopted
to lead and oversee the effective execution of our
sustainability efforts in order to drive accountability
throughout NorthWest. We recognise that effective
sustainability governance requires executive and Board-
level oversight, leadership, strong central support, and
integration into lines of business to effectively achieve
our goals. In 2021, we established a sustainability
committee to guide progress towards our ambition.
The committee regularly engages with the Board of
Trustees on priority topics including sustainability risks
and opportunities, targets, and alignment to our overall
organisational strategy and vision. We have established
working groups to convene relevant cross-functional
stakeholders to coordinate and drive the implementation
of our sustainability initiatives, and facilitate sharing
of best practices across our global organisation.
Governance and team
ESG and the
investment process
Green leases
We are committed to integrating sustainability
across the building lifecycle, including our investment
process, enabling us to support our commitments
in achieving net-zero and providing high-quality
spaces for our healthcare tenant partners.
As part of our current acquisition due diligence process,
we already include select sustainability dimensions that
align to GRESB guidelines, such as building safety, land
contamination, compliance, energy supply, flooding,
infrastructure and water supply. We will continue to integrate
sustainability into our standard investment process by
using Moody’s Four Twenty Seven modelling software to
measure the physical climate risks of each acquisition target
through Measurabl. This process will allow us to mitigate
risks that could impact the long-term value of our portfolio.
NorthWest have committed to embed a green lease
clause within all new leases in recognition of the
importance of having the right mechanisms in place to
ensure we are able to measure the environmental impact
of our buildings and tenants, but also guide tenants
towards taking a more sustainable approach to their
operations and initial fit-out. The green lease clause
should be in all new leases going forward and all tenants
will receive a copy of the landlords fit-out guide.
ANNUAL REPORT
|
73
Executive Sustainability Committee
Board of Trustees
Sustainability
Governance Structure
Global Leadership Team
Working Groups
Head of Sustainability
Chief Administrative
Officer
(Canada)
Managing Director
(Europe)
President and
Managing Director
(ANZ)
Managing Director
(Americas)
• Review of existing documentation, including
the outputs of internal workshops and climate
risk management-related documents
• Review of existing process for identifying and assessing climate-
related risks, including methodology for identifying and assessing
scope, size and impact, time horizons, value chain stages
• Identify processes for managing climate-related risks
• Full gap analysis completed
• Roadmap for achieving CRD
compliance delivered
Reporting and disclosures
• Review of existing documents, process, and
policies for climate risk accountability
• Board’s oversight of climate related risks and opportunities
• Management’s role on assessing and managing
climate-related risks and opportunities
• Choice of cross-industry metrics & consistency
with XRB’s climate-related metric categories
• Relevance and rationale for choice of industry-specific metrics
(as defined by XRB), and any other performance indicators
• Description and rationale for target and process for GHG
report compliance (considering 3rd-party assurance
over inventory and its link to the XRB CRD report)
Governance documentation review and gap analysisTargets and metrics – documentation review and gap analysis
Risk management and strategy – documentation
review and gap analysis
Final CRD recommendations
and roadmap
SEPTEMBERNOVEMBER
OCTOBERDECEMBER
FY22
DISCOVERSTRATEGISE
DEFINEDELIVER
TCFD Framework
Vital is required to provide Climate-related disclosures under Financial Sector
(Climate-related Disclosures and Other Matters) Amendment Act 2021 with the
first report likely to be required for the year ended 30 June 2024. The External
Reporting Board (XRB) is currently developing the Aotearoa New Zealand
Climate Standards that will apply to this reporting. We have engaged Deloitte
to provide gap analysis activities based on current exposure drafts of the
standards to assist us in our development of a roadmap for compliance that is
informed by market experts and understood by our Board and executive team.
Through our partnership with Measurabl and the integration with Moody’s Four
Twenty Seven modelling software, we have measured the physical climate risks
of each of our assets which will form part of our strategy to implement various
sustainability initiatives and manage our climate risks and opportunities.
The below timeline outlines our objectives which will support the rapid
adoption of TCFD, in line with our reporting capabilities and expectations.
74
|
VITAL HEALTHCARE PROPERTY TRUST
• Undertake portfolio climate risk stress testing
(physical and transition risks)
• Generate physical risk heat mapping
• Test portfolios for emissions intensity
• Draft CRD ready to
present to Board
• Present key findings of gap analysis and the road map
for CRD compliance to the Board and executive team
• Identify options for strengthening portfolio resilience
• Identify options for decarbonising portfolios
Report to Vital BoardAdaptation and transition planning
Portfolio stress tests
FEBRUARYNOVEMBER
JUNEAPRIL
FY23FY24
DISCOVERSTRATEGISE
DEFINEDELIVER
GHG emissions tracking, GRESB & CDP
As part of our GHG emissions tracking, NorthWest and Vital have
participated in the Global Real Estate Sustainability Benchmark (GRESB)
survey and will disclose our score in Q2 FY23. Alongside increased efforts
to track environmental and social data, we have also incorporated GRESB
management guidelines into our corporate processes and policies.
Vital has also participated in the Carbon Disclosure Project (CDP) as a
commitment to tracking Scope 1 and Scope 2 emissions in line with GHG
Protocol definitions. By understanding our complete carbon footprint we can
identify ways to actively reduce our emissions, positioning us to reach our
net-zero goals. We will publicly release our CDP score later this year.
ANNUAL REPORT
|
75
Graham Stuart
Independent Chair and
Member of the Audit Committee
(65, Auckland)
Graham Stuart is an experienced corporate
Director with an established track record of
performance in governance and in prior executive
roles. He is currently the Independent Chairman
of EROAD Limited and an Independent Director
and Chair of the Audit Committee at Tower, and
an Independent Director of Metro Performance
Glass. He served for 7 years as the Chief Executive
Officer of Sealord Group and prior to that was
Director, Strategy and Growth and Chief Financial
Officer of Fonterra Co-operative Group.
Graham is a Fellow of Chartered Accountants
Australia & New Zealand (CAANZ). Graham has
a Masters of Science from Massachusetts Institute
of Technology and a Bachelor of Commerce with
first class honours from the University of Otago
Paul Dalla Lana
Director and Member
of the Audit Committee
(56, Toronto)
Paul Dalla Lana is the founder and Chief
Executive Officer of NorthWest Healthcare
Properties REIT – the 100% owner of NorthWest
Healthcare Properties Management Limited,
the Manager of Vital Healthcare Property Trust.
Over the past 25 years, Paul has led NorthWest
in the acquisition and development of over $7.0
billion worth of real estate transactions, with a
significant focus on healthcare properties.
Prior to founding NorthWest, Paul was a
professional in the Real Estate Capital Markets
Group of Citibank, N.A. and an economist with
B.C. Central Credit Union. Paul received his BA
(Economics) and his MBA (Finance and Real
Estate) from The University of British Columbia.
Paul serves as Chairman of the Board of NorthWest
Healthcare Properties REIT. Additionally, he is
actively involved in addressing public health and
education issues in Canada and around the world.
He is an Advisory Board member of the Dalla Lana
School of Public Health and on the President’s
Advisory Council at the University of Toronto.
Angela Bull
Independent Director and
Member of the Audit Committee
(47, Auckland)
Angela Bull is the Chief Executive of Tramco
Group, a large New Zealand owned property
investment company which specialises in large
scale land holdings, notably the Viaduct Harbour
precinct in Auckland and Wairakei Estate in
the Waikato. She holds a Bachelor of Laws
and a Bachelor of Arts (Political Science) and
practised property and environmental law prior
to her executive career. Previously, Angela held a
number of senior positions over a 10-year period
with Foodstuffs Auckland and Foodstuffs North
Island Ltd, most recently being General Manager
Property Development for Foodstuffs North Island.
Angela is an independent director of the Real
Estate Institute of New Zealand, realestate.co.nz,
Foodstuffs South Island Ltd and Foodstuffs NZ Ltd.
Our Board
The Board (as at the date of this report) comprises five highly qualified
directors; three of whom are independent. Both the Chair of the Board
and the Chair of the Audit Committee are independent directors.
76
|
VITAL HEALTHCARE PROPERTY TRUST
Directors are based in Auckland, Toronto, Sydney
and Melbourne. Their current and prior executive
experience includes healthcare, property and finance.
Andrew Evans
Independent Director and Member
of the Audit Committee
(58, Auckland)
Andrew Evans has over 25 years’ experience in
commercial real estate and asset management,
previously holding executive positions in listed
and unlisted real estate investment businesses.
Andrew is Chairperson of Accessible Properties
NZ Limited and Infinity Investment Group
Holdings Limited, is a Director of Holmes
Group Limited, Holmes GP Fire Limited and
Trust Investments Management Limited, and is
a former director of Argosy Property Limited.
In addition, Andrew is a past National President
of the Property Council of New Zealand, a fellow
of the New Zealand Property Institute, and a
government appointee to the Land Valuation
Tribunal (Waikato No.1). He is a Chartered
Fellow of the Institute of Directors of New Zealand
and is on the Auckland Branch Committee.
Andrew has a Bachelor of Business Studies and
MBA (with distinctions) from Massey University and
a Diploma in Finance from Auckland University.
Dr Michael Stanford AM
Independent Director and Chair
of the Audit Committee (63, Melbourne)
Dr Michael Stanford has more than 30 years’
experience in the health sector in either Group
CEO or Board roles. Michael’s current Board
roles include Australian Clinical Labs (ASX:ACL),
Australia’s third largest private pathology provider;
Nucleus Networks, one of the world’s largest Phase
one clinical research organisations, and Diabetes
Australia, a significant Not-for-Profit of which
Michael Is President and Board Chair. Other
Board roles in the last three years have included
Healthscope (ASX:HSO), Australia’s second largest
hospital operator; and Virtus Health (ASX:VRT),
one of the world’s top five providers of Assisted
Reproductive Services.
Michael was the Group CEO of St John of God
Healthcare, Australasia’s third largest private hospital
provider, for 16 years during which time the company
increased revenue fivefold through organic and
M&A growth plus more than A$1 billion greenfield
and brownfield developments. Michael’s other
Managing Director roles included the ASX listed
Australian Hospital Care and two public hospital
Networks in Victoria. Michael holds an MBA from
Macquarie University and Bachelor of Medicine and
Bachelor of Surgery from UNSW. He is a Fellow of
the Australian Institute of Company Directors.
In 2018 Michael was awarded a Member of the
Order of Australia for significant service to the
health sector through executive roles, to tertiary
education and the WA community. In 2010 he
received the WA Citizen of the Year Award –
Industry and Commerce category.
Craig Mitchell
Director and Member of the
Audit Committee (54, Sydney)
Craig Mitchell has more than 20 years'
experience specialising in the property
industry in Australia. His previous roles include
Executive Director and Chief Operating
Officer of Dexus, an ASX top 50 listed REIT.
Craig is President of the NorthWest Group,
having joined in 2018 as CEO of Australia
and New Zealand. He is responsible for funds
management globally including establishment of
new funds, providing strategic direction as part of
the REIT’s global leadership team, and has overall
accountability for the Australian and New Zealand
region, including strategy, performance and leading
the team of over 40 real estate professionals.
Craig has a Master of Business Administration
(Executive) from the Australian Graduate School
of Management, a Bachelor of Commerce
and is a Fellow of CPA Australia. He has
also completed the Advanced Management
Program at Harvard University, Boston
After 15 years on the board of Vital’s
Manager Andrew Evans retired
from the board on 30 June 2022.
ANNUAL REPORT
|
77
Aaron Hockly
Senior Vice President
– New Zealand and Vital Fund Manager
(44, Auckland)
Aaron Hockly returned to New Zealand in 2018
after 17 years in senior management and advisory
roles in Australia. He has an extensive property,
funds management and legal background with
his last role in Australia being the Chief Operating
Officer for Growthpoint Properties Australia.
Growthpoint is a A$4.1bn ASX listed real estate
investment trust with a portfolio of quality office
and industrial properties. At Growthpoint Aaron
had direct management responsibility for strategy,
transaction structuring and execution (property,
debt and equity), reporting and investor relations.
Among other qualifications, Aaron has a Masters
in Applied Finance and a BA/LLB from the
University of Auckland. He is a Fellow of both
Governance New Zealand and the Financial
Services Institute of Australasia (FINSIA).
Aaron currently serves on the board of
Mercy Healthcare (Auckland).
Chris Adams
Executive Director – Projects
(52, Melbourne)
Chris Adams has extensive experience in
the property industry in Australia, New
Zealand and the United Kingdom, including
over 20 years' experience in health sector
property acquisitions, transaction structuring
and large scale hospital development.
Responsibilities with respect to NorthWest include
overseeing development management and
joint responsibility for acquisitions undertaken
by the business. Chris was one of the founding
Executives at Generation Healthcare REIT (now
NorthWest Healthcare Properties Australia REIT).
Prior to joining Generation, Chris established
Vital Health Care’s presence in Australia in
1999 and served as General Manager –
Australia following various roles with the group
in New Zealand. Chris holds a Bachelor
of Property from Auckland University.
Alex Belcastro
Senior Vice President –
Medical Precincts
(34, Sydney)
Alex Belcastro joined the team in April 2021,
prior to which she was the Chief Business
Development Officer at Ramsay Health Care,
where she managed a multi-billion-dollar
portfolio of 73 hospital assets in Australia.
Alex has over 13 years of specialised healthcare
real estate experience across the public and
private sectors, having been involved in over $8b
of hospital, laboratory, and research projects.
Alex holds a Master of Construction Management,
and a Bachelor of Planning and Design
(Property and Construction) from the University
of Melbourne. Alex has undertaken executive
education at Harvard Business School.
Our executive team
Vital’s executive team comprises real estate professionals with
extensive experience in New Zealand, Australia and beyond.
78
|
VITAL HEALTHCARE PROPERTY TRUST
Vanessa Flax
Regional General Counsel
A/NZ and Company Secretary
(51, Melbourne)
Vanessa Flax joined the team on 1 May 2019,
prior to which she was a special counsel at
Ashurst Australia. Vanessa has 25 years of deep
and broad ranging property law experience in
Australia and New Zealand, including acting (for
approximately 15 years) for Vital and NorthWest.
Vanessa's experience covers all aspects of real
property transactions, including acquisitions,
divestments and sales, leasing and Crown leasing,
development transactions and due diligence.
Michael Groth
Chief Financial Officer – A/NZ Region
(48, Melbourne)
Michael Groth is a qualified Chartered
Accountant, has over thirteen years’ experience
in senior finance roles in the listed and unlisted
property funds and funds management industry.
His most recent role has been as the Group Chief
Financial Officer of the Melbourne based and ASX
listed APN Property Group Limited (APN). APN is a
specialist real estate investment manager currently
managing 2 ASX listed and 10 unlisted funds, with
total Funds under Management of A$2.8bn.
Michael has over 5 years’ experience in
healthcare property funds management through
his involvement with Generation Healthcare REIT,
which was in the APN stable of funds before
it was privatised and delisted from the ASX.
Richard Roos
Executive Director – Portfolio
(57, Melbourne)
Richard Roos has over 20 years’ career
experience in commercial real estate financing,
acquisitions and property management, 14 years
of which have been in healthcare real estate.
In his role as Executive Director, Richard is
responsible along with his Melbourne and
Auckland-based teams for the asset management
of the NorthWest Group’s Australian and New
Zealand portfolio, including leasing and tenant
relationships, and joint responsibility for acquisitions
and business development. In particular, Richard’s
strong relationships with healthcare operators
are a crucial element of NorthWest’s success
in sustainability achieving its growth targets.
ANNUAL REPORT
|
79
Corporate governance
Joint Investment Policy
Under the terms of the Joint Investment Policy, which applies to
NWH REIT and its owned and controlled entities (including
the Manager), an Investment Committee has been established
to avoid, manage and resolve actual or perceived conflicts
of interests between members of the NWH REIT group in a
manner which complies with any relevant legal obligations
and is equitable to each party. The Joint Investment Policy
can be found on Vital’s website www.vhpt.co.nz.
The Board of Directors
The role of the Board of Directors is to set the strategic direction of
Vital and to support management in monitoring the delivery of this
against specific performance objectives. The Board also ensures
all business risks are appropriately identified and managed and
compliance with all applicable regulatory, statutory, financial,
health and safety and social responsibilities of the Manager.
Board composition
The Manager is committed to having an effective
Board providing a balance of independent skills,
knowledge, experience and perspectives.
All Directors bring a significant breadth and depth of expertise
and have the composite skills to optimise the financial and
portfolio performance of Vital and returns to Unit Holders.
Attendance at
Board meetings
Attended /
Eligible to attend
Date of appointment
Paul Dalla Lana6/616 January 2012
Andrew Evans
*
6/620 August 2007
Craig Mitchell6/629 June 2021
Michael Stanford6/619 November 2019
Graham Stuart6/612 November 2018
(Appointed Chair
17 November 2020)
Angela Bull1/126 April 2022
*
Retired 30 June 2022
The Board does not impose a restriction on the tenure
of any Director as it considers such a restriction may
lead to the loss of experience and expertise.
The table below shows all relevant interests of Directors
and Officers in units, which include legal and beneficial
interests in Vital units as at 30 June 2022.
DirectorsHoldings (number of
units) non-beneficial
Holdings (number
of units) beneficial
Paul Dalla Lana
1
-17 9 , 415 , 78 8
Andrew Evans78,234686,381
Graham Stuart-50,629
Officers
Aaron Hockly
2
-7 6 , 113
1
Paul Dalla Lana is the founder, Chairman, CEO, Trustee and largest Unit Holder of
NorthWest Healthcare Properties Real Estate Investment Trust (a trust organised under
the laws of Ontario, Canada, Corporation). NorthWest Healthcare Properties Real
Estate Investment Trust directly or indirectly holds approximately 179,415,788 units in
Vital Healthcare Property Trust, in respect of which Mr Dalla Lana is considered to
have a relevant interest.
2
Aaron Hockly makes a voluntary disclosure that members of his immediate family
own an additional 104,777 units in Vital.
Independent Directors
The Manager recognises that Independent Directors are important
in assuring Unit Holders that the Board is properly fulfilling
its role and is diligent in holding management accountable
for its performance. The procedures in place for determining
independence is whether the director is independent of
management and free of any business or other relationship
which might materially interfere with, or might reasonably
be perceived to materially interfere with, the exercise of
their independent judgement. Biographies of each Board
member including their skills, experience and expertise are
included in the Board of Directors section on pages 77-78.
Audit Committee
The Audit Committee is responsible for overseeing
the financial and reporting practices of Vital.
At financial year end and at the date of this report,
the Audit Committee assists the Board in fulfilling its
corporate governance and disclosure responsibilities with
particular reference to financial matters, and internal and
external audit, and is specifically responsible for:
• Recommending to the Board the appointment /
removal of Vital’s external auditor; and
• Reviewing the performance of the external auditor.
Vital Healthcare Property Trust and NorthWest Healthcare Properties Management Limited.
Dated as at 30 June 2022
80
|
VITAL HEALTHCARE PROPERTY TRUST
Attendance at Audit
Committee meetings
Attended /
Eligible to attend
Date of appointment
Paul Dalla Lana4/46 October 2020
Andrew Evans
*
4/414 November 2011
Craig Mitchell4/429 June 2021
Michael Stanford4/46 October 2020
Graham Stuart4/49 May 2019
Angela Bull0/126 April 2022
*
Retired 30 June 2022
Management contract
NorthWest manages Vital in accordance with Vital’s Trust
Deed in return for which NorthWest receives management
fees. From these management fees, NorthWest pays salaries
and other people related costs (including taxes, rent, IT, travel
and training) to its employees approximately 30 of whom are
solely or majority engaged with managing Vital, as well as the
Directors not appointed by all Unit Holders (four at the date of this
report). As a result, the details in this section relate to NorthWest’s
employees rather than Vital’s employees (as there are none).
Remuneration
As noted above, Vital does not have any direct employees.
Instead, NorthWest receives management fees to manage
Vital from which it provides remuneration to employees. As a
result, there is no reporting on individual employee salaries.
Notwithstanding the above, the following is
provided to enhance transparency:
1. Details of the holdings in Vital by Directors and officers as
at 30 June 2022 is provided on the previous page.
2. As at the date of this report, all New Zealand based
Directors and executives own units. Currently the tax
regime for Vital makes it uneconomic for the offshore
based Directors and officers to hold units in Vital.
3. As at the date of this report, Vital’s most senior executive
officer, Fund Manager Aaron Hockly, holds units in Vital
equivalent to more than 50% of his base salary.
4. Details of the costs of Independent Directors appointed
by Unit Holders and, as a result, paid for from Vital are
included in note 22 to the accounts in this report.
5. Over two thirds of the Fund Manager’s annual potential
bonus, and over 1/6th of other key personnel, directly relates
to the performance of Vital. In addition, all NorthWest’s
executive bonuses globally are linked to NorthWest’s unit
price as 100% of these bonuses are paid in NorthWest units.
Vital represents approximately 27% of NorthWest’s assets
under management and 10% of its assets on balance sheet
(accounting for its 26% stake in Vital). As a result, NorthWest
REIT’s investment in Vital is material to the REIT and, accordingly
all executive remuneration is aligned with Vital’s success.
6. The following clawback / malus provisions are included in the
bonus plans for all NorthWest executives globally (including
Vital’s Fund Manager, CFO and other key personnel):
• Where the Participant (i) has been terminated for cause, or
(ii) voluntarily resigns from his or her position with the Trust then
any Deferred Units granted on a discretionary basis pursuant
to Section 7.04 of the NorthWest Healthcare Properties Real
Estate Investment Trust Deferred Unit Plan (2018) which have not
yet vested at the time of the termination for cause or voluntary
resignation, shall be immediately forfeited by such Participant.
Directors’ remuneration
Paid in FY22*
DirectorBase
Audit
Committee
Member
ChairTotal
Andrew Evans
**
Independent Director and
Audit Committee member
NZ$80KNZ$10K-NZ$90K
Angela Bull
Independent Director
and Audit Committee
member
1,3
NZ$90KNZ$10K-NZ$100K
Craig Mitchell
Director and Audit
Committee member
N/A
2
---
Graham Stuart
Independent Director,
Board Chair and Audit
Committee member
NZ$90KNZ$10KNZ$70K
(Board)
NZ$170K
Michael Stanford
Independent Director and
Audit Committee Chair
3
A$90K-A$20K
(Audit
Committee)
A$110K
Paul Dalla Lana
Director and Audit
Committee member
N/A
2
---
Total
NZ$470K
(NZ$260K paid by Unit Holders, and
$210K paid by the Manager)
a) Leasing
Vital pays the Manager leasing fees where the Manager
has negotiated leases instead of or alongside a real
estate agent. Consistent with general market rates, these
fees are charged at 11% of the annual rental for terms
of three years or less (to a minimum of $2,500).
12% of the annual rental for terms of three years, and
12% plus an additional 1% for each year greater
than three years (to a maximum of 20%).
Lease renewals are charged at 50% of a new lease.
*
Fees are pro rata
**
Retired 30 June 2022
1
Appointed 26 April 2022.
2
Executive of NorthWest paid by the Manager. Accordingly, no separate directors’ fees
are payable.
3
Paid by the Manager from management fees. All other amounts listed are paid by the Trust.
ANNUAL REPORT
|
81
Structured rent reviews or market reviews which do not
result in a rental increase are charged an administration
fee of $1,000. Open market reviews are charged at
10% of the rental increase achieved in the first year.
Leasing fees are capitalised to the respective investment or
development property in the Statement of Financial Position
and amortised over the term of the life of the lease.
b) Property management
Vital pays the Manager property management fees
where the Manager acts as the property manager.
Incentive fee
The incentive fee is an amount equal to 10% of the average
annual increase in the Net Tangible Assets of Vital over the
relevant financial year and two preceding financial years
subject to a three year high-water mark. The Manager and
the Supervisor are both entitled to be reimbursed out of the
Trust Fund for all expenses, costs or liabilities incurred by
them respectively in acting as Manager and Supervisor.
Insurance and indemnities
In accordance with the Board Charter, the Manager has
provided insurance and indemnities to its Directors and officers
for any liability / losses arising in respect of actions or omissions
occurring during the normal carrying out of their duties.
Health and safety
The Directors and Manager are committed to ensuring
that as far as practical, a safe and healthy working
environment is provided for all employees, tenants,
contractors and others who may visit our properties.
The Trust’s Health and Safety policy aims to reflect this commitment.
Vital and the Manager have implemented site specific hazard
registers in New Zealand which can be updated in real time and
similar processes apply in Australia. The Manager has implemented
an Operational Risk and Compliance Committee which meets on
a regular basis and a standing agenda item is Health and Safety.
Board diversity and relevant skills
At a Board level, diversity of experience is critical to ensure a
healthy exchange of ideas and opinions to deliver higher quality
decision making and outcomes. All Board appointments are always
based on merit and diversity (including gender and ethnicity).
A majority of the Directors are members of professional
organisations such as the Institute of Directors (or equivalent) or
other industry specific and relevant organisations which support
the ongoing education and training of professional directors.
Healthcare real estate is a specialised sector and the Board
believes it is important to have members with a diverse range
of backgrounds, skills and experience to ensure robust
discussion. It is also important to balance skills and knowledge
gained through length of tenure and the value of fresh ideas
in decision making. The table below summarises the skills,
experience and length of service of the current Board.
Modern slavery
In FY21, the Australian manager of the Vital trusts, NorthWest
Healthcare Australian Property Limited again published a
statement under the Australian Modern Slavery Act 2018,
which underpinned Vital’s philosophical approach and
commitment to ensuring our operations have sufficient risk
mitigation strategies to address supply-chain risks. Vital
committed to training employees to identify these risks.
Our entire organisation has engaged with tenants and suppliers
to conduct further and ongoing due diligence to identity possible
modern slavery supply chain risks. Vital will continue to assess
the potential modern slavery risks in our operations and develop
and review company policies on these possible impacts.
We have also committed to reviewing supplier contracts to ensure
they contain terms consistent with the principles underlying the Act.
Skills & ExperienceGraham
Stuart
Angela
Bull
Paul
Dalla Lana
Andrew
Evans
1
Craig
Mitchell
Michael
Stanford
Accounting/finance/economics ● ● ● ● ● ●•••••
Commercial real estate /asset
management/valuation
•••••
Corporate governance ••••••
Legal / regulatory••••
Healthcare practitioner•
Tenure (years)4<1111513
1
Retired on 30 June 2022
82
|
VITAL HEALTHCARE PROPERTY TRUST
ReferenceRecommendationApproach
Principle 1 – Code of ethical behaviour
1.1
The board should document minimum standards of ethical
behaviour to which the issuer’s directors and employees
are expected to adhere (a code of ethics).
The code of ethics and where to find it should be
communicated to the issuer’s employees. Training should
be provided regularly. The standards may be contained
in a single policy document or more than one policy.
The code of ethics should outline internal reporting procedures
for any breach of ethics, and describe the issuer’s expectations
about behaviour, namely that every director and employee:
a. acts honestly and with personal integrity in all actions;
b. declares conflicts of interest and proactively
advises of any potential conflicts;
c. undertakes proper receipt and use of corporate
information, assets and property;
d. in the case of directors, gives proper
attention to the matters before them;
e. acts honestly and in the best interests of the issuer,
shareholders and stakeholders and as required by law;
f. adheres to any procedures around giving and
receiving gifts (for example, where gifts are given
that are of value in order to influence employees and
directors, such gifts should not be accepted);
g. adheres to any procedures about whistle blowing (for
example, where actions of a whistle blower have complied
with the issuer’s procedures, an issuer should protect and
support them, whether or not action is taken); and
h. manages breaches of the code
In recognition of Vital’s role in the communities in which
we operate, and where our investors live, we continue
to implement and refine policies and practices which
encourage responsible investment practices and
compliance with all legal and regulatory requirements.
All Vital Directors and employees must abide by Vital’s Code of
Conduct and Business Ethics (refreshed in August 2021), which
documents policies on conflicts of interest, fair dealing, compliance
with applicable laws and regulations, maintaining confidentiality of
information, dealing with Vital’s assets and use of Vital’s information.
The Code recognises the importance of a work environment
which actively promotes best practice and does not compromise
business ethics or principles, and the Code’s purpose is to
uphold the highest ethical standards, acting in good faith
and in the best interests of Unit Holders at all times.
Employees, where appropriate, are provided with regular
training, updates and insights in relation to governance.
The Code of Conduct and Business Ethics is supplemented by
a number of other policies including the Joint Investment Policy
and Whistleblower Policy which are available on the website
at https://www.vitalhealthcareproperty.co.nz/governance/.
1.2
An issuer should have a financial product dealing
policy which applies to employees and directors
The Manager’s Directors, officers and employees, their families
and related parties must comply with the Security Trading Policy.
The Manager is committed to ensuring compliance with legal and
regulatory requirements with respect to insider trading and restricted
persons trading. To assist with such compliance, the Manager’s
Security Trading Policy identifies circumstances where directors,
officers and other restricted persons are permitted to trade or are
prohibited from trading units in Vital. Compliance with these policies
is monitored by the Board. In addition, all trading by Directors
and officers of the Manager is required to be reported to NZX
in accordance with the Financial Markets Conduct Act 2013. The
holdings of Directors of the Manager are disclosed on page 80.
Before trading of Vital units a restricted person must get consent
in writing from the Fund Manager or the Chief Financial
Officer of the Manager. Vital has set black-out periods
for directors and staff throughout the year. Also, blackout
periods can be invoked when specific events occur.
Emails are periodically sent to directors and employees
providing information as to the status of the trading
window in relation to the blackout periods.
The Security Trading Policy can be found on Vital’s website at
https://www.vitalhealthcareproperty.co.nz/governance/.
NZX Corporate Governance Code
The NZX Corporate Governance Code (NZX Code) applies to all
issuers of Equity Securities listed on the NZX Main Board. The NZX
Corporate Governance Code does not apply to Vital Healthcare
Properties Trust (Vital), as it is an Issuer of Fund Securities under the
NZX Listing Rules.
Notwithstanding the foregoing, the Board of NorthWest Healthcare
Properties Management Limited (Manager) considers it important
from a governance perspective to identify how, as at 30 June
2022, Vital and the Manager comply with the NZX Code dated 10
December 2020.
The NZX Code is structured around eight principles. The table sets
out each principle and an explanation as to if, and how, Vital and
the Manager comply with the recommendations in the NZX Code.
ANNUAL REPORT
|
83
ReferenceRecommendationApproach
Principle 2 – Board composition and performance
2 .1
The board of an issuer should operate under
a written charter which sets out the roles
and responsibilities of the board. The board
charter should clearly distinguish and disclose
the respective roles and responsibilities
of the board and management.
The Board has adopted a formal Board Charter which is available on Vital’s
website at https://www.vitalhealthcareproperty.co.nz/governance/.
The Charter sets out the roles and responsibilities of the Board,
including in relation to distinguishing between the respective roles
and responsibilities of the Board and management.
The terms of a Director’s appointment are contained in the Board Charter. The
Charter reaffirms Directors must comply with their duties as set out in the Companies
Act 1993, including to act in good faith, together with other duties which include
(but are not limited to) conducting themselves in an appropriate manner.
The Board’s specific responsibilities include approving the Manager’s strategic objectives,
including those applicable to Vital and ensuring that effective risk management
procedures for the Manager and Vital are in place and are being observed.
2.2
Every issuer should have a procedure
for the nomination and appointment
of directors to the board.
Vital partially complies with this recommendation as the process for
appointment of directors is different for a listed managed investment scheme.
Vital is a trust and does not have directors. Its supervisor is Trustees Executors
Limited, which is also the trustee of the Vital Healthcare Property Trust.
The Manager has a Board of Directors, which, subject to the below, is
appointed by its sole shareholder, NWI Healthcare Properties LP.
Two Independent Directors are appointed to the Manager’s Board by Unit
Holders in the manner described in the Trust Deed. A copy of the Trust Deed
is available on Vital’s website and also on the Disclose Register through the
Companies Office https://companies-register.companiesoffice.govt.nz/.
Unit Holders have the opportunity to appoint two of the Independent Directors of
the Manager. Unit Holders are able to nominate and vote on one Independent
Director of the Manager each year. The nominee receiving the most votes will
be approved as a Director of the Manager by the Manager’s shareholders.
2.3
An issuer should enter into written agreements
with each newly appointed director
establishing the terms of their appointment.
The Manager enters into a written agreement with each newly appointed director
setting out the terms of their appointment, including expectations of the director in his
or her role, remuneration entitlements and indemnity and insurance arrangements.
2.4
Every issuer should disclose information about
each director in its annual report or on its website,
including a profile of experience, length of
service, independence and ownership interests.
Vital’s Annual Report includes a profile of experience, length of service,
independence and ownership interest of each director.
2.5
An issuer should have a written diversity policy
which includes requirements for the board or a
relevant committee of the board to set measurable
objectives for achieving diversity (which, at a
minimum, should address gender diversity) and
to assess annually both the objectives and the
entity’s progress in achieving them. The issuer
should disclose the policy or a summary of it.
A breakdown of the Manager’s staff specific diversity is included in the Annual Report.
2.6
Directors should undertake appropriate
training to remain current on how to best
perform their duties as directors of an issuer.
Directors are encouraged to maintain and enhance their skills and capabilities
through ongoing professional development to be undertaken to satisfy the
membership requirements of their respective institutes, including the Institute
of Directors, New Zealand. The Manager also seeks to provide additional
appropriate training relevant to their role as a Director of Vital.
2.7
The board should have a procedure to regularly
assess director, board and committee performance.
Assessment of the Board and each director’s performance is determined by the Chair
and takes into account overall attendance, contribution, training and experience of each
member concerned. In 2021 the Manager conducted a director self-assessment process
and proposes conducting an externally managed self-assessment process in 2022.
2.8
A majority of the board should
be independent directors.
The Board of the Manager is comprised of a majority of independent directors.
2.9
An issuer should have an independent chair of
the board. If the chair is not independent, the
chair and the CEO should be different people.
The Board of the Manager is chaired by an Independent Director.
Principle 3 – Board committees
3 .1
An issuer’s audit committee should operate
under a written charter. Membership on the
audit committee should be majority independent
and comprise solely of non-executive directors
of the issuer. The chair of the audit committee
should not also be the chair of the board.
The Board has adopted a formal written Audit Committee Charter which is available
on Vital’s website at https://www.vitalhealthcareproperty.co.nz/governance/.
The minimum number of members on the Audit Committee is three members who must be
Directors and at least one member must have an accounting or financial background.
The audit committee of the Manager is majority independent but otherwise
comprises the whole Board. The Chair of the audit committee is an independent
director and is not the same person as the Chair of the Board.
3.2
Employees should only attend audit committee
meetings at the invitation of the audit committee.
Management and other employees may attend an audit committee meeting on invitation.
84
|
VITAL HEALTHCARE PROPERTY TRUST
ReferenceRecommendationApproach
3.3
An issuer should have a remuneration committee
which operates under a written charter (unless
this is carried out by the whole board). At least
a majority of the remuneration committee should
be independent directors. Management should
only attend remuneration committee meetings at
the invitation of the remuneration committee.
A key feature of the external management structure under which Vital operates is that
remuneration of management is the responsibility of the Manager, not Vital. As Vital
Unit Holders are not economically exposed to employment remuneration costs, a
remuneration committee is not considered necessary by the Board at this time.
3.4
An issuer should establish a nomination committee
to recommend director appointments to the
board (unless this is carried out by the whole
board), which should operate under a written
charter. At least a majority of the nomination
committee should be independent directors.
Vital does not have a nomination committee and does not comply
with this recommendation. Given its structure and the terms of the
Trust Deed, the process for nomination of directors to the Board of
the Manager is not the same as for a listed company.
3.5
An issuer should consider whether it is appropriate
to have any other board committees as standing
board committees. All committees should
operate under written charters. An issuer should
identify the members of each of its committees,
and periodically report member attendance.
From time to time the Board establishes Due Diligence Committees (DDC) to report on
the due diligence process in relation to any potential transaction for Vital of material
size or complexity. An example would be the recent capital raisings undertaken by
Vital. A DDC will normally comprise an independent director, executive director,
relevant management staff and external consultants appropriate for the transaction.
3.6
The board should establish appropriate protocols
that set out the procedure to be followed if
there is a takeover offer for the issuer including
any communication between insiders and
the bidder. It should disclose the scope of
independent advisory reports to shareholders.
These protocols should include the option of
establishing an independent takeover committee,
and the likely composition and implementation
of an independent takeover committee.
The Takeovers Code does not apply to Vital, as a listed managed
investment scheme. Vital’s Trust Deed includes some provisions which
would regulate takeover-like transactions relating to units in Vital.
As a result of the above, the Board of the Manager has not established protocols
that set out the procedure to be followed if a takeover offer is received.
Principle 4 – Reporting and disclosure
4 .1
An issuer’s board should have a written
continuous disclosure policy.
It is important that the market and investors feel confident in the timing or manner
of any buying or selling of Vital units. As a NZX issuer, the Manager is acutely
aware of the need to ensure the market, investors and regulators remain fully
informed of any material or price sensitive information relevant to Vital. The Board
and all management employees are aware of the NZX Continuous Disclosure
requirements and Vital has internal procedures in place to ensure compliance.
The Continuous Disclosure Policy can be found on Vital’s
website at https://www.vitalhealthcareproperty.co.nz/app/
uploads/2021/09/210927-Continuous-Disclosure-Policy.pdf.
4.2
An issuer should make its code of ethics, board and
committee charters and the policies recommended
in the NZX Code, together with any other key
governance documents, available on its website.
A copy of all relevant policies noted in this document can be viewed on Vital’s website.
4.3
Financial reporting should be balanced, clear
and objective. An issuer should provide non-
financial disclosure at least annually, including
considering environmental, economic and
social sustainability factors and practices. It
should explain how operational or non-financial
targets are measured. Non-financial reporting
should be informative, include forward looking
assessments, and align with key strategies
and metrics monitored by the board.
Vital’s Annual Report includes non-financial disclosures, including environmental,
economic and social sustainability factors and practices. The Manager
maintains and regularly reviews a risk management framework as part of
its compliance assurance programme. Reports are provided to both the
Audit Committee and Board along with an annual risk assessment.
Principle 5 – Remuneration
5 .1
An issuer should recommend director remuneration
to shareholders for approval in a transparent
manner. Actual director remuneration should be
clearly disclosed in the issuer’s annual report.
Vital is a trust and does not have directors. Subject to the below, the
remuneration costs of the Manager’s directors are borne by the Manager. As
a result, Vital Unit Holders are not economically exposed to those costs.
Vital’s Trust Deed provides that the costs associated with the two Independent Directors
appointed to the Board of the Manager by Unit Holders are reimbursed out of the
trust fund. Refer to page 81 of this Annual Report for details of Director remuneration.
5.2
An issuer should have a remuneration policy for
remuneration of directors and officers, which
outlines the relative weightings of remuneration
components and relevant performance criteria.
As noted above, all officers and some Directors’ remuneration is paid by the
Manager not Vital. Any Directors paid by Vital are paid a flat fee for each
service provided (currently a base director fee and additional fees for being the
Chair, Audit Committee Chair and / or Audit Committee Member. Such fees are
market based by reference to other NZX listed entities; this is assessed annually.
Accordingly, the Board considers that it is unnecessary for Vital to maintain a
remuneration policy. As a result, Vital does not comply with this recommendation.
ANNUAL REPORT
|
85
ReferenceRecommendationApproach
5.3
An issuer should disclose the remuneration arrangements
in place for the CEO in its annual report. This should
include disclosure of the base salary, short term incentives
and long term incentives and the performance criteria
used to determine performance based payments.
Vital does not have any employees as it is externally managed by the
Manager. The remuneration of the Fund Manager (CEO equivalent) is
not paid by Vital. The remuneration is paid by the Manager or its related
parties. Accordingly, Vital does not comply with this recommendation.
Principle 6 – Risk management
6 .1
An issuer should have a risk management framework for its
business and the issuer’s board should receive and review
regular reports. An issuer should report the material risks
facing the business and how these are being managed
The Board of Directors maintains a sound understanding of key risks faced
by Vital. Effective management of all financial and nonfinancial risks is
fundamental to the delivery of the Board’s strategy. In addition, the Manager
will engage other external advisers as appropriate to deal with specific risks.
The Manager has a risk management framework that is integrated
into day-to-day operations. As part of this framework, the Board and
Audit Committee work closely with management and external auditors
to support the identification, management and reporting of risks.
This risk management framework is part of Vital’s compliance
assurance requirements under the FMCA. Higher risk groups are
reviewed yearly with lower risk groups reviewed biennially. The
risk management framework/Compliance Assurance Programme
is reviewed on an annual basis and approved by the Board.
6.2
An issuer should disclose how it manages its health
and safety risks and should report on their health
and safety risks, performance and management
The Manager has implemented a site-specific hazard register which can
be updated in real time. The Manager works alongside tenants, suppliers
and contractors to assist in providing a safe working environment. The
Manager has implemented an Operational Risk Committee that meets
once a month to review health and safety and risk management systems.
Health and safety is a standing item on the agenda for Board meetings.
Principle 7 – Auditors
7.1
The board should establish a framework
for the issuer’s relationship with its external
auditors. This should include procedures:
(a) for sustaining communication with
the issuer’s external auditors;
(b) to ensure that the ability of the external auditors to
carry out their statutory audit role is not impaired, or
could reasonably be perceived to be impaired;
(c) to address what, if any, services (whether by type
or level) other than their statutory audit roles may
be provided by the auditors to the issuer; and
(d) to provide for the monitoring and approval by the issuer’s
audit committee of any service provided by the external
auditors to the issuer other than in their statutory audit role.
The Board has established an Audit Committee with a majority of independent
directors. A copy of the Audit Committee Charter can be found on Vital’s
website https://www.vitalhealthcareproperty.co.nz/governance/.
The Audit Committee Charter sets out the procedures to be
followed to ensure the independence of the Trust’s external
auditor. The Audit Committee is responsible for recommending the
appointment of the external auditor and maintaining procedures
for the rotation of the external audit engagement partner.
Under the Audit Committee Charter, the external audit engagement
partner must be rotated at least every five years.
The Audit Committee Charter covers provision of non-audit services with
the general principle being that the external auditor should not have any
involvement in the production of financial information or preparation of financial
statements such that they might be perceived to be auditing their own work.
The Board facilitates regular and full dialogue between its Audit Committee, the
external auditors and management as reflected in the Audit Committee charter.
7. 2
The external auditor should attend the issuer’s
Annual Meeting to answer questions from
shareholders in relation to the audit.
To maximise the effectiveness of communication at the Annual Meeting, the
Manager also requires its external auditors to attend the meeting and be
prepared to answer Unit Holders’ questions about the conduct of the audit,
as well as the preparation and content of the independent auditor’s report.
Vital undertakes an annual audit engagement with its external auditor. As
part of the process the Audit Committee identifies any key areas of focus
and reporting required of the auditors. Management is required to attend
the meeting to discuss the findings of the report and respond to queries.
Any recommendationsfor improvement are discussed and management
is required to agree a timetable for the implementation of the changes.
7. 3
Internal audit functions should be disclosed.Following careful consideration and recommendation from the Audit
Committee, the Board appointed the firm of Deloitte as the Trust’s
statutory external auditor. The firm of KPMG has been appointed as
the auditor of the Manager. Ernst & Young has been appointed as
the global internal auditor by the Manager’s ultimate parent.
No separate internal audit function is currently in place noting that
Vital has a Supervisor in place who undertake assurance functions
on behalf of Unit Holders including in relation to management
fees and conduct and the Manager is audited by KPMG.
86
|
VITAL HEALTHCARE PROPERTY TRUST
ReferenceRecommendationApproach
Principle 8 – Shareholder rights and relations
8 .1
An issuer should have a website where investors
and interested stakeholders can access financial
and operational information and key corporate
governance information about the issuer.
Vital’s website www.vhpt.co.nz enables Unit Holders to access
financial and operational information and key corporate governance
information about Vital. The website’s allows key stakeholders
to access and navigate important information with ease.
8.2
An issuer should allow investors the ability to easily
communicate with the issuer, including providing the option
to receive communications from the issuer electronically.
A key focus of investor relations is to ensure the market and
investors are informed of all details necessary to assess their
investment and Vital’s performance as specified by NZX Listing
Rules. The Board aims to foster constructive communications
and encourages all stakeholders to engage with Vital.
A key element of corporate communication is the Trust’s website at www.
vhpt.co.nz. Vital’s website was recently refreshed and updated to make it
easier for Unit Holders to locate and understand key information. The website
enables all existing and potential Unit Holder to view information including:
an overview of the business and corporate structure, a history of financial
and investment performance, key calendar dates and the ability to access
and download all NZX announcements, presentations and investor forms.
The website also includes key corporate governance documents
including the Board Charter, Statement of Investment Policies and
Objectives (SIPO) and other key policy documentation.
The Manager also actively encourages engagement
through a communication strategy which includes:
• The Annual Meeting for the Unit Holders to meet with and ask questions
of the Board, the Supervisor, management and external auditors;
• Any other meetings called to obtain approval for
the Manager’s action as appropriate;
• Results webcasting providing all investors with the ability
to listen and ask questions of Management; and
• Various investor communications including Annual and Interim Reports.
Through Vital’s external registrar investors have the ability to easily communicate
with the issuer, including providing the option to receive communications from
the issuer electronically. There is a NZ toll free number 0800 225 264 and
email address enquiry@vhpt.co.nz to which general enquiries can be directed.
8.3
Quoted equity security holders should have the right
to vote on any major decisions which may change
the nature of the issuer in which they are invested.
Terms of Vital’s Trust Deed and the FMCA set out requirements under
which the Manager must obtain the approval of Unit Holders.
As a managed investment scheme regulated by the FMCA, investment
objectives, investment philosophy, investment strategy and categories of
authorised investments are required to be set out in a Statement of Investment
Policy and Objectives (SIPO). A copy of Vital’s SIPO is available here:
https://www.vitalhealthcareproperty.co.nz/app/
uploads/2021/02/SIPO_Vital_New.pdf
Changes to the SIPO may only be made in accordance
with section 165 of the FMCA after having given written
notice to Vital’s supervisor, Trustees Executors Limited.
8.4
If seeking additional equity capital, issuers of quoted
equity securities should offer further equity securities to
existing equity security holder of the same class on a
pro rata basis, and on no less favourable terms, before
further equity securities are offered to other investors.
Vital’s most recent equity capital raising was implemented in April
and May 2022 as an accelerated entitlement offer. Eligible Unit
Holders were entitled to subscribe for 1 new unit for every 8.54 units
held at the record date. This structure allowed existing Unit Holders to
participate on a pro rata basis, on no less favourable terms (subject to
certain exceptions, like for Unit Holders outside New Zealand).
Previous equity capital raisings completed in 2020 and 2021 were
structured as a combination of a non-pro rata placement and a Unit
Holder purchase plan and were undertaken as close to a pro-rata
structure as practicable in accordance with the Board approved allocation
policy. The Board of the Manager considers a range of factors when
assessing capital raising options. Those factors include the interests of
existing Unit Holders, cost of capital and register composition.
8.5
The board should ensure that the notices of annual
or special meetings of quoted equity security holders
is posted on the issuer’s website as soon as possible
and at least 20 days prior to the meeting.
Under Vital’s Trust Deed at least 14 days’ notice is required for notices
of meeting to be sent by post. Vital will continue to follow the Trust Deed
when determining the period of notice to be given. Having said that, the
Notices of Meeting for Vital’s annual meeting in 2020 and 2021 were
provided at least 20 days prior to the meeting, as was the Notice of
Meeting for the special meeting of Unit Holders held in 2021. The notice
of meeting is released on the NZX and included on our website.
ANNUAL REPORT
|
87
Financial
statements
88
|
VITAL HEALTHCARE PROPERTY TRUST
ANNUAL REPORT 2022|89
Contents
Consolidated Statement of Comprehensive Income90
Consolidated Statement of Financial Position91
Consolidated Statement of Changes in Equity92
Consolidated Statement of Cash Flows93
Notes to the Consolidated Financial Statements94
ABOUT THIS REPORT94
1. Reporting Entity 94
2. Basis of Preparation94
3. Significant Accounting Policies96
PERFORMANCE97
4. Segment Information 97
5. Taxation99
6. Investment Properties 102
7. Other Expenses110
CAPITAL STRUCTURE, FINANCING AND RISK MANAGEMENT111
8. Units on Issue111
9. Earnings per Unit112
10. Distributable Income 113
11. Borrowings114
12. Lease Liabilities 116
13. Derivative Financial Instruments116
14. Financial and Risk Management 118
15. Commitments and Contingencies 123
EFFICIENCY OF OPERATIONS124
16. Statement of Cash Flows Reconciliation from Operating Activities124
17. Trade and Other Receivables125
18. Other Assets126
19. Trade and Other Payables126
OTHER NOTES127
20. Investment in Subsidiaries 127
21. Subsequent Events 127
22. Related Party Transactions 127
90|VITAL HEALTHCARE PROPERTY TRUST
Consolidated Statement of
Comprehensive Income
For the year ended 30 June 2022
Note
2022
$000s
2021
$000s
Gross property income from rentals127,397113,622
Gross property income from expense recoveries16,23612,522
Property expenses(20,615)(16,481)
Net property income4123,018109,663
Other expenses7(37,235)(30,915)
Strategic transaction expenses(283)-
Finance income21235
Finance expense11.b(29,195)(27,719)
Operating profit56,51751,064
Other gains/(losses)
Revaluation gain on investment property6.a244,239235,383
Net gain/(loss) on disposal of investment property6.a70011,310
Fair value gain/(loss) on foreign exchange derivatives(664)280
Fair value gain/(loss) on interest rate derivatives61,46822,375
Realised gain/(loss) on foreign exchange(11)(4,399)
Unrealised gain/(loss) on foreign exchange262,454
305,758267,403
Profit before income tax362,275318,467
Taxation expense5(58,753)(40,075)
Profit for the year attributable to unit holders of the Trust303,522278,392
Other comprehensive income
Items that may be reclassified subsequently to profit and loss:
Movement in foreign currency translation reserve36,5561,711
Realised foreign exchange gain/(loss) on hedges14.e-46,613
Current taxation (expense)/credit338(6,921)
Fair value gain/(loss) on net investment hedges14.e-(46,352)
Deferred taxation (expense)/credit-7,074
Total other comprehensive income/(loss) after tax36,8942,125
Total comprehensive income after tax340,416280,517
Earnings per unit
Basic and diluted earnings per unit (cents)953.3355.91
The notes on pages 94 to 131 form part of and are to be read in conjunction with these financial statements.
ANNUAL REPORT 2022|91
Consolidated Statement of
Financial Position
As at 30 June 2022
Note
2022
$000s
2021
$000s
Non-current assets
Investment properties63,339,1692,634,588
Derivative financial instruments1320,692-
Deferred tax5-6,477
Total non-current assets3,359,8612,641,065
Current assets
Cash and cash equivalents1622,0556,880
Trade and other receivables172,4421,634
Other current assets1815,45112,736
Derivative financial instruments1325245
Total current assets39,97321,495
Total assets3,399,8342,662,560
Unit holders' funds
Units on issue81,150,881777,199
Reserves44,5904,208
Retained earnings970,405722,044
Total unit holders' funds2,165,8761,503,451
Non-current liabilities
Borrowings111,012,952814,895
Lease liability - ground lease123,9034,094
Derivative financial instruments1315040,379
Deferred tax5178,316129,361
Total non-current liabilities1,195,321988,729
Current liabilities
Trade and other payables1931,94641,005
Income in advance621854
Derivative financial instruments13535640
Lease liability - ground lease12170142
Taxation payable5,36513,334
Borrowings11-114,405
Total current liabilities38,637170,380
Total liabilities1,233,9581,159,109
Total unit holders' funds and liabilities3,399,8342,662,560
For and on behalf of the Manager, NorthWest Healthcare Properties Management Limited
G Stuart, Independent Chair
11 August 2022
M Stanford,
Independent Director
The notes on pages 94 to 131 form part of and are to be read in conjunction with these financial statements.
92|VITAL HEALTHCARE PROPERTY TRUST
Consolidated Statement of
Changes in Equity
For the year ended 30 June 2022
Units on
issue
$000s
Retained
earnings
$000s
Translation
of foreign
operations
$000s
Foreign
exchange
hedges
$000s
Share
based
payments
$000s
Total
unit
holders'
funds
$000s
For the year ended 30 June 2021
Balance at the start of the period594,752488,096(73,003)62,6596,4751,078,979
Changes in unit holders' funds182,447---(6,475)175,972
Manager's incentive fee----12,42712,427
Profit for the period-278,392---278,392
Distributions to unit holders-(44,444)---(44,444)
Other comprehensive income for the period
Movement in foreign currency translation reserve--1,711--1,711
Realised foreign exchange gains on hedges---39,692-39,692
Fair value gains on net investment hedges---(39,278)-(39,278)
Balance at the end of the year777,199722,044(71,292)63,07312,4271,503,451
For the year ended 30 June 2022
Balance at the start of the period777,199722,044(71,292)63,07312,4271,503,451
Changes in unit holders' funds373,682---(12,427)361,255
Manager's incentive fee----15,91515,915
Profit for the period-303,522---303,522
Distributions to unit holders-(55,161)---(55,161)
Other comprehensive income for the period
Movement in foreign currency translation reserve--36,556--36,556
Realised foreign exchange gains on hedges---338-338
Balance at the end of the year1,150,881970,405(34,736)63,41115,9152,165,876
The notes on pages 94 to 131 form part of and are to be read in conjunction with these financial statements.
ANNUAL REPORT 2022|93
Consolidated Statement of
Cash Flows
For the year ended 30 June 2022
Note
2022
$000s
2021
$000s
Cash flows from operating activities
Property income126,517118,196
Recovery of property expenses15,93411,814
Interest received21235
Property expenses(18,762)(13,139)
Management and trustee fees(17,478)(14,610)
Interest paid(26,514)(28,089)
Tax paid(15,849)(13,776)
Other trust expenses(3,573)(3,855)
Net cash provided by/(used in) operating activities1660,48756,576
Cash flows from investing activities
Receipts from foreign exchange derivatives5041,296
Capital additions on investment properties(137,780)(147,586)
Purchase of properties(299,858)(242,784)
Deposits and acquisiton costs paid – Investment Property(10,178)(2,539)
Proceeds from disposal of properties14,35599,056
Tenant fitout reimbursement proceeds31,527-
Payments for foreign exchange derivatives(506)(2,026)
Strategic transaction expenses(283)(925)
Net cash provided by/(used in) investing activities(402,219)(295,508)
Cash flows from financing activities
Debt drawdown835,1151,204,354
Repayment of debt(780,338)(1,092,839)
Issue of units342,817159,652
Loan issue costs(3,963)(2,523)
Costs associated with new equity raised(5,353)(2,637)
Distributions paid to unit holders(31,371)(25,460)
Net cash from/(used in) financing activities356,907240,547
Net increase/(decrease) in cash and cash equivalents15,1751,615
Cash and cash equivalents at the beginning of the period6,8805,265
Cash and cash equivalents at the end of the year22,0556,880
The notes on pages 94 to 131 form part of and are to be read in conjunction with these financial statements.
94|VITAL HEALTHCARE PROPERTY TRUST
Notes to the Consolidated Financial Statements
About this Report
1. Reporting Entity
Vital Healthcare Property Trust (“VHP” or the “Trust”) is a unit trust established under the Unit Trusts Act 1960 by a Trust Deed dated
11 February 1994 (as subsequently amended and replaced), domiciled in New Zealand. The Trust is managed by NorthWest Healthcare
Properties Management Limited (the “Manager”), with its registered office at Level 17, HSBC Tower, 188 Quay Street, Auckland
Central 1010.
The consolidated financial statements of VHP for the year ended 30 June 2022 comprise VHP and its subsidiaries (together referred to as
the “Group”). VHP is listed on the New Zealand Stock Exchange (NZX) and is a FMC reporting entity for the purpose of the Financial
Markets Conduct Act 2013. The Group's principal activity is direct and/or indirect investments in healthcare real estate.
These consolidated financial statements were approved by the Board of Directors of the Manager on 11 August 2022.
2.
Basis of Preparation
(a) Statement of compliance
These financial statements have been prepared in accordance with Generally Accepted Accounting Practice in New Zealand (NZ GAAP)
and comply with New Zealand equivalents to International Financial Reporting Standards (NZ IFRS) and other applicable Financial
Reporting Standards, as appropriate for
profit-oriented entities. Accordingly these financial statements comply with International Financial
Reporting Standards (IFRS).
(b)
Basis of consolidation
The Group’s financial statements incorporate the financial statements of the Trust and entities controlled by the Trust (its subsidiaries) as
set out in Note 20. Control is achieved where the Trust has power over the investees; is exposed, or has rights, to variable returns from
its involvement with the investees; and has the ability to use its power to affect its returns. The results of subsidiaries are included in the
consolidated financial statements from the date of acquisition to the date of disposal. All intra-group transactions, balances, cashflows,
income and expenses are eliminated on consolidation.
(c)
Basis of measurement
The Group uses the historical cost basis except for derivative financial instruments and investment properties which are measured at fair
value. Historical cost is based on the fair value of the consideration given or received in exchange for assets or liabilities. Fair value is
the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the
measurement date, regardless of whether that price is directly observable or estimated using another valuation technique.
(d)
Functional and presentation currency
These financial statements are presented in New Zealand Dollars ($), which is the Trust's functional and presentation currency. All
information has been rounded to the nearest thousand dollars ($000), unless stated otherwise.
In preparing the financial statements, transactions in currencies other than the Trust’s functional currency (i.e. a foreign currency transaction)
are recorded at the rates of exchange prevailing at the dates of the transactions. At the end of each reporting period, foreign currency
denominated monetary items are retranslated at the rate of exchange prevailing at that time. Exchange differences are recognised in profit
or loss in the period in which they arise, except for exchange differences on transactions entered into to hedge foreign currency exposure.
The assets and liabilities of the Group’s foreign operations are translated to New Zealand Dollars using exchange rates prevailing at the
end of the reporting period. Income and expense items are translated at the average exchange rates for the period. Exchange differences
arising on translation are recognised in other comprehensive income and the foreign currency translation reserve.
ANNUAL REPORT 2022|95
(e) Changes in accounting policy and presentation
All accounting policies have been applied on a basis consistent with the prior year's financial statements.
(f) Standards and Interpretations in issue not yet effective
At the date of authorisation of these financial statements, the Group has not applied new and revised NZ IFRS standards and amendments
that have been issued but are not yet effective. It is not expected that the adoption of these standards and amendments will have a material
impact on the financial statements of the Group.
(g) Other accounting policies
Significant accounting policies that summarise the measurement basis used and are relevant to an understanding of the consolidated
financial statements are provided throughout the notes to the consolidated financial statements.
(h) Impact of COVID-19
In March 2020 the World Health Organisation declared the outbreak of a novel coronavirus (‘COVID-19’) as a pandemic, which has
now spread throughout New Zealand, Australia and the world. Governments in New Zealand and Australia responded with lock-downs,
business trading restrictions and social distancing measures all of which impacted large parts of the economy, including the ability for the
Group’s tenants to operate on a business as usual basis.
The widespread uptake of COVID-19 vaccination and booster programs has resulted in the Governments of New Zealand and Australia
adopting a strategy of managing COVID-19, within the context of open international borders and minimising cases in the community without
introducing on-going restrictions or lock-downs. Periodic outbreaks that directly or indirectly disrupt normal business as unusual activity
persist for the Group’s tenants. As at the reporting date, trade receivables and loss allowances related to rent deferral arrangements with
tenants impacted by previous lock-downs and trading restrictions remain.
COVID-19 continues to create transactional market uncertainty in the evidence used by a small number of independent professionally
qualified valuers to inform their assumptions and opinions that determine the fair value of investment property in the markets the Group
operates (refer Note 6.g for further details).
Currently there remains the potential for further community transmission outbreaks caused by a more transmissible and/or virulent COVID-19
mutation. Should this occur the viability of the Group’s tenants and therefore potentially the operating performance and the financial position
of the Group may be adversely impacted if the Governments of New Zealand and Australia were forced to respond with prolonged
lock-downs and business trading restrictions to protect the community and manage the demand of the health systems.
(i)
The notes to the consolidated financial statements
The following notes include information required to understand these financial statements that is relevant and material to the operations,
financial position and performance of the Group. The notes have been collated into sections to help users find and understand inter-related
information. Information is considered material and relevant if, for example:
•the amount in question is significant by virtue of its size or nature;
•it is important to understand the results of the Group;
•it helps explain the impact of significant changes in the Group's business; or
•it relates to an aspect of the Group's operations that is important to its future performance.
96|VITAL HEALTHCARE PROPERTY TRUST
Notes to the Consolidated Financial Statements
3. Significant Accounting Policies
Critical accounting estimates and judgements
In the application of NZ IFRS, the Board and management are required to make judgements, estimates and assumptions about carrying
values of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on
experience and other factors that are believed to be reasonable under the circumstances, however actual results may differ from these
estimates and assumptions.
Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in
which the estimate is revised and in any future periods affected.
The critical judgements, estimates and assumptions made in the current period are contained in the following notes:
NoteDescription
Note 5Current and deferred taxation
Note 6Valuation of investment properties
Note 22Related party transactions
ANNUAL REPORT 2022|97
Performance
This section shows the results and performance of the Group and its reporting segments and includes detailed information in respect to its
revenues, expenses and profitability. It also provides information on the investment properties that underpin the Group's performance.
4. Segment Information
The principal business activity of the Group is to invest in Health Sector related properties. Segment profit represents the profit earned by
each segment including allocation of identifiable administration costs, finance costs, revaluation gains/(losses) on investment properties,
and gains/(losses) on disposal of investment properties. This is the measure reported to the Board, who are the chief operating decision
makers for the purposes of resource allocation and assessment of segment performance. The Group operates in both Australia and
New Zealand.
The following is an analysis of the Group’s results by reportable segment.
Australia
$000s
New Zealand
$000s
Total
$000s
Segment profit/(loss) for the year ended 30 June 2022:
Gross property income from rentals91,79235,605127,397
Gross property income from expense recoveries6,6589,57816,236
Property expenses(10,200)(10,415)(20,615)
Net property income88,25034,768123,018
Other expenses(14,888)(22,347)(37,235)
Strategic transaction expenses-(283)(283)
Net finance expense(14,991)(13,992)(28,983)
Operating profit58,371(1,854)56,517
Fair value gain/(loss) on interest rate derivatives-61,46861,468
Revaluation gains on investment properties188,64855,591244,239
Net gain/(loss) on disposal of investment property700-700
Other foreign exchange gains/(losses)(11)(638)(649)
Total segment profit before income tax247,708114,567362,275
Taxation expense(58,753)
Profit for the year303,522
Segment profit/(loss) for the year ended 30 June 2021:
Gross property income from rentals83,60530,017113,622
Gross property income from expense recoveries6,3056,21712,522
Property expenses(9,325)(7,156)(16,481)
Net property income80,58529,078109,663
Other expenses(12,607)(18,308)(30,915)
Net finance expense(8,297)(19,387)(27,684)
Operating Profit59,681(8,617)51,064
Fair value gain/(loss) on interest rate derivatives-22,37522,375
Revaluation gains on investment properties162,64772,736235,383
Net gain/(loss) on disposal of investment property11,310-11,310
Other foreign exchange gains/(losses)(3)(1,662)(1,665)
Total segment profit before income tax233,63584,832318,467
Taxation expense(40,075)
Profit for the year278,392
98|VITAL HEALTHCARE PROPERTY TRUST
Notes to the Consolidated Financial Statements
Net property income comprises rental income and expense recoveries from tenants less property expenses. The Group has three Australian
tenants that contributed $72.5m of gross property income (2021: four Australian tenants that contributed $77.4m).
There were no inter-segment sales during the year (2021: nil).
Australia
$000s
New Zealand
$000s
Total
$000s
Segment assets at 30 June 2022:
Investment properties2,391,228947,9413,339,169
Other non-current assets-20,69220,692
Current assets18,78221,19139,973
Consolidated assets2,410,010989,8243,399,834
Segment assets at 30 June 2021:
Investment properties1,933,502701,0862,634,588
Other non-current assets-6,4776,477
Current assets16,3695,12621,495
Consolidated assets1,949,871712,6892,662,560
Segment liabilities at 30 June 2022:
Borrowings993,23419,7181,012,952
Other liabilities190,10630,900221,006
Consolidated liabilities1,183,34050,6181,233,958
Segment liabilities at 30 June 2021:
Borrowings800,950128,350929,300
Other liabilities173,31356,496229,809
Consolidated liabilities974,263184,8461,159,109
All assets and liabilities have been allocated to reportable segments.
ANNUAL REPORT 2022|99
5. Taxation
Income tax recognised in the consolidated statement of comprehensive income
2022
$000s
2021
$000s
Profit/(loss) before tax for the period362,275318,467
Taxation (charge)/credit - 28% on profit before income tax(101,437)(89,171)
Effect of different tax rates in foreign jurisdictions32,20330,393
Tax exempt income16,74821,899
Tax impact of leasing deals1914,653
Tax impact of profit on property sales-(1,880)
Foreign tax credits4,7539,890
Tax charges on overseas investments(11,500)(13,494)
Over/(under) provided in prior periods449(470)
Other adjustments(160)(1,895)
Taxation expense(58,753)(40,075)
The taxation (charge)/credit is made up as follows:
Current taxation(8,280)(7,858)
Deferred taxation(50,473)(32,217)
Total taxation expense(58,753)(40,075)
The key assumptions used in the preparation of the Group’s tax calculation are as follows:
Tax rate:
The Group's New Zealand entities are subject to New Zealand tax on assessable income at a rate of 28% while its Australian subsidiary
trusts are subject to Australian witholding tax on assessable income at a rate of 10% for interest income or 15% for 'fund payment' amounts as
they are Australian Managed Investment Trusts (MIT).
100|VITAL HEALTHCARE PROPERTY TRUST
Notes to the Consolidated Financial Statements
Deferred Tax balances
Interest rate
swaps
$000s
Revaluation
of investment
properties
$000s
Borrowings
$000s
Other
$000s
Total
$000s
At 1 July 202017,750(108,221)(7,074)187(97,358)
Charge to profit and loss for the year(6,265)(25,899)(38)(15)(32,217)
Change in exchange rate-(383)--(383)
Charge to other comprehensive income--7,074-7,074
At 30 June 202111,485(134,503)(38)172(122,884)
At 1 July 202111,485(134,503)(38)172(122,884)
Charge to profit and loss for the year(17,211)(33,274)(48)60(50,473)
Change in exchange rate-(5,112)-153(4,959)
At 30 June 2022(5,726)(172,889)(86)385(178,316)
2022
$000s
2021
$000s
Deferred tax asset-6,477
Deferred tax liability(178,316)(129,361)
Total deferred tax(178,316)(122,884)
ANNUAL REPORT 2022|101
Imputation credits
2022
$000s
2021
$000s
Imputation (deficit)/credits at end of year(410)(2,534)
Recognition and measurement
Income tax comprises current and deferred tax. It is recognised in the consolidated profit or loss unless it relates to items recognised in other
comprehensive income, in which case the current or deferred tax is recognised in other comprehensive income.
Current tax
Current tax is the expected tax payable on the taxable income for the financial year, determined using tax rates enacted or substantively
enacted at the reporting date in the countries where the Group operates, and any adjustments to tax payable in respect of previous
financial years. Management periodically evaluates positions taken in tax returns where the applicable tax regulation is subject to
interpretation and establishes appropriate provisions on the basis of amounts expected to be paid to the tax authorities.
Deferred tax
Deferred tax is provided using the balance sheet liability method, recognising temporary differences between the carrying amounts of assets
and liabilities for financial reporting purposes and their amounts for taxation purposes.
Deferred tax liabilities are recognised for all taxable temporary differences. Deferred tax assets are recognised for all deductible temporary
differences and carried forward tax losses, to the extent that it is probable that taxable profit will be available to utilise them.
The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer
probable that sufficient taxable profits will be available to utilise them.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply to the period(s) when the asset or liability giving
rise to them is realised or settled, based on the tax rates and laws enacted or substantively enacted at balance date.
Deferred tax assets and liabilities are offset where there is a legally enforceable right to set off, they relate to the same taxation authority,
and the Group intends to settle its obligations on a net basis.
Significant
estimates and judgements
Significant estimates and judgements made in the determination of deferred tax include:
•Deferred tax on depreciation: Deferred tax is provided in respect of New Zealand based properties for the depreciation expected to be
recovered on the sale of investment property.
•Deferred tax on changes in fair value of investment properties: Deferred tax for Australian based properties is provided on the capital
gain expected to be assessable on the land and building component from the sale of investment properties at fair value.
•Deferred tax on fixtures and fittings: It is assumed that all fixtures and fittings will be sold at their tax book value.
•Deferred tax positions are based an estimated split between land and buildings as determined by registered valuers
102|VITAL HEALTHCARE PROPERTY TRUST
Notes to the Consolidated Financial Statements
6. Investment Properties
Investment properties comprise real estate predominately leased, or targeted to be leased, to health sector tenants that is held for either
deriving rental income, for capital appreciation or both.
(6.a) Reconciliation of Carrying Amounts
2022
$000s
2021
$000s
Carrying value of investment property at the beginning of the year2,634,5882,086,309
Acquisition of properties298,745237,072
Capitalised costs94,549121,642
Capitalised interest costs5,9214,852
Net capitalised incentives
1
(382)31,631
Disposal of properties(13,186)(87,771)
Foreign exchange translation difference74,6954,901
Revaluation gain on investment property244,239235,383
Right of use asset recognised-569
Carrying value of investment property at the end of the year3,339,1692,634,588
12021: Includes payments associated with the Belmont Private Hospital rent being rebased to market and lease extension.
The Group holds the freehold to all properties except the car parks at the rear of Ascot Hospital and Ascot Central, which are the subject of
a ground lease ("right-of-use" asset) that has a weighted average term remaining of 16.8 years (2021: 17.8 years). As at reporting date the
fair value of this right-of-use asset totals $8.1m (2021: $7.9m).
(6.b)
Acquisition of Property
During the year the Group:
•acquired a development site of 20,131 square metres at 187–195 Foxwell Rd, Coomera, Queensland, Australia for an acquisition price
of A$9.4 million (excluding transaction costs) on 15 July 2021.
•acquired a development site of 982 square metres at 1 Beck Court, Noble Park, Victoria, Australia (adjacent to Vital’s South Eastern
Hospital) for an acquisition price of A$1.95 million (excluding transaction costs) on 28 September 2021.
•acquired a development site of 749 square metres at 61 – 71 Park Rd, Grafton, Auckland, New Zealand for an acquisition price of
NZ$7.25 million (excluding transaction costs) on 30 September 2021.
•acquired a “Cancer Centre of Excellence” in Adelaide known as Tennyson Centre at 520 South Road, Kurralta Park, SA, Australia,
as well as an adjoining development site of 1,920 square metres at 502–504 South Road for A$90 million and A$2.75 million
respectively (excluding transaction costs) on 11th October 2021.
•settled on a ambulatory care facility at 120 Thames St, Box Hill, Victoria, Australia for an acquisition price of A$10.1 million (excluding
transaction costs), which had previously been accrued for in Other Payables (refer Note 19).
•acquired residential properties throughout the year to be held for future development in Meadowbrook, Queensland, Australia for
A$10.2 million (excluding transaction costs).
•acquired Hutt Valley Health Hub, an ambulatory care facility at 135 Witako Street, Lower Hutt, New Zealand for NZ$46.5 million
(excluding transaction costs) on 1 February 2022.
•acquired a development site of 4,340 square metres adjacent to The Hills Clinic in north-west Sydney, Australia for an acquisition price
of A$13.5 million (excluding transaction costs) on 8 February 2022.
•acquired 68 Saint Asaph Street, a medical office building in Christchurch, New Zealand for NZ$50.7million (excluding transaction
costs) on 1 April 2022.
•acquired Endoscopy Auckland, an endoscopy centre at 148 Gillies Ave, Auckland, New Zealand for NZ$13.0 million and
development land at 22 Kipling Ave, Auckland, New Zealand for NZ$6.3 million (both excluding transaction costs) on 13 May 2022.
•acquired a development / repositioning site at 2 Mount Eliza Way and 1 St Johns Lane, Mt Eliza, Victoria, Australia for A$11.0 million
(excluding transaction costs) on 30 May 2022.
ANNUAL REPORT 2022|103
•acquired a development site of 3,415 square metres at 80 Ascot Ave, Auckland, New Zealand adjacent to Ascot Hospital and Ascot
Central for an acquisition price of NZ$16.0 million (excluding transaction costs) on 30 June 2022.
(6.c) Disposal of Property
During the period the Group:
•sold Gold Coast Surgery Centre (QLD) for A$12.75 million (excluding transaction costs) on 27 October 2021.
•sold a development site at 4 Pearl St, Hurstville, NSW for A$1.4 million on 7 March 2022.
(6.d) Leasing Arrangements
The majority of the investment properties are leased to tenants under long term operating leases. Rentals are receivable from tenants
monthly. Minimum lease payments to be received under non-cancellable operating leases of investment properties not recognised in the
consolidated
financial statements as receivable are as follows:
2022
$000s
2021
$000s
Not later than one year137,989110,304
Later than one year and not later than five years482,909514,869
Later than five years1,339,2531,191,333
1,960,1511,816,506
(6.e) Contractual arrangements
The Group was party to contracts to purchase or construct property (including in respect to Epworth Eastern, Victoria and Wakefield
Hospital, Wellington) or provide lease incentives to tenants which are not recognised in the financial statements for the following amounts:
2022
$000s
2021
$000s
Capital expenditure commitments214,878135,952
Property acquisition commitments109,70118,593
Tenant incentive commitments11,06610,742
At 30 June 2022 the Group has:
•committed to acquiring Kawarau Park Health Precinct, a newly developed health precinct comprising 6 tenanted buildings including
Queenstown's only private hospital, situated in Kawarau Park in Queenstown, New Zealand for NZ$94m (plus transaction costs).
Settlement occured on 7 July 2022.
•committed to acquiring a 7,693 sqm parcel of land in Newtown, Hobart, Australia for A$9.5m (plus transaction costs) for future
development. Settlement occured on 6 July 2022.
In addition, excluded from the above property acquisition committments, the Group has entered into a conditional contract to acquire a
multi-stage ground lease development site in Campbelltown, Sydney, Australia, comprising:
•A$52.0m for the acquisition, tenant incentive and development costs (Stage 1) of a cancer centre of excellence pre-leased to
GenesisCare from completion; and
•A$24.6m for the development rights for Stages 2 and 3 that provide capacity for Vital to develop up to 40,000 square metres of
additional gross floor area.
An incentive of A$10m (plus GST) is payable to Epworth in return for a term extension of 3 years on the 3
rd
anniversary of the
commencement of the lease on the Epworth Camberwell property. Following this payment Epworth’s tenancy (before extension options) at
this property will expire on 30 June 2044.
(6.f)
Individual Valuations and Carrying Amounts
The details of the New Zealand and Australian investment property portfolio, including its location, sub sector, fair value, market
capitalisation rate, occupancy and weighted average lease expiry term are as follows:
104|VITAL HEALTHCARE PROPERTY TRUST
Notes to the Consolidated Financial Statements
Latest
independent
valuationFair valueMarket capitalisation rateOccupancyWALE
PropertiesLocationSub sectorMajor TenantDate
$M
Jun-22
$M
Jun-21
%
Jun-22
%
Jun-21
%
Jun-22
%
Jun-21
Years
Jun-22
Years
Jun-21
Australia
New South Wales
Lingard Private HospitalMerewether, New South WalesHospital (Acute)Healthe CareJun-22224.6193.94.14.5100.0100.023.724.7
Maitland Private HospitalEast Maitland, New South WalesHospital (Acute/Specialty)Healthe CareJun-22133.9118.34.85.1100.0100.015.516.5
Hurstville Private HospitalHurstville, New South WalesHospital (Acute)Healthe CareDec-2191.380.65.85.8100.0100.019.820.8
The Hills ClinicKellyville, New South WalesHosptial (Specialty)AuroraJun-2264.254.44.04.5100.0100.025.026.0
Toronto Private HospitalToronto, New South WalesHospital (Acute/Specialty)AuroraJun-2254.047.75.05.4100.0100.020.121.1
Mons Road Medical CentreWestmead, New South WalesAmbulatory CareCastlereagh ImagingJun-2248.739.74.85.494.594.52.93.6
Lingard Day CentreMerewether, New South WalesAmbulatory CareHealthe CareJun-2247.340.64.14.5100.0100.023.724.7
Hirondelle Private HospitalChatswood, New South WalesHospital (Specialty)AuroraJun-2234.030.25.05.3100.0100.019.920.9
Fairfield Aged CareFairfield, New South WalesAged CareHall & PriorDec-2121.619.36.36.3100.0100.013.714.7
Darlington Aged CareBanora Point, New South WalesAged CareBolton ClarkeJun-2219.918.36.06.3100.0100.014.315.3
Clover Lea Aged CareBurwood Heights, New South WalesAged CareHall & PriorDec-2115.414.16.36.3100.0100.013.714.7
Grafton Aged CareSouth Grafton, New South WalesAged CareHall & PriorDec-2112.811.97.07.0100.0100.014.815.8
Victoria
Epworth Eastern HospitalBox Hill, VictoriaHospital (Acute)Epworth FoundationDec-21448.8375.24.04.395.0100.020.517.8
South Eastern Private HospitalNoble Park, VictoriaHospital (Specialty)AuroraJun-22100.186.04.34.8100.0100.018.719.7
Epworth CamberwellCamberwell, VictoriaHospital (Specialty)Epworth FoundationJun-2284.778.14.24.3100.0100.019.020.0
Ekera Medical CentreBox Hill, VictoriaAmbulatory CareImaging AssociatesDec-2136.533.35.05.3100.0100.02.93.3
Epworth Rehabilitation
1
Brighton, VictoriaHospital (Specialty)Epworth FoundationJun-2229.929.05.35.5100.0100.01.62.6
120 Thames StreetBox Hill, VictoriaAmbulatory CareEpworth FoundationDec-2113.313.05.56.559.6100.02.53.6
Queensland
Belmont Private HospitalCarina Heights, QueenslandHospital (Specialty)AuroraDec-21161.8133.54.04.3100.0100.023.224.2
Palm Beach Currumbin ClinicCurrumbin, QueenslandHospital (Specialty)AuroraJun-2281.969.24.34.8100.0100.013.214.2
The Southport Private HospitalSouthport, QueenslandHospital (Acute/Specialty)Ramsay Health CareDec-2157.551.44.85.0100.0100.022.723.7
Eden Rehabilitation
1
Cooroy, QueenslandHospital (Acute/Specialty)AuroraJun-2235.733.05.35.3100.0100.015.416.4
Baycrest Aged CareHervey Bay, QueenslandAged CareBolton ClarkeJun-2221.619.86.06.3100.0100.014.015.0
Gold Coast Surgery CentreSouthport, QueenslandAmbulatory CareSouth Coast Radiologyn.a.-12.2-7.5-88.9-1.4
Tantula Rise Aged CareAlexandra Headland, QueenslandAged CareBolton ClarkeJun-2226.824.76.06.3100.0100.014.015.0
Western Australia
Marian CentreWembley, Western AustraliaHospital (Specialty)AuroraDec-2166.357.84.44.6100.0100.012.113.1
Abbotsford Private HospitalWest Leederville, Western AustraliaHospital (Specialty)AuroraDec-2154.737.94.34.5100.0100.019.620.6
Hamersley Aged CareSubiaco, Western AustraliaAged CareHall & PriorDec-2114.913.56.56.8100.0100.013.714.7
Rockingham Aged CareRockingham, Western AustraliaAged CareHall & PriorDec-218.17.36.87.0100.0100.013.714.7
South Australia
Tennyson CentreKurralta Park, South AustraliaAmbulatory CareICON Cancer CareJun-22106.8-4.5-100.0-3.8-
Sportsmed Hospital, Clinic & Cons.Stepney, South AustraliaHospital (Acute)Sportsmed SAJun-2292.483.35.05.3100.0100.013.614.6
Playford Health - Retail & CarparkElizabeth Vale, South AustraliaAmbulatory CareSA HealthJun-2224.3-5.5-53.9-9.5-
Total Australia2233.81827.04.54.898.699.717.118.2
1The independent valuer, in determining or informing the fair value for this property, has advised that the transactional market evidence used is continuing to be impacted by uncertainty caused by the COVID-19 pandemic. Therefore less certainty and a higher degree of caution should be applied to the properties reported value than normally the case.
ANNUAL REPORT 2022|105
Latest
independent
valuationFair valueMarket capitalisation rateOccupancyWALE
PropertiesLocationSub sectorMajor TenantDate
$M
Jun-22
$M
Jun-21
%
Jun-22
%
Jun-21
%
Jun-22
%
Jun-21
Years
Jun-22
Years
Jun-21
Australia
New South Wales
Lingard Private HospitalMerewether, New South WalesHospital (Acute)Healthe CareJun-22224.6193.94.14.5100.0100.023.724.7
Maitland Private HospitalEast Maitland, New South WalesHospital (Acute/Specialty)Healthe CareJun-22133.9118.34.85.1100.0100.015.516.5
Hurstville Private HospitalHurstville, New South WalesHospital (Acute)Healthe CareDec-2191.380.65.85.8100.0100.019.820.8
The Hills ClinicKellyville, New South WalesHosptial (Specialty)AuroraJun-2264.254.44.04.5100.0100.025.026.0
Toronto Private HospitalToronto, New South WalesHospital (Acute/Specialty)AuroraJun-2254.047.75.05.4100.0100.020.121.1
Mons Road Medical CentreWestmead, New South WalesAmbulatory CareCastlereagh ImagingJun-2248.739.74.85.494.594.52.93.6
Lingard Day CentreMerewether, New South WalesAmbulatory CareHealthe CareJun-2247.340.64.14.5100.0100.023.724.7
Hirondelle Private HospitalChatswood, New South WalesHospital (Specialty)AuroraJun-2234.030.25.05.3100.0100.019.920.9
Fairfield Aged CareFairfield, New South WalesAged CareHall & PriorDec-2121.619.36.36.3100.0100.013.714.7
Darlington Aged CareBanora Point, New South WalesAged CareBolton ClarkeJun-2219.918.36.06.3100.0100.014.315.3
Clover Lea Aged CareBurwood Heights, New South WalesAged CareHall & PriorDec-2115.414.16.36.3100.0100.013.714.7
Grafton Aged CareSouth Grafton, New South WalesAged CareHall & PriorDec-2112.811.97.07.0100.0100.014.815.8
Victoria
Epworth Eastern HospitalBox Hill, VictoriaHospital (Acute)Epworth FoundationDec-21448.8375.24.04.395.0100.020.517.8
South Eastern Private HospitalNoble Park, VictoriaHospital (Specialty)AuroraJun-22100.186.04.34.8100.0100.018.719.7
Epworth CamberwellCamberwell, VictoriaHospital (Specialty)Epworth FoundationJun-2284.778.14.24.3100.0100.019.020.0
Ekera Medical CentreBox Hill, VictoriaAmbulatory CareImaging AssociatesDec-2136.533.35.05.3100.0100.02.93.3
Epworth Rehabilitation
1
Brighton, VictoriaHospital (Specialty)Epworth FoundationJun-2229.929.05.35.5100.0100.01.62.6
120 Thames StreetBox Hill, VictoriaAmbulatory CareEpworth FoundationDec-2113.313.05.56.559.6100.02.53.6
Queensland
Belmont Private HospitalCarina Heights, QueenslandHospital (Specialty)AuroraDec-21161.8133.54.04.3100.0100.023.224.2
Palm Beach Currumbin ClinicCurrumbin, QueenslandHospital (Specialty)AuroraJun-2281.969.24.34.8100.0100.013.214.2
The Southport Private HospitalSouthport, QueenslandHospital (Acute/Specialty)Ramsay Health CareDec-2157.551.44.85.0100.0100.022.723.7
Eden Rehabilitation
1
Cooroy, QueenslandHospital (Acute/Specialty)AuroraJun-2235.733.05.35.3100.0100.015.416.4
Baycrest Aged CareHervey Bay, QueenslandAged CareBolton ClarkeJun-2221.619.86.06.3100.0100.014.015.0
Gold Coast Surgery CentreSouthport, QueenslandAmbulatory CareSouth Coast Radiologyn.a.-12.2-7.5-88.9-1.4
Tantula Rise Aged CareAlexandra Headland, QueenslandAged CareBolton ClarkeJun-2226.824.76.06.3100.0100.014.015.0
Western Australia
Marian CentreWembley, Western AustraliaHospital (Specialty)AuroraDec-2166.357.84.44.6100.0100.012.113.1
Abbotsford Private HospitalWest Leederville, Western AustraliaHospital (Specialty)AuroraDec-2154.737.94.34.5100.0100.019.620.6
Hamersley Aged CareSubiaco, Western AustraliaAged CareHall & PriorDec-2114.913.56.56.8100.0100.013.714.7
Rockingham Aged CareRockingham, Western AustraliaAged CareHall & PriorDec-218.17.36.87.0100.0100.013.714.7
South Australia
Tennyson CentreKurralta Park, South AustraliaAmbulatory CareICON Cancer CareJun-22106.8-4.5-100.0-3.8-
Sportsmed Hospital, Clinic & Cons.Stepney, South AustraliaHospital (Acute)Sportsmed SAJun-2292.483.35.05.3100.0100.013.614.6
Playford Health - Retail & CarparkElizabeth Vale, South AustraliaAmbulatory CareSA HealthJun-2224.3-5.5-53.9-9.5-
Total Australia2233.81827.04.54.898.699.717.118.2
1The independent valuer, in determining or informing the fair value for this property, has advised that the transactional market evidence used is continuing to be impacted by uncertainty caused by the COVID-19 pandemic. Therefore less certainty and a higher degree of caution should be applied to the properties reported value than normally the case.
106|VITAL HEALTHCARE PROPERTY TRUST
Notes to the Consolidated Financial Statements
Latest
independent
valuationFair valueMarket capitalisation rateOccupancyWALE
PropertiesLocationSub sectorMajor TenantDate
$M
Jun-22
$M
Jun-21
%
Jun-22
%
Jun-21
%
Jun-22
%
Jun-21
Years
Jun-22
Years
Jun-21
New Zealand
Ascot Hospital & ClinicsGreenlane, AucklandHospital (Acute)Ascot Hospital and Clinics LimitedDec-21140.5126.34.44.6100.099.515.817.0
Grace HospitalTauranga, Bay of PlentyHospital (Acute)Norfolk Southern Cross LimitedDec-21115.5104.54.64.8100.0100.028.529.5
Wakefield HospitalNewtown, WellingtonHospital (Acute)Evolution HealthcareDec-21128.199.64.84.9100.0100.025.426.4
Royston HospitalHastings, Hawkes BayHospital (Acute)Evolution HealthcareDec-2198.381.34.85.0100.0100.027.428.4
Bowen HospitalCrofton Downs, WellingtonHospital (Acute)Evolution HealthcareDec-2178.263.54.54.8100.0100.027.428.4
Ormiston HospitalFlatbush, AucklandHospital (Acute)Ormiston Surgical and Endoscopy LimitedDec-2152.645.44.85.3100.0100.01.92.6
68 Saint Asaph StChristchurch Central, ChristchurchAmbulatory CareSyft Technologies LimitedJun-2252.2-4.5-100.0-7.8-
Boulcott HospitalLower Hutt, WellingtonHospital (Acute)Boulcott Pulse Health LimitedDec-2151.547.04.85.0100.0100.016.017.0
Ascot CentralGreenlane, AucklandAmbulatory CareFertility Associates LimitedDec-2144.843.34.85.3100.080.96.76.5
Hutt Valley Health HubLower Hutt, WellingtonAmbulatory CareRopata Health LimitedJun-2241.7-4.3-100.0-13.7-
Apollo Health & Wellness CentreAlbany, AucklandAmbulatory CareApollo Medical LimitedDec-2132.327.65.35.884.884.07.28.1
Kensington HospitalWhangarei, NorthlandHospital (Acute)Kensington Hospital LimitedDec-2127.523.25.15.3100.0100.024.025.0
Endoscopy AucklandEpsom, AucklandAmbulatory CareEvolution HealthcareJun-2220.3-4.5-100.0-19.9-
Napier Health CentreNapier, Hawkes BayAmbulatory CareHawke's Bay District Health BoardDec-2118.016.35.96.0100.0100.011.512.5
Ascot Carpark (right of use asset)Greenlane, AucklandHospital (Acute)Ascot Hospital and Clinics LimitedDec-218.17.98.48.892.289.813.514.6
Total New Zealand909.6685.84.75.099.297.518.720.7
Properties held for development195.8121.5
TOTAL FAIR VALUE OF
INVESTMENT PROPERTIES3339.22634.34.64.998.899.217.618.7
ANNUAL REPORT 2022|107
Latest
independent
valuationFair valueMarket capitalisation rateOccupancyWALE
PropertiesLocationSub sectorMajor TenantDate
$M
Jun-22
$M
Jun-21
%
Jun-22
%
Jun-21
%
Jun-22
%
Jun-21
Years
Jun-22
Years
Jun-21
New Zealand
Ascot Hospital & ClinicsGreenlane, AucklandHospital (Acute)Ascot Hospital and Clinics LimitedDec-21140.5126.34.44.6100.099.515.817.0
Grace HospitalTauranga, Bay of PlentyHospital (Acute)Norfolk Southern Cross LimitedDec-21115.5104.54.64.8100.0100.028.529.5
Wakefield HospitalNewtown, WellingtonHospital (Acute)Evolution HealthcareDec-21128.199.64.84.9100.0100.025.426.4
Royston HospitalHastings, Hawkes BayHospital (Acute)Evolution HealthcareDec-2198.381.34.85.0100.0100.027.428.4
Bowen HospitalCrofton Downs, WellingtonHospital (Acute)Evolution HealthcareDec-2178.263.54.54.8100.0100.027.428.4
Ormiston HospitalFlatbush, AucklandHospital (Acute)Ormiston Surgical and Endoscopy LimitedDec-2152.645.44.85.3100.0100.01.92.6
68 Saint Asaph StChristchurch Central, ChristchurchAmbulatory CareSyft Technologies LimitedJun-2252.2-4.5-100.0-7.8-
Boulcott HospitalLower Hutt, WellingtonHospital (Acute)Boulcott Pulse Health LimitedDec-2151.547.04.85.0100.0100.016.017.0
Ascot CentralGreenlane, AucklandAmbulatory CareFertility Associates LimitedDec-2144.843.34.85.3100.080.96.76.5
Hutt Valley Health HubLower Hutt, WellingtonAmbulatory CareRopata Health LimitedJun-2241.7-4.3-100.0-13.7-
Apollo Health & Wellness CentreAlbany, AucklandAmbulatory CareApollo Medical LimitedDec-2132.327.65.35.884.884.07.28.1
Kensington HospitalWhangarei, NorthlandHospital (Acute)Kensington Hospital LimitedDec-2127.523.25.15.3100.0100.024.025.0
Endoscopy AucklandEpsom, AucklandAmbulatory CareEvolution HealthcareJun-2220.3-4.5-100.0-19.9-
Napier Health CentreNapier, Hawkes BayAmbulatory CareHawke's Bay District Health BoardDec-2118.016.35.96.0100.0100.011.512.5
Ascot Carpark (right of use asset)Greenlane, AucklandHospital (Acute)Ascot Hospital and Clinics LimitedDec-218.17.98.48.892.289.813.514.6
Total New Zealand909.6685.84.75.099.297.518.720.7
Properties held for development195.8121.5
TOTAL FAIR VALUE OF
INVESTMENT PROPERTIES3339.22634.34.64.998.899.217.618.7
108|VITAL HEALTHCARE PROPERTY TRUST
Notes to the Consolidated Financial Statements
(6.g) Recognition and Measurement
Recognition and measurement
Investment Property
Investment properties are initially measured at cost, including any related transaction costs. Expenditure is capitalised to a property's
carrying value only when its cost can be measured reliably and it is probable that future economic benefits will flow to the Group. All other
repairs and maintenance expenditure is charged to the statement of comprehensive income.
Subsequent to initial recognition, investment properties, including investment properties held for sale, are measured at fair value (inclusive
of adjustments for straight line rental revenue recognition, unamortised lease incentives and costs, and capital expenditure obligations) with
any gains or losses arising on re-measurement recognised in
profit or loss.
Lessee arrangements and Right-of-Use assets
On inception of a lease arrangement, the lease liability is initially measured as the aggregate of fixed and variable lease payments due
(net of incentives receivable), expected residual value guarantees and the exercise price of purchase options (if reasonably certain to be
exercised) and expected lease termination payments, discounted using the interest rate implicit in the lease, or if this cannot be determined,
the Group's incremental cost of borrowing.
Subsequent to initial recognition, lease payments are allocated between finance costs (which is expensed to the consolidated statement
of comprehensive income over the term of the lease using the effective interest rate method) and a reduction of the initial lease liability
recognised. Refer to Note
12 for the lease liabilities recognised by the Group.
Right-of-Use assets are initially measured at cost, comprising the aggregate of the initial measurement of the lease liability (net of
incentives received), lease payments made before commencement date, initial direct costs and restoration costs and are classified as
Investment Property.
Subsequent to initial recognition right-of-use assets are measured at fair value.
Development of investment property
Investment property that is being developed is measured at cost until either its fair value becomes reliably measurable or the development
reaches practical completion. Borrowing costs are capitalised from when activities to prepare the property for development commence, until
the property is substantially ready for use.
Rental income
Rental income from investment properties is comprised of lease components (including base rent, recovery of property taxes and insurance)
and non-lease components (including property outgoings recoveries). Rental income is recognised at the fair value of consideration
receivable (excluding GST).
Rental income relating to lease components is recognised on a straight-line basis over the term of the lease for the period where the rental
income is fixed and determinable. For leases where the rental income is determined based on unknown future variables such as inflation,
market reviews or other factors, rental income is recognised on an accruals basis in accordance with the terms of the lease.
Rental income from property outgoing recoveries is recognised as the costs are incurred, which is typically when the services are provided.
Rental income not received at reporting date is reflected in the consolidated statement of financial position as a receivable or, if paid in
advance, as income in advance.
Lease incentives, commissions and other costs
Lease incentives provided to tenants, such as fit-outs or rent free periods, and leasing commissions and other costs incurred when entering
into a lease are recognised as a reduction of net property income on a straight-line basis over the non-cancellable term of the lease.
ANNUAL REPORT 2022|109
Derecognition
An investment property is derecognised upon disposal or when no future economic benefits are expected from use. The gain or loss arising
on derecognition of the property is measured as the difference between the net proceeds from disposal and the carrying amount at disposal
date and is recognised in the consolidated statement of comprehensive income in the period in which the property is derecognised.
Valuation process
The purpose of the valuation process is to ensure that investment properties are held at fair value. In accordance with the Group's valuation
policy, external valuations are performed by independent professionally
qualified valuers who hold a recognised and relevant professional
qualification and have specialised expertise in the type of investment property being valued. The valuation policy requires that a valuer
may not value the same property for more than two consecutive valuations. All valuations are reviewed by the Manager and approved by
the Board.
The fair value of investment property as at 30 June 2022 was determined through independent professional valuers for approximately 42%
of the portfolio and the remainder was determined by the Manager. The Manager's valuations were informed by market data and valuation
advice provided by independent valuers, comparable transactional evidence and current period leasing activities. The valuers of properties
which have been independently valued at 30 June 2022 included: Ernst & Young, Colliers International, Jones Lang LaSalle Australia,
Valued Care, Absolute Value and CBRE. The properties which have been independently valued at 30 June 2022 are disclosed above in
Note 6.f.
The methods used for assessing the fair value of investment property are the Direct Comparison, Discounted Cash Flow (using a risk adjusted
discount rate), Capitalisation of Contract and Market Income approaches and are unchanged from the prior year. The principal factors
that
influence a valuation include the market capitalisation / discount rates, occupancy, market rent assessments and the weighted average
lease term to expiry (WALE).
COVID-19 impact
In determining the fair value of investment properties at 30 June 2022, some independent professionally qualified valuers advise that due
to the continued uncertainty caused by the COVID-19 pandemic, asset values could change quickly if market circumstances change, and
therefore general caution should be exercised when relying on reported valuations. While market evidence and transactional activity has
increased in the period to 30 June 2022, some valuers still advise that less certainty and a high degree of caution should be attached to
independent property valuations. Directors’ valuations at 30 June 2022 have been informed by this recent evidence. Refer to note 6.f.
Fair Value Hierarchy
Investment properties are classified as Level 3 under the fair value valuation hierarchy. This level 3 classification refers to a valuation
technique that uses inputs that are not based on observable market data (i.e. unobservable inputs are used).
Significant
estimates and judgements
Generally, as:
•occupancy and weighted average lease term, term to expiry increase, yields firm, resulting in increased fair values for investment
properties and vice versa;
•capitalisation rates and discount rates used in the valuation approaches decrease (firm), the fair value of the investment property will
increase, and vice versa.
110|VITAL HEALTHCARE PROPERTY TRUST
Notes to the Consolidated Financial Statements
7. Other Expenses
2022
$000s
2021
$000s
Other Expenses
Auditor's remuneration:
Audit and review of financial statements197197
AGM scrutineering33
Manager's fees15,73713,014
Manager's incentive fee15,91412,402
Trustee fees532654
Other operating expenses4,8524,645
Total other expenses37,23530,915
Deloitte has been engaged to provide gap analysis activities as the Group prepares for the Climate-related Disclosures standards.
ANNUAL REPORT 2022|111
Capital Structure, Financing and Risk Management
This section outlines how the Group manages its capital structure and related financing activities and presents the resultant returns delivered
to unit holders via distributions and earnings per unit.
8. Units on Issue
2022
$000s
2021
$000s
Balance at the beginning of the year777,199594,752
Issue of units under Distribution Reinvestment Plan23,79118,983
Issue of units under placement and unit purchase plan142,803159,650
Issue of units under rights issue200,014-
Issue of units to satisfy Manager's incentive fee12,4276,450
Issue costs of units(5,353)(2,636)
Balance at the end of the year1,150,881777,199
2022
000s
2021
000s
Reconciliation of number of units
Balance at the beginning of the year519,753453,783
Issue of units under the Distribution Reinvestment Plan8,1096,388
Issue of units under placement and unit purchase plan49,40157,017
Issue of units under rights issue67,801-
Units issued to satisfy Manager's incentive fee4,0912,565
Balance at the end of the year649,155519,753
Distributions for the financial year were 9.625 cents per unit (2021: 8.875 cents per unit) including the final quarter distribution of 2.4375
cents per unit (2021: 2.25 cents per unit) declared subsequent to the reporting date. Refer Note 21.
On 20 October 2021, 39,655,172 units were issued at $2.90 per unit under an underwritten placement and on 10 November 2021,
9,746,042 units were issued at $2.852 per unit under a unit purchase plan. (2021: On 13 October 2020, 44,642,858 units were issued
at $2.80 per unit under an underwritten placement and on 4 November 2020, 11,607,176 units were issued at $2.80 per unit under a unit
purchase plan).
On 6 May 2022, 37,238,343 units were issued at $2.95 per unit under an underwritten institutional rights offer and on 19 May 2022,
30,562,909 units were issued at $2.95 per unit under an underwritten retail rights offer.
Recognition and measurement
Issued capital
Issued and paid up units are recognised at the fair value of the consideration received by the Group, net of directly incurred transaction
costs. Fully paid ordinary units carry one vote per unit and carry the right to distributions.
Distributions are recognised as a liability in the Group’s financial statements in the period in which the distributions are declared.
112|VITAL HEALTHCARE PROPERTY TRUST
Notes to the Consolidated Financial Statements
Share based payments (Managers incentive fee)
Subject to the Trust Deed, the Manager is entitled to an incentive fee that is settled in newly issued units (i.e. a share based payment). As
such, the incentive fee expense is recognised in the share based payment reserve as the services are provided until such a time as it is settled
via the issuance of new units, at which point the amount is reclassifed to units on issue.
On 30 August 2021, 4,090,950 units were issued against the 2021 Manager’s incentive fee of $12.4 million (2021: 2,565,076 were
issued against the 2020 Manager’s incentive fee of $6.5 million).
Capital risk management
The Manager's objective when managing the capital of the Group is to ensure compliance with the capital requirements under the Trust
Deed (i.e. total borrowings do not exceed 50% of the gross value of the Trust Fund) and that the Group will be able to continue as a going
concern while maximising the return to investors through the optimisation of the Group's cost of capital. The Manager maintains or adjusts the
capital of the Group through various methods including by adjusting the quantum of distributions paid, raising or repaying debt, issuing or
buying back units, or buying or selling assets.
As at reporting date, the Group's total borrowings to the Gross Value of the Group (as defined in the Trust Deed) was 30.0% (2021: 35.0%).
The Group’s policies in respect of capital management and allocation are reviewed regularly by the Board of Directors. There have been
no material changes in the Group’s overall capital risk management strategy during the year.
9.
Earnings per Unit
20222021
Profit attributable to unit holders of the Trust ($000s)303,522278,392
Weighted average number of units on issue (000's of units)569,104497,892
Basic and diluted earnings per unit (cents)53.3355.91
Recognition and measurement
Basic and diluted earnings per unit is calculated by dividing the profit attributable to unit holders of the Trust by the weighted average
number of ordinary units on issue during the year.
ANNUAL REPORT 2022|113
10. Distributable Income
Statutory profit attributable to unit holders is determined in accordance with NZ GAAP and includes a number of non-cash items including
fair value movements, straight line lease accounting adjustments and amortisation of borrowing and leasing costs and incentives.
The Manager uses Adjusted Funds from Operations (AFFO) and AFFO per unit as the Group's key performance metric, representative of
the Group's underlying performance, and as a guide to informing the Group's distribution policy. AFFO adjusts statutory operating profit for
certain items that are non-cash, unrealised, capital in nature or are one-off or non-recurring (i.e. outside the Group's ordinary operations or
not reflective of its underlying performance). As AFFO is a non GAAP measure it may not be directly comparable with AFFO presented by
the Group's peers.
A reconciliation of statutory operating profit to AFFO and AFFO per unit is outlined as follows:
2022
$000s
2021
$000s
Adjusted funds from operations
Operating profit before tax and other income56,51751,064
Add/(deduct):
Current tax expense(8,280)(7,858)
Incentive fee15,91412,402
Strategic transaction expenses283-
Current tax on translation of foreign currency funding transactions98227
Amortisation of borrowing costs1,270878
Amortisation of leasing costs & tenant inducements2,7782,421
IFRS 16 Operating lease accounting(163)(144)
Funds from operations (FFO)68,41758,990
Add/(deduct):
Actual capex from continuing operations(593)(1,533)
Adjusted funds from operations (AFFO)67,82457,457
AFFO (cpu)11.9211.54
Distribution per unit (cpu)9.6258.875
AFFO payout ratio81%77%
Units on issue (weighted average, 000s)569,104497,892
114|VITAL HEALTHCARE PROPERTY TRUST
Notes to the Consolidated Financial Statements
11. Borrowings
2022
$000s
2021
$000s
AUD denominated loans1,018,777807,377
NZD denominated loans-125,000
Borrowing costs(5,825)(3,077)
Total borrowings1,012,952929,300
Current liability-114,405
Non current liability1,012,952814,895
Total borrowings1,012,952929,300
2022
$000s
2021
$000s
Total borrowings at the beginning of the year929,300813,515
Drawdowns during the year835,1111,204,354
Repayments during the year(780,338)(1,092,839)
Additional facility refinancing fee(4,018)(2,523)
Facility refinancing fee amortised during the year1,270878
Foreign exchange movement31,6275,915
Total borrowings at the end of the year1,012,952929,300
Recognition and measurement
Borrowings are initially measured at fair value, net of transaction costs. Subsequent to initial recognition, borrowings are measured at
amortised cost using the effective interest rate method. Gains and losses on derecognition are recognised in the consolidated statement of
comprehensive income in the period in which they arise. The carrying values of these balances are approximately equivalent to their fair
values because the loans have floating rates of interest that generally reset every 90 days.
Borrowings are classified as current liabilities unless the Group has an unconditional right to defer settlement of the facility for at least 12
months after the reporting date.
ANNUAL REPORT 2022|115
(11.a) Summary of Borrowing Arrangements
On 25th February 2021 the Group replaced its syndicated revolving multi-currency facility with a club financing arrangement governed by
a common terms deed and bi-lateral facility agreements. Currently there are six financiers (2021: 5 financiers) that provide facilities to the
Group. The facilities' expiry profile and undrawn limits are as follows:
Jun-22Jun-21
A$m LimitA$m UndrawnExpiryA$m LimitA$m UndrawnExpiry
Common Terms Deed - AUD
Facility A1100.0-Oct-28--n.a.
Facility A2125.0-Oct-23125.0-Oct-23
Facility A475.075.0Mar-29--n.a.
Facility A575.044.3Mar-25--n.a.
Facility B1100.0-Apr-24--n.a.
Facility C162.5-Mar-2662.5-Mar-25
Facility C262.5-Mar-2762.5-Mar-25
Facility C3125.0-Mar-27--n.a.
Facility D1125.0-Mar-27125.0-Feb-26
Facility D275.0-Mar-25--n.a.
Facility K170.170.1Mar-2670.1-Feb-26
Facility K221.0-Oct-26--n.a.
Facility L75.0-Sep-28--n.a.
Facility M19.0-Oct-26--n.a.
Facility A3---62.5-Jul-22
Facility B2---137.5-Jul-22
Facility E1---50.050.0Nov-21
Facility E2---50.022.8Nov-21
Facility F1---75.070.7Jan-22
Facility F2---75.0-Jan-22
Total AUD Facility1,110.1189.4895.1143.5
Common Terms Deed - NZD
NZ$m LimitNZ$m UndrawnExpiryNZ$m LimitNZ$m UndrawnExpiry
Facility A50.050.0Oct-2350.0-Oct-23
Facility B75.075.0Mar-2675.0-Mar-26
Total NZD Facility125.0125.0125.0-
In addition to the above, the Group has available a A$5.0m (2021: $Nil) bank guarantee facility of which A$0.6m (2021: $Nil) has been
utilised at the reporting date.
The facilities provided are governed by the common terms deed and are secured and cross collateralised over the Group's investment
properties (by first ranking real property mortgages) and other assets (via a first ranking general 'all assets' security agreement).
The common terms deed contains both financial and non-financial covenants and undertakings that are customary for secured facilities of
this nature. The key financial covenants (with capitalised terms being defined terms in the common terms deed) are as follows:
116|VITAL HEALTHCARE PROPERTY TRUST
Notes to the Consolidated Financial Statements
Covenant
2022
Actual
2021
Actual
Banking Covenants
Loan to value ratio< 55%32.1%38.0%
Interest cover> 2.00x3.202.88
Total EBITDA of Obligors v total EBITDA of GroupNot < 95%100%100%
Total assets of Obligors v total assets of GroupNot < 95%100%100%
Total value of unmortgaged properties v total assets of GroupNot > 10%3.4%4.8%
(11.b) Finance Expense
2022
$000s
2021
$000s
Expenses
Interest expense35,11632,571
Borrowing costs capitalised(5,921)(4,852)
Total finance expenses29,19527,719
The effective interest rate on borrowings, incorporating interest rate hedges, as at the reporting date was 3.73% per annum (2021: 3.32%).
Recognition and measurement
Interest expense is recognised in the consolidated statement of comprehensive income using the effective interest rate method except where
it is incurred in relation to a qualifying asset, where it is capitalised during the period of time that is required to hold, complete and/or
prepare the asset for its intended use. It comprises interest payable on borrowings and interest paid on interest rate hedging instruments.
The effective interest rate method calculates the amount to be recognised over the relevant period at the rate that exactly discounts estimated
future cash payments through the expected life of the financial instrument or a shorter period where appropriate, to the net carrying amount
on initial recognition.
12.
Lease Liabilities
The Group holds a ground lease over the car parks at the rear of Ascot Hospital and Ascot Central that has a weighted average term
remaining of 16.8 years (2021: 17.8 years).
13.
Derivative Financial Instruments
(13.a) Interest Rate Swaps
The Group has exposure to debt facilities that are subject to floating interest rates. The Group uses derivative financial instruments, on a
portfolio basis, to manage its exposure to interest rates such as interest rate swaps (to lock-in fixed interest rates) and/or interest rate caps
(to limit exposure to rising floating interest rates). At the reporting date, 44.5% of borrowings were at fixed rates (2021: 49.0%). Refer
Note14.c for further information on the Group's exposure to interest rate risk.
All derivative financial instrument providers receive the benefit of pari-passu security and cross collateralisation rights over the
Group’s investment properties (via first registered real property mortgages) and other assets (via a first ranking general 'all assets'
security agreement).
Generally, interest rate contracts settle on a quarterly basis coinciding with the dates on which the interest is payable on the underlying debt.
The floating rate incurred on the debt is based on New Zealand BKBM or Australian BBSW. The difference between the fixed and floating
interest rate is generally settled on a net basis by the relevant counterparty. The interest rate contracts have not been identified as hedging
instruments and any movements in their fair value are recognised immediately in the consolidated statement of comprehensive income.
ANNUAL REPORT 2022|117
2022
$000s
2021
$000s
Non-current assets
Interest rate derivative assets20,692-
Current liabilities
Interest rate derivative liabilities(93)(640)
Non-current liabilities
Interest rate derivative liabilities(149)(40,379)
Total20,450(41,019)
During the period the Group recognised a fair value gain of $61.5m (2021: $22.4m gain) on interest rate contracts. The Group's interest
rate swaps outstanding at the reporting date are as follows:
2022
$000s
2021
$000s
Nominal value of interest rate swaps - AUD410,000425,000
Average fixed interest rate2.89%2.94%
Floating rates based on AUD BBSW1.51%0.12%
Interest rate derivatives mature over the next eight years and have fixed interest rates ranging from 1.54% to 4.23% (2021: from 1.54%
to 4.35%).
Recognition and measurement
Interest rate derivatives are categorised as financial instruments at fair value through profit or loss and are initially recognised and
subsequently measured at fair value derived from counterparty bank valuations. Counterparty bank valuations are tested for reasonableness
by discounting the estimated future cashflows and using market interest rates for a substitute instrument at the measurement date. The resulting
gain or loss is recognised immediately in the consolidated statement of comprehensive income as hedge accounting has not been applied.
(13.b)
Forward Exchange Contracts
The Group has exposure to foreign currency risk arising from owning investment property in Australia. Derivative financial instruments, such
as forward exchange contracts, may be used to reduce its exposure to foreign exchange risk by locking in the conversion of Australian
dollar denominated income (transaction hedging) or net assets (translation hedging) to New Zealand dollars. Refer Note14.c for further
details on the Group's exposure to foreign exchange risk.
Transaction hedging arrangements generally settle on a quarterly basis while translation hedging arrangements settle on a periodic basis
depending on the term of the contract. At reporting date forward exchange contracts have not been designated as hedging instruments and
any movements in the fair value are recognised immediately in the consolidated statement of comprehensive income.
118|VITAL HEALTHCARE PROPERTY TRUST
Notes to the Consolidated Financial Statements
2022
$000s
2021
$000s
Current assets
Foreign exchange derivative assets2542
Current liabilities
Foreign exchange derivative liabilities(442)(77)
Non-current liabilities
Foreign exchange derivative liabilities(1)-
Total(418)(35)
During the period the Group recognised a fair value loss of $0.66m (2021: $0.28m gain) on forward exchange contracts. The Group's
forward exchange contracts outstanding at the reporting date are as follows:
2022
$000s
2021
$000s
Nominal value of foreign exchange contracts - AUD26,50018,100
Average foreign exchange rate0.91340.9199
Recognition and measurement
Foreign exchange derivatives are categorised as financial instruments at fair value through profit or loss and are initially recognised and
subsequently measured at fair value derived from counterparty bank valuations. Counterparty bank valuations are tested for reasonableness
by using a valuation model based on the applicable forward price curves derived from observable forward prices. As hedge accounting
has not been applied any resulting gain or loss is recognised immediately in the consolidated statement of comprehensive income.
(13.c)
Fair value hierarchy
The fair value hierarchy categorises the inputs used in valuation techniques into the following three categores based on the degree to which
the inputs used to measure fair value are observable:
Level 1 fair value measurements are those derived from quoted prices in active markets for identical assets or liabilities.
Level 2 fair value measurements are those derived from inputs other than quoted prices included within Level 1 that are observable for the
asset or liability, either directly (that is, as prices) or indirectly (that is, derived from prices).
Level 3 fair value measurements are those derived from valuation techniques that include inputs for the asset or liability that are not based on
observable market data (unobservable inputs).
The Group has determined that interest rate swaps and foreign exchange contract derivatives are valued using Level 2 inputs (observable
prices of similar instruments). There have been no reclassifications between levels in the current year (2021: nil).
14.
Financial and Risk Management
The Group’s activities expose it primarily to credit risk, market risk (interest rate risk and foreign exchange risk) and liquidity risk. The Group’s
overall risk management programme focuses on the unpredictability of financial markets and seeks to minimise potential adverse effects on
the Group’s financial performance. The Group uses financial derivatives to manage market risks. The use of financial derivatives is governed
by the Group’s policies approved by the Board, which provide written principles that are consistent with the Group’s risk management
strategy. The Group does not use derivative financial instruments for speculative purposes.
ANNUAL REPORT 2022|119
(14.a) Financial Instruments
The Group has the following financial instruments:
•cash and cash equivalents;
•receivables;
•payables;
•borrowings; and
•derivative financial instruments.
Transactions in these instruments expose the Group to a variety of financial risks including market risk (which includes interest rate risk, foreign
exchange risk and other price risks), credit risk and liquidity risks.
Categories of financial instruments
The Group’s financial instruments are classified as:
Financial assets
at amortised
cost
$000s
Financial
liabilities at
amortised cost
$000s
Financial
assets at fair
value through
profit or loss
$000s
Financial
liabilities at fair
value through
profit or loss
$000s
30 June 202224,497(1,048,970)20,717(685)
30 June 20218,514(974,542)245(41,019)
Cash, cash equivalents, trade and other receivables, trade and other payables and borrowings
The carrying values of these financial instruments approximate their fair values because of their short terms to maturity or interest reset dates.
(14.b)
Credit Risk
The Group is subject to credit risk (the risk that a counterparty will default on its contractual obligations resulting in financial loss to the
Group) predominately through its trade and other receivables, derivatives and cash exposures. The maximum exposure to credit risk at a
reporting date is the carrying value of each financial asset as disclosed in the applicable note to the financial statements.
Credit risk is managed by:
•ensuring that at the time of entering into a contractual arrangement or acquiring a property, counterparties or tenants are of appropriate
credit worthiness, provide appropriate security or other collateral and/or do not show a history of default;
•seeking to optimise tenant mix by actively managing the property portfolio composition and leasing arrangements; and
•only entering into foreign exchange and interest rate derivative transactions and placing cash and deposits with high credit quality
financial institutions.
The Group applies an expected credit losses (ECL's) model (simplified approach) that uses historical experience, external indicators and
forward looking information to calculate the expected lifetime credit loss for financial assets carried at amortised cost.
The expected lifetime credit loss of trade receivables is assessed on a collective basis (grouped based on days past due), reflecting shared
credit characteristics, and is determined based on the forecast shortfalls in contractual cash flows considering the potential for default at any
point during the life of the financial instrument. Details of the expected credit loss recognised in relation to trade receivables is disclosed
in Note17.a.
(14.c)
Market Risk
The Group is subject to market risk (the risk that borrowings or derivatives are repriced to different interest rate margins on refinance or
renewal arising from changes in the debt markets), interest rate risk (the risk of a change in interest rates may impact the Group’s profitability,
cashflows and/or financial position) and foreign exchange risk (the risk of a change in foreign exchange rates on translation of foreign
120|VITAL HEALTHCARE PROPERTY TRUST
Notes to the Consolidated Financial Statements
currency denominated assets, liabilities, revenue and expenses) predominantly through its investment property, borrowings, derivatives and
cash exposures.
The interest rates applicable to each category of financial instrument are disclosed in the relevant note to the financial statements.
Interest rate risk
The following table indicates the effective interest rates and the earliest period in which financial instruments reprice. Fixed rate balances are
presented with the effect of hedging derivatives:
Weighted
effective
interest rate
%
Less than
1 year
$000s
1-2 years
$000s
2-3 years
$000s
3+ years
$000s
Total
$000s
30 June 2021
Cash and cash equivalents
(floating rates)
0.12%6,880---6,880
Borrowings (floating rates)1.28%(475,829)---(475,829)
Borrowings (fixed rates)4.10%(16,113)(21,485)(32,227)(386,723)(456,548)
(485,062)(21,485)(32,227)(386,723)(925,497)
30 June 2022
Cash and cash equivalents
(floating rates)
1.51%22,055---22,055
Borrowings (floating rates)2.39%(565,087)---(565,087)
Borrowings (fixed rates)3.77%(22,131)(33,197)(22,131)(376,231)(453,690)
(565,163)(33,197)(22,131)(376,231)(996,722)
Interest rate sensitivity
The Group’s sensitivity to interest rate risk can be expressed in two ways:
Fair value sensitivity
A change in interest rates impacts the fair value of the Group’s fixed rate financial instruments. Fair value changes impact profit or loss or
equity only where the instruments are carried at fair value. Accordingly, the fair value sensitivity to a 100 bps movement in interest rates
(based on the financial instruments held at reporting date) is:
Impact on
profit/(loss)
2022
$000s
Impact on
unit holders'
funds
2022
$000s
Impact on
profit/(loss)
2021
$000s
Impact on
unit holders'
funds
2021
$000s
If interest rates had been 100 bps higher:17,42917,42924,01824,018
If interest rates had been 100 bps lower:(18,423)(18,423)(25,591)(25,591)
Cash flow sensitivity analysis
A change in interest rates impacts interest income and expense on the Group’s interest bearing floating rate financial instruments.
Accordingly, the one-year cash flow sensitivity to a 100 bps movement in interest rates (based on the financial instruments held at reporting
date) is:
ANNUAL REPORT 2022|121
Impact on
profit/(loss)
2022
$000s
Impact on
unit holders'
funds
2022
$000s
Impact on
profit/(loss)
2021
$000s
Impact on
unit holders'
funds
2021
$000s
If interest rates had been 100 bps higher:(5,651)(5,651)(3,223)(3,223)
If interest rates had been 100 bps lower:5,6515,6513,2233,223
Foreign exchange risk
The following table presents the foreign currency risk that the Group is exposed to arising from Australian dollar (AUD) denominated assets
and liabilities:
2022
$000s
2021
$000s
Non-financial instrument assets and liabilities denominated in Australian dollars
Investment properties2,391,2271,933,502
Other assets12,66011,824
Deferred tax(166,724)(129,361)
Total non-financial instrument assets and liabilities2,237,1631,815,965
Non-derivative financial instruments
Cash and cash equivalents4,4163,208
Trade and other receivables1,7021,337
Trade and other payables(23,370)(43,953)
Borrowings(1,018,777)(807,377)
Total exposure from non-derivative financial instruments(1,036,029)(846,785)
Derivative financial instruments
Foreign exchange derivatives(418)245
Interest rate swaps20,450(41,019)
Total exposure from derivative instruments20,032(40,774)
Net exposure to currency risk1,221,166928,406
Foreign currency sensitivity
A change in the New Zealand dollar (NZD) / AUD exchange rate impacts profit after tax and equity on the conversion of AUD
denominated assets, liabilities, revenue and expenses. A 10% change in the exchange rate (2021:10%), based on year end exposures, has
the following effect:
2022
$000s
2021
$000s
If the New Zealand Dollar versus the Australian Dollar was 10% higher for the year:
Profit and loss2,8644,837
Other comprehensive income(106,633)(90,198)
Unit Holders' funds(103,769)(85,361)
If the New Zealand Dollar versus the Australian Dollar was 10% lower for the year:
Profit and loss(3,501)(5,912)
Other comprehensive income130,329110,242
Unit Holders' funds126,828104,330
122|VITAL HEALTHCARE PROPERTY TRUST
Notes to the Consolidated Financial Statements
(14.d) Liquidity Risk
The Group is subject to liquidity risk (the risk that the Group will not be able to meet its contractual or other operating obligations).
Liquidity risk is managed by continuously monitoring forecast and actual cash flows, maintaining appropriate head room under debt
facilities and matching the maturity profiles of financial assets and liabilities. To help reduce liquidity risks the Group:
•has readily accessible unutilised credit facilities and other funding arrangements in place;
•seeks a debt maturity profile that limits the total debt maturing in any one 12-month period; and
•seeks to maintain sufficient loan covenant headroom to ensure that the Group can withstand downward movements in investment
property valuations, a reduction in revenue and/or an increase in interest rates without breaching loan facility covenants.
Liquidity risk exposure
The following table details the Group’s exposure to liquidity risk based on the contractual undiscounted cash flows relating to financial
liabilities, foreign exchange contracts and interest rate derivatives:
Carrying
value
$000s
Contractual
cash flows
$000s
Less than 1
year
$000s
1-2 years
$000s
2-3 years
$000s
3+ years
$000s
30 June 2021
Non-derivative
financial instruments
Borrowings (excluding
borrowing costs)(932,377)(951,815)(115,660)(218,393)(189,221)(428,541)
Trade and other payables(41,006)(41,006)(41,006)---
Lease liability - ground lease(4,236)(4,236)(163)(170)(178)(3,725)
(977,619)(997,057)(156,829)(218,563)(189,399)(432,266)
Derivative
financial instruments
Interest rate swaps(41,019)(43,078)(12,858)(10,227)(7,900)(12,093)
Foreign exchange derivatives245245245---
(40,774)(42,833)(12,613)(10,227)(7,900)(12,093)
30 June 2022
Non-derivative
financial instruments
Borrowings (excluding
borrowing costs)(1,018,777)(1,164,084)(31,947)(281,961)(144,008)(706,168)
Trade and other payables(31,945)(31,945)(31,945)---
Lease liability - ground lease(4,073)(4,073)(170)(178)(185)(3,540)
(1,054,795)(1,200,102)(64,062)(282,139)(144,193)(709,708)
Derivative
financial instruments
Interest rate swaps20,45022,394334,6354,25213,474
Foreign exchange derivatives(418)(418)(418)---
20,03221,976(385)4,6354,25213,474
ANNUAL REPORT 2022|123
(14.e) Hedge Accounting
The Group is exposed to foreign exchange risk on its net investment in its AUD functional currency subsidiaries and seeks to hedge this risk
using AUD-denominated borrowings and foreign exchange derivatives (net investment hedges).
As a result of the February 2021 refinancing exercise the Group paid down all of its NZ domiciled AUD borrowings which it had
designated a portion as net investment hedges.
Recognition and measurement
For a financial instrument to be classified and accounted for as an effective hedge there must be:
•an economic relationship between the hedged item and the financial instrument;
•the effect of credit risk does not dominate the value changes that result from that economic relationship; and
•the hedge ratio of the hedging relationship is the same as that resulting from the quantity of the hedged item that the Group actually
hedges and the quantity of the financial instrument that the Group actually uses to hedge that quantity of hedged item.
The Group documents its hedging relationships at their inception in accordance with the requirements of NZ IFRS 9 and the Board
approved risk management strategy.
Hedge effectiveness is determined by the Group at the inception of the hedge relationship, and through semi-annual prospective
effectiveness assessments, to ensure that an economic relationship exists between the hedged item and the financial instrument. That portion
of the foreign exchange differences arising on the financial instruments determined to be an effective hedge is recognised directly in other
comprehensive income. Any ineffective portion is recognised in
profit or loss.
On disposal of the foreign operation, the cumulative value of such gains or losses recognised in other comprehensive income is reclassified
to the profit and loss in the statement of comprehensive income.
15.
Commitments and Contingencies
Other than the contractual obligations disclosed in Note6.e and Note15.a, there are no other commitments and contingencies in effect at
the reporting date (2021: nil).
(15.a)
NZSX Bank Bond
As a condition of listing on the New Zealand Stock Exchange (NZSX), NZSX requires all issuers to provide a bank bond to NZSX under
NZSX/DX Listing Rule 1.23.2. The bank bond required by the Group for listing on the NZSX is $50,000.
124|VITAL HEALTHCARE PROPERTY TRUST
Notes to the Consolidated Financial Statements
Efficiency of Operations
This section presents the Group's working capital position and the efficiency in which it converts operating profits into cash available for unit
holders or reinvestment back into the operations of the Group.
16. Statement of Cash Flows Reconciliation from Operating Activities
2022
$000s
2021
$000s
Cash and cash equivalents
Australian financial institutions4,4173,208
New Zealand financial institutions17,6383,672
Cash at bank22,0556,880
Reconciliation of profit after income tax to net cash flows from operating activities
Profit after tax for the year303,522278,392
Adjustments for non-cash items
Change in fair value of investment properties(244,239)(235,383)
Fair value (gain)/loss on derivative financial instruments(60,804)(22,655)
Unrealised foreign exchange (gain)/loss(26)(2,454)
Realised foreign exchange (gain)/loss114,399
Deferred taxation50,47332,217
Income in advance(233)(16)
Manager's incentive fee15,91412,402
Other2,173903
Operating cash flow before changes in working capital66,79167,805
Change in trade and other payables3,5321,467
Change in taxation payable(7,969)2,181
Change in trade and other receivables(1,450)(2,876)
Items classified as investing activities(417)(12,001)
Net cash from operating activities60,48756,576
Excluded from investing and financing activities are distributions paid during the year of $23.8m (2021: $19.0m) that have been reinvested
under the Distribution Reinvestment Plan (DRP).
Recognition and measurement
Cash and cash equivalents comprise cash at bank and call deposits, net of outstanding bank overdrafts.
The statement of cash flows is prepared on a GST exclusive basis. The GST component of cash flows arising from investing and financing,
which is recoverable from, or payable to, the taxation authority, is classified as part of operating cash flows.
ANNUAL REPORT 2022|125
17. Trade and Other Receivables
2022
$000s
2021
$000s
Trade receivables1,931968
Loss allowance(291)(345)
1,640623
Other receivables8021,011
Total trade and other receivables2,4421,634
(17.a) Ageing of receivables Past Due
2022
$000s
2021
$000s
0-30 days past due785656
31-60 days past due32050
61-90 days past due82433
1,929739
2022
$000s
2021
$000s
Movement in the loss allowance
Balance at the beginning of the year345281
(Decrease)/increase in allowance recognised in profit or loss(54)64
Balance at the end of the year291345
During the year the Group recognised bad debt write offs of $0.06m (2021: nil) in the statement of comprehensive income.
The Group holds $2.5m security or other collateral (2021: $2.3m) in respect of rent receivables past due. The Group does not have
significant credit risk exposure to any single counterparty or counterparties having similar characteristics in respect of rent receivables
past due (2021: nil). There are no significant financial assets that have had renegotiated terms that would otherwise have been past due
(2021: nil).
Recognition and measurement
Rent receivables
Rent receivables are recorded initially at fair value (including GST) and subsequently at amortised cost in accordance with NZ IFRS 9
Financial Instruments (“NZ IFRS 9”).
Impairment of financial assets and rent receivables
Loss allowances for rent receivables and other financial assets (other than those measured at fair value through profit and loss) are
measured using the simplified approach based on a lifetime expected loss allowance. Refer Note14.b for further details.
126|VITAL HEALTHCARE PROPERTY TRUST
Notes to the Consolidated Financial Statements
18. Other Assets
2022
$000s
2021
$000s
Current
Deposits paid on property acquisitions8,6352,012
GST refundable1,0039,698
Other5,8131,026
Total Current15,45112,736
19. Trade and Other Payables
2022
$000s
2021
$000s
Current liabilities
Interest accrued on borrowings3,6202,209
Other creditors and accruals28,32629,031
Other payables (Thames St)-9,765
Total trade and other payables31,94641,005
Recognition and measurement
Trade and other payables are recognised initially at fair value (inclusive of GST) and subsequently measured at amortised cost using the
effective interest method. The average credit term on purchases is generally 30 days and they are non-interest bearing. The Group has
management policies in place to ensure that all amounts are paid within the applicable credit terms.
ANNUAL REPORT 2022|127
Other Notes
20. Investment in Subsidiaries
The Trust has control over the following subsidiaries:
Holding
Name of subsidiaryPrincipal activity
Place
of incorporation
and operation20222021
Vital Healthcare Australian Property TrustProperty investmentAustralia100%100%
Vital Healthcare Investment TrustProperty investmentAustralia100%100%
Vital Healthcare Property LimitedProperty investmentNew Zealand100%100%
Colma Services LimitedHolding companyNew Zealand100%100%
All subsidiaries have the same reporting date as the Trust.
21.
Subsequent Events
On 11 August 2022 a final cash distribution of 2.4375 cents per unit was announced by the Trust. The Record Date for the final distribution
is 8 September 2022 and a payment is scheduled to unit holders on 22 September 2022. Imputation credits of nil cents per unit will be
attached to the distribution.
Post 30 June 2022 the Group has:
•settled the acquisition of Kawarau Park Health Precinct, a newly developed health precinct comprising 6 tenanted buildings including
Queenstown's only private hospital, situated in Kawarau Park in Queenstown, New Zealand for NZ$94m (plus transaction costs).
Settlement occured on 7 July 2022.
•settled the acquisition of a 7,693 sqm parcel of land in Newtown, Hobart, Australia for A$9.5m (plus transaction costs) for future
development. Settlement occured on 6 July 2022, and subsequently agreed terms with Nexus Hospitals to fund through the development
of a new day hospital and ambulatory care facility for ~A$98m (including land).
•unconditionally agreed to acquire a strata lot at 1/173 Chisholm Road, Ashtonfield, NSW Australia for A$3.97m (plus transaction
costs). This property adjoins Vital's East Maitland Private Hospital and is expected to settle in September 2022.
•received approval from Campbelltown City Council to be nominated as the tenant to the multi-stage ground lease development site
in Campbelltown, Sydney, Australia (refer note 6.e) on 15 July 2022, resulting in all contractual conditions now being satisfied for the
acquisition of this development site.
22.
Related Party Transactions
The Trust has control over the following subsidiaries:
The Manager
Vital is managed by NorthWest Healthcare Properties Management Limited (the "Manager"), a wholly owned subsidiary of NWI
Healthcare Properties LP (NWI LP).
The ultimate parent of NWI LP is Toronto listed NorthWest Healthcare Properties Real Estate Investment Trust (NWH REIT) that, as at
reporting date, holds a 27.6% (2021: 26.0%) interest in Vital. NWH REIT and its controlled entities (including the Manager) are considered
related parties to Vital and its controlled entities by virtue of common ownership and/or directorships.
128|VITAL HEALTHCARE PROPERTY TRUST
Notes to the Consolidated Financial Statements
Other related parties by virtue of common ownership and/or directorship to the Manager of Vital include Australian Properties Limited and
NorthWest Healthcare Australian Property Limited.
Remuneration of the Manager
Vital pays fees to the Manager in accordance with the Trust Deed. The aggregate of Base Fees, Incentive Fees and Activity Fees is capped
at 1.75% per annum of Vital's gross asset value (GAV) as at the end of a financial year.
Current fee arrangements
In accordance with and from the effective date of the amended Trust Deed, the fee arrangements are as follows:
Base Fee
The Base Fee structure is as follows:
•65 bps per annum up to $1bn of GAV:
•55 bps per annum from $1bn to $2bn of GAV;
•45 bps per annum from $2bn to $3bn of GAV; and
•40 bps per annum over $3bn of GAV.
Incentive Fee
The Incentive Fee is determined as 10% of the average annual increase in Vital’s Net Tangible Assets (NTA) (as defined by the Trust Deed)
over the respective
financial year and the two preceding financial years, with payment being made by way of subscribing for new units. The
incentive fee calculations are also subject to a ‘three year high watermark”, such that the Manager will not be paid an Incentive Fee in a
year where NTA grows if it is still below where it was on the last business day of any of the past three financial years.
Activity Fees
The Activity Fee structure is as follows:
a. Leases or licences
Vital pays the Manager leasing or licence fees where the Manager has negotiated leases or licences. The fees are charged at 11% of the
aggregate annual rental for terms less than 3 years, 12% of the aggregate annual rental for terms of 3 years, and 12% plus an additional 1%
for each full year (pro rata for part years) for terms greater than three years (to a maximum of 20%), subject to a minimum fee of $2,500.
Lease or licence renewals are charged at 50% of a new lease or licence fee.
Leasing or licence fees are capitalised to the respective investment or property in the consolidated statement of financial position and
amortised over the term of the lease.
b. Property management
Vital pays the Manager property management fees where the Manager acts as the property manager. These fees are charged at 1%
- 2% of gross income depending on the number of tenants at the property and may be recovered from tenants if permitted under
lease agreements.
Property management fees, net of recoveries from tenants, are expensed through the consolidated statement of comprehensive income in the
year in which they arise.
c. Facilities management
Vital pays the Manager a facilities management fee where the Manager acts as a property facilities manager based on the market rate
(referenced to a reputable and high-quality third party service provider) for similar services at similar properties. This fee may be recovered
from tenants if permitted under lease agreements.
Facilities management fees are expensed, net of recoveries from tenants, through the consolidated statement of comprehensive income in the
year in which they arise.
ANNUAL REPORT 2022|129
d. Project management
Vital pays project management fees to the Manager for managing capital expenditure projects where the purpose of the project is to
upgrade, repair or otherwise extend the life of the property, including via the replacement or repair of major plant and equipment, structural
items and building envelope.
Project management fees for projects with a budget of between $0.2m and $2.5m are 2% of the committed spend where the Manager is
the project lead and 1% of committed spend where the Manager has an oversight role, increasing to 4% and 2% respectively for projects
with a budget greater than $2.5m.
Project management fees are capitalised to the respective investment or property in the consolidated statement of financial position.
Additional Costs
The Additional Costs structure is as follows:
a. Acquisitions
Vital pays fees to the Manager for managing the due diligence, financing, legal aspects and settlement of the purchase of an investment or
property instead of, or alongside, a third party agent. These fees are charged at 1.5% of the capitalised cost of the relevant investment or
property, being the contracted price payable, excluding any deductions netted off the settlement price (such as rates), together with other
related capitalised acquisition costs.
Acquisition fees are capitalised to the respective investment or property in the consolidated statement of financial position.
b. Disposals
Vital pays fees to the Manager for managing the due diligence, legal aspects and settlement of the sale of an investment or property
instead of, or alongside, a third party agent. These fees are charged at 1% of the contracted sale price of the relevant investment or property
actually received, provided that, if a third party agent has been engaged to provide services for the disposal, then the fee payable to the
Manager will be net of the third party agent’s costs and commissions.
Disposal fees are expensed through the consolidated statement of comprehensive income in the year in which they arise.
c. Development Management
Vital pays fees where the Manager acts as a development manager on Vital developments. These fees are charged at 4% of the committed
spend (excluding land) approved by the Board of the Manager provided that, if a third party agent has been engaged to provide
development management services, then the fee payable to the Manager will be reduced by the non-rentalisable third party costs paid.
Development management fees are capitalised to the respective property in the consolidated statement of financial position.
130|VITAL HEALTHCARE PROPERTY TRUST
Notes to the Consolidated Financial Statements
Transactions with related parties
Amounts charged by the Manager and related parties and owing are as follows:
30 June 2022
$000s
30 June 2021
$000s
Statement of
Comprehensive
Income
Statement
of Financial
PositionTotal
Amounts
Owing/
(Receivable)
Statement of
Comprehensive
Income
Statement
of Financial
PositionTotal
Amounts
Owing/
(Receivable)
Base fee15,737-15,737-13,014-13,01453
Incentive Fee
1
15,914-15,91415,91412,402-12,40212,427
Activity Fees:
Leasing/licensing
2
1573,1363,2931,1391471,3451,4921,375
Property management
3
1,541-1,5412581,500-1,500326
Facilities management
3
--------
Project management
4
-157157161-158158158
AFSL fee1,210-1,210-995-995-
34,5593,29337,85217,47228,0581,50329,56114,339
Additional Costs:
Acquisitions
5
-7,8647,8644,446-4,0504,0501,852
Disposals----1,011-1,011-
Development management
6
-4,3564,3562,771-3,4473,4473,709
-12,22012,2207,2171,0117,4978,5085,561
Other Amounts:
Reimbursement of third
party expenses:
Other expenses141-141-92-92-
Amounts paid to directors:
7
Andrew Evans90-90-90-90-
Graham Stuart171-171-143-143-
402-402-325-325-
34,96115,51350,47424,68929,3949,00038,39419,900
1Manager's incentive fee outstanding at 30 June 2022 of $15.9m (Jun 20: $12.4m) is payable to NorthWest Healthcare Properties Management Limited
2Amounts outstanding at 30 June 2022 are: NorthWest Healthcare Properties Management Limited $1.0m (Jun 21:$0.2m); NorthWest Healthcare Australian Property Limited $0.1m (Jun
21: $1.2m)
3Property Management and Facilities Management fees, exclusive of recoveries from tenants, incurred by the Trust totalled $1.5m and nil respectively for the 30 June 2022 year (Jun 21:
$1.5m and nil respectively).
Amounts outstanding at 30 June 2022 are: NorthWest Healthcare Properties Management Limited $0.1m (Jun 21: $0.1m); NorthWest Healthcare Australian Property Limited $0.2m
(Jun 21:$0.2m)
4Amounts outstanding at 30 June 2022 are: NorthWest Healthcare Properties Management Limited $0.1m (Jun 21: $0.1m) NorthWest Healthcare Australian Property Limited $0.1m (Jun
21: $0.1m)
5Amounts outstanding at 30 June 2022 are: NorthWest Healthcare Properties Management Limited $1.3m (Jun 21: $0.1m); NorthWest Healthcare Australian Property Limited $3.1m (Jun
21: $1.7m)
6Amounts outstanding at 30 June 2022 are: NorthWest Healthcare Properties Management Limited $1.6m (Jun 21: $1.4m); NorthWest Healthcare Australian Property Limited $1.2m (Jun
21: $2.3m)
7Directors' fees for Michael Stanford and Angela Bull are currently paid by the Manager
ANNUAL REPORT 2022|131
Other Related Parties
There have been no transactions that occurred during the reporting period or remain outstanding at the reporting date with other
related parties.
On 21 August 2020 the Group acquired the remaining 50% interest in Playford Health Hub in South Australia from the NorthWest Australia
Real Estate Investment Trust for A$7.4m, excluding transaction costs.
132|VITAL HEALTHCARE PROPERTY TRUST
Independent auditor’s report
Independent Auditor’s Report
To the Unitholders of Vital Healthcare Property Trust
Opinion
Basis for opinion
Audit materiality
Key audit matters
We have audited the consolidated financial statements of Vital Healthcare Property Trust
and its subsidiaries (the ‘Group’ ), wh ich comprise the consolidated statemen t of financial
position as at 30 June 2022, and the consolidated statement of comprehensive income,
statement of changes in equity and statement of cash flows for the year then ended, and
notes to the consolidated financial statements, including a summary of significant
accounting policies.
In our opinion, the accompanying consolidated financial statements, on pages 92 to 131,
present fairly, in all material respects, the consolidated financial position of the Group as at
30 June 2022, and its consolidated financial performance and cash flows for the year then
ended in accordance with New Zealand Equivalents to International Financial Reporting
Standards (‘NZ IFRS’) and International Financial Reporting Standards (‘IFRS’).
We conducted ou r aud it in accordance with International Standards on Auditing (‘ISAs’) and
International Standards on Auditing (New Zealand) (‘ISAs (NZ)’). Ou r responsibilities under
those standards are further described in the Auditor’s Responsibilities for the Audit of the
Consolidated Financial Statements section of our report.
We believe that the audit evidence we have obtained is sufficient and appropriate to
provide a basis for our opinion.
We are independent of the Group in accordance with Professional and Ethical Standard 1
International Code of Ethics for Assurance Practitioners (including International
Independence Standards) (New Zealand) issued by the New Zealand Auditing and Assurance
Standards Board and the International Ethics Standards Board for Accountants’
International Code of Ethics for Professional Accountants (including International
Independence Standards), and we have fulfilled our other ethical responsibilities in
accordance with these requirements.
Our firm carries out other assignments for the Group in the area of sustainability reporting
non-assurance services and as independent AGM vote scutineer. These services have not
impaired our independence as auditor of the Group. The firm has no other relationships
with, or interests in, the Group.
We consider materiality primarily in terms of the magnitude of misstatement in the financial
statements of the Group that in our judgement would make it probable that the economic
decisions of a reasonably knowledgeable person would be changed or influenced (the
‘quantitative’ materiality). In addition, we also assess whethe r othe r matters that come to
our attention during the audit would in our judgement change or influence the decisions of
such a person (the ‘qualitative’ materiality). We use materiality both in planning the scope
of our audit work and in evaluating the results of our work.
We determined materiality for the Group financial statements as a whole to be $2.8 million.
Key audit matters are those matters that, in our professional judgement, were of most
significance in our audit of the consolidated financial statements of the current period.
These matters were addressed in the context of our audit of the consolidated financial
statements as a whole, and in forming our opinion thereon, and we do not provide a
separate opinion on these matters.
ANNUAL REPORT 2022|133
Key audit matter How our audit addressed the key audit matter
Valuation of Investment Properties
The Group’s investment properties consist of health sector
properties totalling $3,339 million as at 30 June 2022.
Revaluation gains on the Group’s investment properties for
the year ended 30 June 2022 of $244 million were
recognised in profit or loss. Information about the Group’s
property portfolio and valuation are set out in Note 6.
Investment properties are carried at fair value. Where
significant development is in progress at a property, this is
carried at cost, until either its fair value becomes reliably
measurable or the development reaches practical
completion.
The valuation of investment property is highly dependent on
forecasts and estimates including a number of unobservable
inputs to take into account property-specific attributes.
The Group’s policy is to engage external valuers for no more
than two years as per the Trust Deed, to perform valuations
for each of the properties on an annual basis (either at the
interim or annual reporting date). Independent registered
valuers determined the fair value of approximately 42
percent of the investment properties at 30 June 2022, and
the Board of Directors of the Manager determined the fair
value of the remaining properties.
The valuation methods used for assessing the fair value
include a combination of direct comparison, discounted
cash flow, capitalisation of contract and market income
approaches.
The external valuers and the Manager, amongst other
matters, take into consideration occupancy rates, weighted
average lease term to expiry (‘WALE’) and capitalisation
rates.
COVID-19 continues to cause disruption to economies in
which the Group operates. Note 6g discloses information
about the ongoing impact of COVID-19 on the valuation of
investment properties. operates. Some independent
valuations are reported on the basis of significant valuation
uncertainty.
The valuation of investment properties is a key audit matter
due to the subjective judgements and assumptions in the
valuation models, including those that relate to the
continued impacts of COVID-19.
We have evaluated the appropriateness of the valuation of
investment property by performing the following:
•Reviewing the external valuers’ valuation reports
and the valuation reports prepared by the Board
of the Manager. We evaluated the key metrics,
including capitalisation rate, market rent and
contract rent on a property and portfolio basis for
year on year movements and assessed whether in
our judgement, the movements represented outliers
to investigate. We held discussions, on a sample
basis, with the valuers and separately, with
representatives of the Manager and challenged
assumptions, including the possible outliers
identified.
•Agreeing property specific information supplied to
the external valuer and used in the Manager’s
valuations, including occupancy data, current rentals,
and lease terms, to the underlying records held by
the Group.
•Evaluating the objectivity, independence and
expertise of the external valuers.
•Evaluating the expertise of the Board of Directors of
the Manager.
•With respect to significant property developments:
owhere the Group has determined the
development has reached practical completion,
obtaining evidence supporting the Group’s
estimates of the expected future rental cash
flows that will apply upon completion and the
costs to complete the development;
owhere property developments are carried at
cost, testing the cost incurred to date on a
sample basis.
•Involving our valuation specialists to consider and
challenge, on a sample basis, the reasonableness of
the assumptions and valuation methodology applied,
including comparing assumptions to market data
where available.
•Reviewing valuation reports for continued impacts
of COVID-19 and how this was considered in the
valuation, including rental deferrals or abatements.
•Reviewing the valuations for any limitations of scope,
as a result of the continued COVID-19 pandemic, that
would impact the reliability of the valuations.
134|VITAL HEALTHCARE PROPERTY TRUST
Other information
The Board of Directors of the Manager are responsible on behalf of the Group for the
other information. The other information comprises the information in the Annual Report
that accompanies the consolidated financial statements and the audit report.
Our opinion on the consolidated financial statements does not cover the other
information and we do not express any form of assurance conclusion thereon.
Our responsibility is to read the other information and consider whether it is materially
inconsistent with the consolidated financial statements, or our knowledge obtained in the
audit or otherwise appears to be materially misstated. If so, we are required to report that
fact. We have nothing to report in this regard.
Board of Directors’
responsibilities for the
consolidated financial
statements
The Board of Directors of the Manager are responsible on behalf of the Group for the
preparation and fair presentation of the consolidated financial statements in accordance
with NZ IFRS and IFRS, and for such internal control as the directors determine is
necessary to enable the preparation of consolidated financial statements that are free
from material misstatement, whether due to fraud or error.
In preparing the consolidated financial statements, the Board of Directors of the Manager
are responsible on behalf of the Group for assessing the Group’s ability to continue as a
going concern, disclosing, as applicable, matters related to going concern and using the
going concern basis of accounting unless the Board of Directors of the Manager either
intend to liquidate the Group or to cease operations, or have no realistic alternative but to
do so.
Auditor’s responsibilities for the
audit of the consolidated
financial statements
Our objectives are to obtain reasonable assurance about whether the consolidated
financial statements as a whole are free from material misstatement, whether due to
fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable
assurance is a high level of assurance but is not a guarantee that an audit conducted in
accordance with ISAs and ISAs (NZ) will always detect a material misstatement when it
exists. Misstatements can arise from fraud or error and are considered material if,
individually or in the aggregate, they could reasonably be expected to influence the
economic decisions of users taken on the basis of these consolidated financial statements.
A further description of our responsibilities for the audit of the consolidated financial
statements is located on the External Reporting Board’s website at:
https://www.xrb.govt.nz/standards-for-assurance-practitioners/auditors-
responsibilities/audit-report-1
This description forms part of our auditor’s report.
Restriction on use
This report is made solely to the Group’s unitholders, as a body. Our audit has been
undertaken so that we might state to the Group’s unitholders those matters we are
required to state to them in an auditor’s report and for no other purpose. To the fullest
extent permitted by law, we do not accept or assume responsibility to anyone other than
the Group’s shareholders as a body, for our audit work, for this report, or for the opinions
we have formed.
Silvio Bruinsma, Partner
for Deloitte Limited
Auckland, New Zealand
11 August 2022
ANNUAL REPORT 2022|135
Unit Holder statistics
Analysis of unit holders as at 30 June 2022
Holding RangeNumber of unit holdersTotal units% of total units issued
1 - 49923042,0550.01
500 - 9998560,2320.01
1,000 - 1,999270394,7640.06
2,000 - 4,9998102,772,8500.43
5,000 - 9,9991,0497,488,7721.15
10,000 - 49,9992,05045,259,6876.97
50,000 - 99,99929019,508,8593.01
100,000 - 499,99912621,868,1293.37
500,000 - 999,99995,771,9950.89
1,000,000 Over17545,987,85384.11
Rounding-0.01
Total4,936649,155,196100
Substantial unit holders as at 30 June 2022
Unit holdersDate notice of filesNumber of units% of total units issued
1
NORTHWEST HEALTHCARE PROPERTIES REAL ESTATE
INVESTMENT TRUST1-Jul-22179,415,78827.64
FORSYTH BARR INVESTMENT MANAGEMENT LIMITED21-Mar-2240,830,7147.07
ACCIDENT COMPENSATION CORPORATION31-Mar-2229,235,9515.05
ANZ NEW ZEALAND INVESTMENTS LTD21-Mar-2226,304,8415.06
1On date notice filed
Twenty largest unit holders as at 30 June 2022
Unit holdersTotal% of units
NZGT SECURITY TRUSTEE LIMITED173,085,62526.66
FORSYTH BARR CUSTODIANS LIMITED56,518,6398.71
CUSTODIAL SERVICES LIMITED51,147,2447.88
CITIBANK NOMINEES (NEW ZEALAND) LIMITED - NZCSD33,996,9255.24
ACCIDENT COMPENSATION CORPORATION - NZCSD32,870,3265.06
HSBC NOMINEES (NEW ZEALAND) LIMITED - NZCSD31,647,5104.88
HSBC NOMINEES (NEW ZEALAND) LIMITED A/C STATE STREET -NZCSD21,059,2313.24
ANZ WHOLESALE TRANS-TASMAN PROPERTY SECURITIES FUND - NZCSD18,259,8322.81
JPMORGAN CHASE BANK NA NZ BRANCH- SEGREGATED CLIENTS ACCT - NZCSD16,497,4272.54
NEW ZEALAND DEPOSITORY NOMINEE LIMITED14,854,5692.29
JBWERE (NZ) NOMINEES LIMITED12,495,9091.92
TEA CUSTODIANS LIMITED CLIENT PROPERTY TRUST ACCOUNT - NZCSD10,892,6761.68
BNP PARIBAS NOMINEES (NZ) LIMITED - NZCSD10,463,0661.61
FNZ CUSTODIANS LIMITED10,224,4461.58
INVESTMENT CUSTODIAL SERVICES LIMITED6,696,9601.03
ANZ WHOLESALE PROPERTY SECURITIES - NZCSD5,202,6860.80
MFL MUTUAL FUND LIMITED - NZCSD <MFLA90>5,060,1840.78
NORTHWEST HEALTHCARE PROPERTIES MANAGEMENT LIMITED4,569,9840.70
BNP PARIBAS NOMINEES (NZ) LIMITED - NZCSD4,536,3220.70
FORSYTH BARR CUSTODIANS LIMITED3,877,8630.60
Top 20 holders of Units523,957,42480.71
Total Remaining Holders Balance125,197,77219.29
About Vital
Vital Healthcare Property Trust (Vital, the Trust) is an NZX-
listed investment fund (NZX:VHP) that invests in high-
quality healthcare properties in New Zealand and
Australia. The Trust is externally managed by NorthWest
Healthcare Properties Management Limited.
Vital's portfolio of 47
1
properties is valued at
~$3.3 billion with 72% (by value) located in Australia
and the balance in New Zealand. The portfolio
has over 135 tenants and over 2,800 beds.
Vital’s tenants include hospital operators and healthcare
providers who deliver a wide range of services
across the full spectrum of health services.
Further information is available at vhpt.co.nz
About the Manager
NorthWest Healthcare Properties Management Limited
(NWHPM, the Manager) is an external manager that
provides management services to Vital and its Unit Holders.
The Manager’s primary responsibilities include the day-to-
day administration of Vital, portfolio management, sourcing
new opportunities and conducting due diligence on potential
acquisitions. The Manager is also responsible for providing
specialist property management, project management,
development management and leasing services to the Trust.
The Manager’s Board of five comprises three
independent directors and two NorthWest
appointees. Refer to page 76 for more details.
Vital’s leadership team is led by Aaron Hockly (Fund
Manager), and draws on the skills and experience of over
60 real estate professionals across New Zealand and
Australia with offices in Auckland, Melbourne, Sydney
and the Gold Coast. Refer to page 78 for more details.
NorthWest
The Manager is a subsidiary of Toronto Stock
Exchange-listed NorthWest Healthcare Properties REIT
(NorthWest REIT). NorthWest REIT operates across
seven countries in four continents and was founded
by its current CEO, Paul Dalla Lana, in 2004. Among
other roles, Paul is a director of Vital’s Manager.
NorthWest REIT has ~NZ$12.4 billion of assets under
management globally and over 300 real estate professionals.
In Australia and New Zealand, NorthWest is led by regional
CEO and NorthWest REIT President, Craig Mitchell.
Vital is the only NZX listed specialist
landlord of healthcare property and the
fourth largest NZX listed property vehicle.
Vital’s structure
Vital benefits from being managed by a global
healthcare property owner and manger.
1
Includes post 30 June 2022 acquisition of Kawarua Park Health Precinct, Queenstown
13 6
|
VITAL HEALTHCARE PROPERTY TRUST
OUR STRUCTURE – A UNIT TRUST
Vital Unit Holders
New Zealand’s largest specialist and
only listed owner of healthcare real estate
~NZ$12.4bn7
assets under
management
number of countries
NorthWest
operates in
Vital’s Manager and largest Unit Holder
Management of Vital in accordance with the Trust Deed
Majority NZ based institutions and retail investors
~$3.3bn portfolio healthcare
real estate in Australia and New Zealand
~27%
~73%
>300
healthcare
real estate
professionals
In Australia and New Zealand, NorthWest has
a 60+ team of healthcare property professionals.
ANNUAL REPORT
|
137
Healthy properties
deliver healthy returns
13 8
|
VITAL HEALTHCARE PROPERTY TRUST
MANAGER
NorthWest Healthcare Properties
Management Limited
Level 17, HSBC Tower,
188 Quay Street
Auckland 1010
Telephone: 0800 225 264 (NZ freephone);
+64 9 973 7300
Email: enquiry@vhpt.co.nz
NorthWest Healthcare Properties
Management – Australia
Level 45, Rialto South Tower,
525 Collins Street
Melbourne 3000
Sydney Office
NorthWest Healthcare Properties REIT
Level 2, 285 George Street
Sydney, NSW 2000, Australia
Gold Coast Office
Gold Coast, QLD 4218, AU
BOARD AND OFFICERS
OF THE MANAGER
Graham Stuart – Independent Chair
Angela Bull – Independent Director
(Appointed 26 April 2022)
Paul Dalla Lana – Director
Andrew Evans – Independent Director
(retired on 30 June 2022)
Craig Mitchell – Director
Dr Michael Stanford – Independent Director
Aaron Hockly – Fund Manager
Michael Groth – Chief Financial Officer
Vanessa Flax – Regional General Counsel
A/NZ and Company Secretary
AUDITOR
Deloitte Limited
Deloitte Centre
80 Queen Street
Auckland 1010
Private Bag 115-033
Auckland 1140
Telephone: +64 9 303 0700
Facsimile: +64 9 303 0701
LEGAL ADVISERS TO THE
TRUST AND THE MANAGER
Bell Gully
Vero Centre
48 Shortland Street
PO Box 4199
Auckland 1140
Telephone: +64 9 916 8800
Facsimile: +64 9 916 8801
Ashurst Australia
Level 16, 80 Collins Street,
South Tower,
GPO Box 4958
Melbourne, Victoria 3001
Telephone: +61 3 9679 3000
SUPERVISOR
Trustees Executors Limited
Level 11/51 Shortland Street
Auckland 1010
PO Box 4197
Auckland 1140
Telephone: 0800 878 783
Facsimile: +64 9 308 7101
BANKERS TO THE TRUST
ANZ Bank New Zealand Limited
ANZ Centre
23–29 Albert Street
Auckland 1010
Australia and New Zealand
Banking Group Limited
ANZ Centre Melbourne, Level 9
833 Collins Street, Docklands
Victoria 3008, Australia
Bank of New Zealand
Deloitte Centre
80 Queen Street
Auckland 1010
Westpac Banking Corporation
Westpac Place
275 Kent St
Sydney NSW 2000
Australia
The Hongkong and Shanghai
Banking Corporation Limited
International Towers
100 Barangaroo Avenue
Sydney NSW 2000
Australia
Industrial and Commercial Bank
of China Limited – Australia
International Towers
100 Barangaroo Avenue
Sydney NSW 2000
Australia
Industrial and Commercial Bank of
China Limited – New Zealand
2 Queen Street,
Auckland CBD,
Auckland 1010
New Zealand
Credit Agricole CIB Australia Limited
Aurora Place
88 Phillip Street
Sydney NSW 2000
Australia
UNIT REGISTRAR
Computershare Investor Services Limited
159 Hustmere Road
Takapuna, Auckland 0622
Private Bag 92119
Auckland 1142
New Zealand
vital@computershare.co.nz
Telephone: +64 9 488 8777
Facsimile: +64 9 488 8787
This document is printed on an environmentally responsible
paper, produced using Elemental Chlorine Free (ECF),
FSC(R) certified, Mixed Source pulp from Responsible
Sources, and manufactured under the strict ISO14001
Environmental Management System.
Directory
ANNUAL REPORT
|
13 9
DISCLAIMER:
This document has been prepared by NorthWest Healthcare Properties Management
Limited (the Manager) as manager of the Vital Healthcare Property Trust (the Trust).
This document provides general information only and is not intended as investment,
legal, tax, financial product or financial advice or recommendation to any person and
must not be relied on as such. You should obtain independent professional advice
prior to making any decision relating to your investment or financial needs.
All references to $ are to New Zealand dollars unless otherwise indicated.
This document may contain forward-looking statements. Forward-looking statements can include
words such as “expect”, “intend”, “plan”, “believe”, “continue” or similar words in connection
with discussions of future operating or financial performance or conditions. Any indications
of, or guidance or outlook on, future earnings or financial position or performance and future
distributions are also forward-looking statements. The forward-looking statements are based
on management’s and directors’ current expectations and assumptions regarding the Trust’s
business, assets and performance and other future conditions, circumstances and results. As with
any projection or forecast, forward-looking statements are inherently susceptible to uncertainty
and to any changes in circumstances. The Trust’s actual results may vary materially from those
expressed or implied in the forward-looking statements. The Manager, the Trust, and its or their
directors, employees and/or shareholders have no liability whatsoever to any person for any
loss arising from this document or any information supplied in connection with it. The Manager
and the Trust are under no obligation to update this document or the information contained
in it after it has been released. Past performance is no indication of future performance.
The information in this document is of general background and does not purport to
be complete. It should be read in conjunction with Vital’s market announcements
lodged with NZX, which are available at www.nzx.com/companies/VHP.
---
FY22 Annual
Results Presentation
11 AUGUST 2022
All amounts are in NZD unless otherwise shown
Contents
Overview of Vital 3
FY22 highlights 4
Financial results and capital management
1
2
Portfolio and acquisitions
17
5 largest assets and asset groupings 22
Developments 28
Future focus
33
Appendices 38
Acquisitions and de
velopments detail
3
9
Additional por
tfolio information
49
Additional financial information
5
6
Presenters
Aaron Hockly
Fund Manager
Richard Roos
Exec. Director, Portfolio
Michael Groth
Chief Financial Officer
Chris Adams
Exec. Director, Projects
VITAL HEALTHCARE PROPERTY TRUST | ANNUAL RESULTS 2022 | 2
~$3.3bn17.6 years
VITAL IS THE ONLY SPECIALIST HEALTHCARE LANDLORD LISTED ON THE NZX
Overview of Vital
1
~$2.4bn
~$0.9bn
31 PROPERTIES (AUS)
16 PROPERTIES (NZ)
47
1
PROPERTIES
(AUS & NZ)
W
ALE
WESTERN
AUSTRALIA
NORTHERN
TERRITORY
SOUTH
AUSTRALIA
NEW
SOUTH
WALES
TASMANIA
VICTORIA
QUEENSLAND
4
3
6
6
12
T he owner of a ~$3.3 billion healthcare
property portfolio in New Zealand
(28% of assets) and Australia (72%);
T he only NZX-listed specialist
healthcare landlord (NZX ticker: VHP);
Externally managed by a subsidiary
of Toronto-listed, global healthcare
real estate owner and manager,
NorthWest Healthcare Properties REIT
(TSX ticker: NWH);
Underpinned by rental income that
tracks inflation with ~80% of lease
income indexed to CPI in some way;
and
T argeting 2–3% AFFO and DPU
growth per annum over the medium
term, whilst retaining a conservative
pay-out ratio.
VITAL HEALTHCARE PROPERTY
TRUST (VITAL) IS:
1
Number of properties include Kawarau Park Health Precinct, Queenstown, but excludes strategic assets.
All other figures exclude Kawarau Park Health Precinct, Queenstown
As at 30 June 2022
14
2
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2022
|
3
FY22
highlights
Key events over FY22
2021
JULY 2021
P ractical completion of Wakefield
Hospital, Wellington Stage 1 for
a total cost of ~$50.8m
AUGUST 2021
FY22 AFFO and distribution
guidance announced of 11.8cpu
and 9.5cpu respectively
Acquisition of Hutt Valley Health
Hub, Wellington for $46.5m
announced
OCTOBER 2021
A$315m debt refinance to extend
debt capacity by A$65m and
extend debt tenor
Acquisition of Tennyson Centre,
Adelaide for A$92.75m
$115m placement primarily to
existing institutional holders at
$2.90 per unit
Commencement of $91.5m
Wakefield Hospital Stage 2 with
demolition of existing building
Terms agreed for $74m of
new and extended brownfield
developments across five of
Evolution Healthcare’s facilities in
New Zealand
NOVEMBER 2021
$27.8m raised via a Unit Purchase
Plan from existing retail holders at
$2.85 per unit
Completion of Stage 1 of Playford
Health Hub, Adelaide for ~A$20m
Commencement of $6.3m Royston
Stage 2, $31.7m Grace Hospital
and $6.3m Bowen Hospital
developments
MoU signed with Calvary Health
Care to operate a ~A$93m
hospital (Stage 3 of Playford
Health Hub)
VITAL HEALTHCARE PROPERTY TRUST | ANNUAL RESULTS 2022 | 5
Key events over FY22 (cont'd)
2022
FEBRUARY 2022
Acquisition of land for expansion
of The Hills Clinic in Sydney for
~A$50m (includes land cost and
estimated construction costs)
Announcement of acquisition of
multi-stage development site in
South West Sydney for A$76.6m
(includes acquisition costs, Stage
1 construction costs and tenant
incentive)
Upgrade to annualised AFFO and
distribution guidance to at least
11.9cpu and 9.75cpu, respectively
3.2% and 8.5% above FY21
Practical completion achieved for
Royston DSU with a project value
of $9.5m
APRIL 2022
Appointment of Angela Bull
as an Independent Director
Acquisition of 68 St Asaph St,
Christchurch for $50.7m
Acquisition of Kawarau Park
Health Precinct, Queenstown
for ~$95m (settled July 2022)
Acquisition and expansion of
Endoscopy Auckland announced
for $43.8m (acquisition cost plus
estimated development spend)
Announcement of expansion of
Ormiston Hospital, Auckland
for ~$40m (includes land
already owned by Vital)
MAY 2022
$200m in new equity raised
through an entitlement
offer at $2.95 per unit
A cquisition of a vacant aged
care facility in Mt Eliza, Victoria
for ~$A12m (includes transaction
costs) for redevelopment
Ormiston Hospital $40m
expansion commenced
JUNE 2022
Retirement of Andrew Evans
as an Independent Director
after 15 years on the board
Acquisition of 80 Ascot
Ave, Remuera for $16m
Agreement to undertake a
~A$98m development of a new
health facility in Hobart, Tasmania
MARCH 2022
P ractical completion of A$97m
Epworth Eastern East Wing Tower
A$39.3m Playford Health
Hub Stage 2 commenced with
demolition of existing building
A$350 debt refinance completed,
increasing facility limits by A$150m
and weighted average term to
maturity by 1.1 years to 4.4 years
VITAL HEALTHCARE PROPERTY TRUST | ANNUAL RESULTS 2022 | 6
FY22 highlights – capital and Unit Holder returns
TRANSACTIONS UNDERTAKEN TO GROW FUTURE EARNINGS AND SUPPORT FUTURE PORTFOLIO GROWTH
$379mA$665m
$397m
18.0%
15.3%
8.5%
equity raised
1
debt refinanced
property transactions
increase in earnings;
3.3% per unit
$382m
2
acquisitions and $15m disposals
increase in NTA per unit
increase in
distributions per unit
1
Excludes issue costs and comprises equity raising (x2), DRP (x4) and incentive units issued to the Manager
2
Excluding transaction costs but including Kawarau Park Health Precinct, Queenstown which settled in July 2022
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2022
|
7
FY22 highlights – increased development focus
ENHANCED PORTFOLIO METRICS IN ALIGNMENT WITH STRATEGY
10 developments$100m
$148m
$169m
$196m
underway, $215m spend
remaining with a further ~$1.8bn
1
being actively considered
of development and
capital expenditure
works undertaken
2
of developments moved from
“potential” to “committed”
fund-through developments
3
of strategic land held for
future development
1
Development timing and therefore spend expected to be over a staged and lengthy period (at least 10 years)
2
Includes $86m of developments, ~$12m of value-add capex and ~$2m maintenance and tenant incentive capex
3
Developments where Vital is funding through the development rather than acting as developer
VITAL HEALTHCARE PROPERTY TRUST | ANNUAL RESULTS 2022 | 8
MATERIAL ACHIEVEMENT OF ALL FY22 TARGETS; FULL DETAILS AVAILABLE IN VITAL'S FY22 SUSTAINABILITY REPORT
FY22 highlights – sustainability
Continue to improve diversity on the
Board and in Management
F ocus on mentoring and career
progression
Encourage greater community involvement
Continue existing professional
development
Establish baseline environmental reporting
Meet distribution guidance
and AFFO target
Maintain prudent AFFO pay-out ratio
Continue charitable and community
support programme
Extend and diversify debt
P articipate in third-party assessments
through GRESB and CDP
Improve CDP score
Deploy sustainability initiatives with
key stakeholders including tenants
Continue to progress investigation of
additional solar installations
PeoplePracticePlaces
NWH released its first Sustainability Report for its
global operations including Vital. View the report at:
www.nwhreit.com/mailers/sustainability/nwh-sustainability-report.pdf
During FY22, Vital and NorthWest joined the New Zealand Green Building Council and the Green Building Council of Australia
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2022
|
9
Short, medium and longer term progression
1
PORTFOLIO ENHANCEMENTS SUPPORT TARGET OF GROWING AFFO AND DISTRIBUTIONS BY 2–3%
2
PER UNIT PER ANNUM
Portfolio enhanced through acquisitions, development and disposals to: (1) increase diversity of assets and tenants,
(2) reduce age of building and (3) maintain long WALE. This helps to reduce income risk for Vital’s Unit Holders.
1
All date references are to 30 June of that year unless otherwise stated
2
Average building age = the later of the date of construction or the last significant capital works
3
Includes $214.9m of committed development spend remaining and ~$1.8bn of developments being considered. Development timing and therefore spend expected to be over
4
Committed and potential development pipeline
489%
growth (FY12-FY22)
Market leading WALE
TOTAL PROPERTY VALUEWALE
17.6 years
2022
11.9 years
2 012
~ $0.57bn
(AUS: 71%,
NZ: 29%)
2 012
~$1.93bn
(AUS: 76%,
NZ: 24%)
2 019
~$3.34bn
(AUS: 72%,
NZ: 28%)
2022
2 019
18.1years
Younger buildings reduce
maintenance capex requirements
AVERAGE BUILDING AGE
11.1 years
20222 012
Data not
available
156%
increase (FY12- FY22)
NET PROPERTY INCOME (ANNUAL)
$123m
FY22
$48m
F Y 12
Enhance earnings and valuation
growth and support portfolio
development
DEVELOPMENT PIPELINE
$2.1bn
4
2022
$279m
2 019
~$60m
2 012
19 %
2022
4.58%
2022
49%
2 019
5.61%
2 019
40%
2 012
9.30%
2 012
Concentration
risk reduced
Diversity of assets reduces
risk and enhances earnings
LARGEST SINGLE TENANT EXPOSURESECTOR SPLIT
2022
Hospital 80%,
Ambulatory Care
16%,
Aged Care 4%
2 012
Hospital 88%,
Ambulatory Care
12%,
Aged Care 0%
Reduction demonstrates: (1)
quality of assets and tenants;
and (2) value added by leasing
and development undertaken
WEIGHTED AVERAGE CAP RATE
2 019
Hospital 83%,
Ambulatory Care
14%,
Aged Care 3%
13.5 years
2 019
$98m
F Y 19
VITAL HEALTHCARE PROPERTY TRUST | ANNUAL RESULTS 2022 | 10
Balance sheet strengthened through raising $379m (before costs) of new equity and extending
debt whilst supporting portfolio growth as a means to grow AFFO and distributions
BALANCE SHEET STRENGTHENED
241%
growth (FY12-FY22)
NTA PER UNIT
Short, medium and longer term progression
1
$3.34
2022
$2.31
2 019
$0.98
2 012
30.0%
2022
35.3%
2 019
42.3%
2 012
BALANCE SHEET GEARING
No debt expiring
until October 2023
3.9 years
20222 019
2.2 years
2 012
3.8 years
AVERAGE DEBT MATURITY
Significantly
expanded
11 . 9 2 c
FY22
9.625
FY22
9.9c
F Y 19
8 . 75
F Y 19
8.0c
1
F Y 12
7. 7
F Y 12
AFFO PER UNIT (CPU)DISTRIBUTIONS PER UNIT (CPU)
49%
growth (FY12-FY22)
25%
growth (FY12-FY22)
1
Net Distributable Income per unit (AFFO not reported)
VITAL HEALTHCARE PROPERTY TRUST | ANNUAL RESULTS 2022 | 11
Financial results and
capital management
Financial performance
PROPERTY EARNINGS GROWTH HAS FACILITATED AFFO GROWTH
FY22
F Y 21
($)
CHANGE
(%)
CHANGE
Net property income123,018 109,663 13,355 12.2
Expenses ex. finance(37,518)(30,915)(6,603)(21.4)
Net finance expenses(28,983)(27,684)(1,299)(4.7)
Operating profit before tax and other income56,51751,0645,45310.7
Property revaluations and other income305,758267,40338,35514.3
Profit before income tax362,275 318,467 43,808 13.8
Adjusted funds from operations (AFFO)67, 8 24 57,457 10,367 18.0
Adjusted funds from operations (cpu)11 . 9 2 11 . 5 4 0.38 3.3
Distributions per unit (cpu) 9.63 8.88 0.75 8.5
Average NZD/AUD exchange rate in the period0.93770.9306
Contribution from structured
rent reviews, acquisitions and
development rents
$244m of revaluation gains
during FY22
All values shown as $000s
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2022
|
13
Net property income
NPI GROWTH (EXCL FX) INCREASED FROM ACQUISITIONS, DEVELOPMENTS AND RENT REVIEWS
NET PROPERTY INCOME BRIDGE
($M)
Acquisitions – income from late FY21
Development income – rentalisation
of capital expenditure and holding
income from strategic site acquisitions
Disposals – income adjustment from
strategic disposal of three regional
hospitals in FY21 for ~A$100m and
sale of Gold Coast Surgical Centre for
~A$13m in FY22 (before selling costs)
Maintenance capex – remains modest
due to long term leases, minimal
upcoming expiries, young building
age and ability to capitalise or rentalise
upgrades as part of developments
1
Acquisitions of Grace Hospital, Epworth Camberwell, Tennyson Centre, Nelson Rd Box Hill and Hutt Valley Health Hub
2
Incremental development income contributed from Wakefield, Royston, South Eastern and Playford Health Hub - Retail and Carpark
3
Disposals of regional Healthe Care assets (Mayo, North West and Dubbo) in FY21 and Gold Coast Surgery Centre in FY22
4
Amortisation, Non-recurring R&M and abatements
~80% of Vital's leases (by income) are indexed to CPI in some way
109.7
9.9
3.7
4 .1
(0.7)
(3.0)
(0.7)
12 3 . 0
90
95
100
105
11 0
11 5
12 0
12 5
13 0
FY21Acquisitions
1
Development
Income
2
Rent Reviews
& Leasing Activity
Disposals
3
Amortisations
& Other
4
Foreign
Exchange
FY22
+12.2% growth (incl FX) / +12.8% (excl FX)
FY22 property income growth of +2.8%
(like-for-like, same currency basis)
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2022
|
14
Balance sheet
STRENGTHENED BY SIGNIFICANT REVALUATION GAINS, NEW EQUITY AND DEBT EXTENSION
FY22
F Y 21
($)
CHANGE
(%)
CHANGE
Investment properties3,339,169 2,634,588 704,581 26.7
Other assets60,6652 7, 9 7 232,693 11 6 . 9
Bank debt1,018,777 932,377 86,400 9.3
Other liabilities215 ,18 0226,733(11,553)(5.1)
Debt to gross assets
1
30.035.0(14.41)
Unitholder funds2,165,876 1,503,451 662,425 44.1
Units on issue (000s)649,155519 , 75 3129,402 24.9
Net tangible assets ($/unit)3.34 2.890.44 15.3
All values shown as $000s
Period end NZD/AUD exchange rate0.90370.9309
$379m (before costs) of new
equity raised via placement,
UPP, rights offer and four DRP's
Increase due to:
Development and capital works
expenditure of $100m
2
Acquisitions totalling $299m
(including transaction costs)
Revaluation gains of $244m
Disposals of $(13m) (book value
at sale date)
FX impact of $75m
1
Calculated in accordance with Vital's Trust Deed
2
Includes $86m of developments, ~$12m of value-add capex and ~$2m maintenance and tenant incentive capex
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2022
|
15
Debt duration
INCREASED WEIGHTED AVERAGE DEBT DURATION AND AVAILABLE HEADROOM FOR UTILISATION
Increased the weighted
average debt duration from
2.5 years to 3.9 years with no
expiries until October 2023
1
Trust Deed debt ratio is based on total borrowings to gross asset value of the Trust
2
Bank LVR is based on total indebtedness to secured property value as determined by external valuers
DEBT DURATION PROFILE – 30 JUNE 2022 (A$)
Headroom available under
existing facility to support
future growth primarily via
the development pipeline
0
50
100
150
200
250
300
350
Dec-23 Jun-24 Dec-24 Jun-25 Dec-25 Jun-26 Dec-26 Jun-27 Dec-27 Jun-28 Dec-28 Jun-29
VALUE ($M)
BANK FACILITIES30 JUNE 202230 JUNE 2021
Debt to gross assets (Trust Deed)
1
30.0%35.0%
Bank loan to value ratio - actual
2
32.1%38.0%
Bank loan to value ratio - covenant55.0%55.0%
Weighted average duration to expiry3.9 yrs2.5 yrs
Undrawn facility limit (A$)$302m$144m
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2022
|
16
Portfolio and
acquisitions
Portfolio update
~$3.3BN INVESTED IN 47 CORE HEALTHCARE PROPERTIES WITH OVER 2,800 BEDS AND OVER 135 SEPARATE TENANTS
CPI aligned leases support income growth
WA
NT
SA
NSW
TAS
VIC
QLD
NZ
$287m (excluding transaction costs) of acquisitions
undertaken; all of which have development upside
which is being pursued. Details of acquisitions
not previously announced are on pages 20-
21 of this presentation. Details of acquisitions
announced during FY22 are on pages 40-47 of
this presentation.
Portfolio composition enhanced through first South
Island acquisitions and growth in target markets of
NSW and NZ.
12.2% growth in net property income; 2.8% for
same properties on a like-for-like and constant
currency basis
GEOGRAPHIC DIVERSIFICATION
(BY VALUE
1
)
Income
4%
7%
12 %
26%
23%
26%
2%
1
Excludes post 30 June 2022 acquisition of Kawarau Park Health Precinct, Queenstown
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2022
|
18
Portfolio update (cont'd)
19 %
16 %
22%
15 %9%
4%
3%
3%
3%
2%
4%
Healthe Care Surgical 16%
Norfolk Southern Cross Limited 4%
Evolution Health
care
9%
Epwor
th 15%
Hall & Prior
4%
Bolton Clarke 3%
Sportsmed 3%
Mercy Ascot
3%
R
amsay
2%
Oth
er 22%
Aurora Healthcare 19%
Largest single tenant exposure
reduced largely through
acquisitions and disposals from
~50% two years ago to <20%
Vital has a diverse portfolio
and income stream by
location and tenant
Seeking to continuously
enhance diversity of income
Diversification
TENANT DIVERSIFICATION
% OF RENT
occupancy for the portfolio
98.8%
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2022
|
19
Recent acquisitions
A development approval was lodged in March 2022 for
18,347 square metres of GFA for both public and private
health services to support the growing catchment.
The public health services offered include general medical
and a broad range of surgical services including obstetrics,
paediatrics and psychiatry. The hospital is located in South
Brisbane and services a population of >340,000 within one
of Queensland’s fastest growing areas.
Meadowbrook
Queensland
Logan Hospital is undergoing
a A$540 million expansion to
deliver 688 beds by 2023.
VITAL HEALTHCARE PROPERTY TRUST | ANNUAL RESULTS 2022 | 20
Recent acquisitions (cont'd)
Tasman Medical Centre
Hobart, TAS
In July 2022, Vital agreed terms with
Nexus Hospitals to fund through the
development of a new, purpose-built
8,747 square metre day hospital and
ambulatory care facility in Hobart,
Tasmania. The facility will be known as
"Tasman Medical Centre".
Total costs are expected to be ~A$98m
including A$9.5m of land which
Vital acquired in early July 2022.
Construction is expected to complete
by the end of 2024. Vital will receive
a ~4.5% yield during construction and
from practical completion. Tasman
Medical Centre is 100% pre-leased
from practical completion to a mixture
of Nexus (60% of rent) and a mix of
healthcare and ancillary tenants.
The WALE is expected to be 13.3 years
from practical completion with annual
rent reviews a mixture of CPI with a
floor of 2.5% and a cap of 5% and
fixed rent reviews (typically 2.5%). This
fund-through is Vital's sole investment in
Tasmania after previously selling a small
facility in Burnie, Tasmania in late 2020.
In May 2022, Vital acquired a former 60-bed aged care
facility ~7kms from Frankston for ~A$12m (including transaction
costs). A process is underway to redevelop this facility.
Mt Eliza
Mornington
Peninsula, VIC
New development fund-through
planned; Vital's first asset in
Hobart and its only exposure to
Tasmania.
In late June, Vital acquired 3,415
square metres of vacant land adjoining
Ascot Hospital in Remuera, Auckland
for $16m.
Planning work is underway to expand
Vital's footprint comprising two existing
buildings plus a car park in this leading
healthcare precinct.
80 Ascot Ave
Auckland, NZ
VITAL HEALTHCARE PROPERTY TRUST | ANNUAL RESULTS 2022 | 21
5 largest assets
and asset groupings
5,330sqm of development land
available for further expansion
Epworth Eastern Precinct, Melbourne, VIC
A$482m
VALUE
ASSETS
Epworth Eastern Hospital campus, 17-23
Nelson Rd (development land), Ekera
Medical Centre and 120 Thames St
PATIENT BEDSLAND AREANLA
270~15,000sqm~35,000sqm
PROXIMITY TO
PUBLIC HOSPITAL
% OF VITAL'S
PORTFOLIO
YEAR ACQUIRED
BY VITAL
50m16.0%1999
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2022
|
23
Lingard Private Hospital Precinct, Newcastle, NSW
Recent expansion completed and further
expansion being considered
A$256m
VALUE
ASSETS
Lingard Private Hospital, Lingard
Day Centre and 27 Hopkins
Street (development land)
LAND AREANLA
~15,000sqm11,500sqm
PROXIMITY TO
PUBLIC HOSPITAL
% OF VITAL'S
PORTFOLIO
YEAR ACQUIRED
BY VITAL
3.6km8.5%2 010
PATIENT BEDS
14 0
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2022
|
24
Ascot Hospital Precinct, Auckland, NZ
~3,400sqm of development
land available for expansion
$209m
VALUE
ASSETS
Ascot Hospital, Ascot Central,
80 Ascot Ave (development land)
and Ascot Carpark
LAND AREANLA
~40,000sqm~16,000sqm
PROXIMITY TO
PUBLIC HOSPITAL
% OF VITAL'S
PORTFOLIO
YEAR ACQUIRED
BY VITAL
5.6km6.3%19 9 7
PATIENT BEDS
88
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2022
|
25
Belmont Private Hospital, Brisbane, QLD
A$22.6m expansion underway
A$146m
VALUEASSETS
Belmont Private Hospital
LAND AREANLA
~43,000sqm~8,700sqm
PROXIMITY TO
PUBLIC HOSPITAL
% OF VITAL'S
PORTFOLIO
YEAR ACQUIRED
BY VITAL
11.0km4.8%2 010
PATIENT BEDS
15 0
VITAL HEALTHCARE PROPERTY TRUST | ANNUAL RESULTS 2022 | 26
Wakefield Hospital, Wellington, NZ
$130m
VALUE
Wakefield Hospital
ASSETS
14,500sqm of NLA anticipated on
completion of Stage 2 of redevelopment
LAND AREANLA
~20,000sqm14,500sqm
PROXIMITY TO
PUBLIC HOSPITAL
% OF VITAL'S
PORTFOLIO
YEAR ACQUIRED
BY VITAL
850m3.9%2 017
PATIENT BEDS
68
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2022
|
27
Developments
Development strategy and value-add
TARGETING 10–15% OF THE PORTFOLIO (BY VALUE) TO BE UNDER DEVELOPMENT
NorthWest has a market leading development team
with an unmatched depth of experience in the sector
Earnings and
capital growth
Enhancing the
portfolio
Meeting the needs
of our operator
partners
1
Development timing and therefore spend expected to be over a staged and lengthy period (at least 10 years)
2
Developments where Vital is funding through the development rather than acting as developer
Developments are key for:
FOCUS
PIPELINE
Development land has been
acquired in key locations in
New Zealand and Australia;
planning is being progressed
$293m of committed
developments, representing
~9% of total portfolio value;
$215m of spend remaining
~$1.8bn
1
of potential
development opportunities
identified (subject to business
cases, due diligence and
approvals)
In addition, $169m of fund-
through
2
developments have
been committed to
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2022
|
29
Having identified the opportunity within the Box Hill
Health and Education Precinct to co-locate a private
hospital with the existing public hospital, Epworth
Eastern Private Hospital completed in 2005, consisting
of 208 beds, eight operating theatres, associated
radiology, pathology and consulting suites.
Subsequent expansion of the Epworth Eastern
Tower was announced in 2018 responding
to the precinct's growth requirements.
The Epworth Eastern Tower project consists of
14-storey building including five operating theatres
and 63 beds. Construction was successfully
completed throughout COVID-19 lockdowns with
practical completion reached in March 2022.
The project had a total cost of A$97 million
bringing the total value of the Epworth
Eastern campus to over A$400 million.
Epworth have taken a head lease over all floors
to level 10 with the remaining levels 11-14 to
be leased to individual consulting surgeons.
Development case study - Epworth Eastern Precinct
NORTHWEST HAS A LONGSTANDING PARTNERSHIP WITH EPWORTH HEALTHCARE, HELPING VITAL DEVELOP THIS PRECINCT OVER 20 YEARS
Future growth has been provisioned for
via the acquisition of an adjacent land
parcel with potential for a 40,000sqm
mixed use development. Master
planning for this site has commenced.
total cost
fully let blended yield
$97m
~5.8%
completion
March 2022
WALE
20.5 years
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2022
|
30
As part of the acquisition Vital and the
hospital operator (a joint venture between
Evolution Healthcare and Southern Cross)
have been undertaking design and
planning to extend the existing facility.
As part of the acquisition, Vital committed
to funding masterplanned works at Grace
Hospital over five years from settlement of
the transaction. Stage 1 of the masterplan
works was to complete the fit-out two cold
shell theatres, taking the total number of
operational theatres to 11 and to improve
admission areas and patient flows.
This initial stage has been completed
and will officially open in July 2022.
The development spend is forecast
to increase the value of Grace
Hospital by over 25%.
expected completion
Late 2023
project value
$31.7m
yield
5.3%
spend to date
$5.5m
Development case study - Grace Hospital
IN LATE 2020 VITAL ANNOUNCED THAT IT HAD ACQUIRED GRACE HOSPITAL
VITAL HEALTHCARE PROPERTY TRUST | ANNUAL RESULTS 2022 | 31
Work underway to convert ~$196m of strategic land holdings into income producing properties (including the above).
Update on new and proposed developments
Stage 1 Medical Office Building
Development Application lodged
in April 2022 and Stage 2 Mental
Health Development Application
lodged in June 2022.
Early works have commenced on site
to expand Ormiston Hospital. Leasing
pre-commitment sits at approximately
70% with strong enquiry.
Development Application lodged in
July 2022. Detailed Design phase
commenced with procurement strategy
to be determined in late 2022.
Coomera
BRISBANE, QLD
Ormiston
SOUTH AUCKLAND, NZ
Woolloongabba
SOUTH BRISBANE, QLD
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2022
|
32
Future
focus
Ehara tāku toa I te toa takitahi,
engari he toa takitini.
My strength is not as an individual,
but as a collective.
Whakataukī
Māori proverb
TENANT ENGAGEMENT
AND INTERACTION
Workshop with our key tenants
encouraging active engagement in our
sustainability efforts
STRATEGIC TENANT ALLIANCES
To support establishing a baseline,
tracking and transparently reporting
against Scope 3 GHG emissions
F urther prioritise and develop ESG
alliance with Epworth Healthcare and
Evolution Healthcare and implement
similar ESG alliances with other key
operators
OPTIMISING SPACES FOR
PATIENT WELLNESS
Continue to undertake air quality
testing with 100% of our managed and
controlled properties to be assessed
against wellness dimensions
Sustainability initiatives
GREEN STAR PERFORMANCE
Explore opportunities for full Green Star
certification on a number of the landlord-
controlled assets within the portfolio
NET-ZERO EMISSIONS
All new projects must be net zero-emissions
ready and enable a transition to 100%
renewable energy powered buildings, with
zero onsite fossil fuels
Over the next 18 months we will set a
short-term emissions and 100% renewable
energy target, and explore opportunities
to phase out fossil fuels from our existing
portfolio
EMBODIED EMISSIONS AND
LIFE CYCLE ASSESSMENTS
R educing upfront carbon emissions is a key
requirement for all new building projects
and redevelopments
HEALTH AND WELLBEING
Sustainable procurement, healthy
designs and building materials will be
incorporated on all projects, including
increased daylight, improved fresh air
provisions and sustainable materials
CLIMATE RESILIENCE
All projects must be climate resilient with
climate change risks identified
SEISMIC RESILIENCE
C ommitted to carrying out seismic
strengthening of 68 Saint Asaph St to
achieve a 100% IL3 rating, which is
designed for a 1/1000 year event
Healthy planet
Thriving partners
VITAL HEALTHCARE PROPERTY TRUST | ANNUAL RESULTS 2022 | 34
Sustainability initiatives (Cont'd)
KEYSTONE TRUST
T hree year Key Scholarship Partner
programme through an annual
scholarship, mentoring and support
to a student from the University of
Auckland
CHARITABLE GIVING AND
COMMUNITY INVOLVEMENT
P artner with our tenants and local
communities through charitable giving
of time and resources
LEARNING AND DEVELOPMENT
C ontinue personalised learning and
development initiatives for all permanent
and contract staff
CAREER PROGRESSION
Identify and further support enhanced
development and growth opportunities
for staff
TCFD FRAMEWORK
Vital is required to provide Climate-related disclosures under Financial Sector (Climate-related
Disclosures and Other Matters) Amendment Act 2021. We have engaged Deloitte to provide
gap analysis activities based on current exposure drafts of the standards to assist us in our
development of a roadmap for compliance that is informed by market experts and understood
by our Board and executive team.
GREEN LEASES
We have committed to embed a green lease clause within all new leases
INDIGENOUS WORKGROUP
AND RAP INITIATIVE
Deliver on-line training for all our
staff in A/NZ to ensure a baseline
understanding of indigenous matters
across Māori, Aboriginal and
Torres Strait Islander cultures and
the development of a Reconciliation
Action Plan (RAP)
Inclusive company
Enablers
Strong communities
VITAL HEALTHCARE PROPERTY TRUST | ANNUAL RESULTS 2022 | 35
Sustainability remains a key focus for Vital and NorthWest
Significant development pipeline
$293m committed
$215m remaining cost to complete
~$1.8bn
1
potential pipeline
opportunities identified
In addition, $169m of fund-through
2
developments have been committed to.
Development is now a key focus
for short-medium term growth
Outlook and guidance
CONTINUED DELIVERY AND FOCUS ON EARNINGS GROWTH
FY23 distribution guidance of 9.75 cpu;
1.3% above FY22 to provide a projected
5 year CAGR of 2.2% per annum to 30
June 2023
Conservative ~80% pay-out ratio
expected to be retained
Health care assets (businesses
and real property) remain in high
demand evidenced by recent and
proposed acquisitions
Investors attracted to the stable
and growing returns offered by this
key sector
1
Development timing and therefore spend expected to be over a staged and lengthy period (at least 10 years)
2
Developments where Vital is funding through the development rather than acting as developer
VITAL HEALTHCARE PROPERTY TRUST | ANNUAL RESULTS 2022 | 36
Why invest in Vital
VITAL IS THE ONLY SPECIALIST NZX-LISTED OWNER OF HEALTHCARE PROPERTY
Private healthcare is typically
a non-discretionary or high
priority discretionary spend
Less impacted by economic
or business cycles than other
property sectors
Ageing demographics and
growing population in both
Australia and New Zealand
Rising life expectancy
Improvements in science,
technology and healthcare
increase service offerings
Landlord to some of New
Zealand and Australia’s leading
private healthcare operators
~$3.3bn portfolio
98.8% occupancy
WALE: 17.6 years
Average building age
1
:
11.1 years
Targeting 2–3% AFFO
and DPU growth with a
conservative pay-out ratio
92% of leases increase
by CPI or fixed %
Embedded earnings
growth enhanced
by acquisitions and
developments
$215m
2
of remaining spend
on existing developments
and ~$1.8bn
3
of identified,
potential pipeline to be
partially funded by asset
recycling and existing debt
facilities
Weighted average project
yield of 5.8%; provide value
creation and earnings growth
DEFENSIVE SECTORHIGH DEMANDHIGH QUALITY
PORTFOLIO
EARNINGS GROWTHDEVELOPMENT UPSIDE
1
Average building age = the later of the date of construction or last significant capital works
2
Excludes fund-through developments
3
Development timing and therefore spend expected to be over a staged and lengthy period (at least 10 years)
Vital seeks to deliver stable and growing total Unit Holder returns, including an attractive risk-adjusted
income distribution, sourced from healthcare property
VITAL HEALTHCARE PROPERTY TRUST | ANNUAL RESULTS 2022 | 37
Appendices
Acquisitions and
developments detail
General Notes: All non fund-through development costs excluding land
Committed developments – Australia and New Zealand
DEVELOPMENTS ENHANCE EARNINGS GROWTH AND IMPROVE ASSET QUALITY
ALL VALUES SHOWN IN $MDESCRIPTION OF WORKSDEVELOPMENT
COST
SPEND
TO DATE
COST TO
COMPLETE
FORECAST
NET RETURN
FORECAST
COMPLETION DATE
STATUS
Abbotsford Private Hospital (WA)47 beds, parking, therapy rooms and adminA$18.6A$14.0A$4.66.1%Late-22Structure complete. Internal fitout well advanced.
Belmont Private Hospital (QLD)48 new inpatient beds, 13 private practice consulting suites
and 70 new car parks
A$22.6A$10.4A$12.25.8%Late-22Main structure complete with roofing works underway. Services
installation commenced on lower floors.
Playford Health Hub Stage 2 (SA)Specialist Medical Centre - Radiology, Oncology,
Radiotherapy & Consulting
A$39.3A$5.3A$34.07.3%Early-24Demolition of existing shops completed. Main works contractor
appointed, works to commence onsite end of July.
Total Australian Developments A$A$80.5 A$29.7 A$50.8 6.6%
Wakefield Hospital Stage 2
(Wellington)
Second stage of hospital rebuild delivering 8 operating
theatres, 42 beds, new Day Surgery Unit and additional
expansion capacity
NZ$91.5NZ$29.1NZ$62.45.6%Late-24Stage 2 commenced Oct-21. Demolition and benching of the site
completed. Piling for foundations well advanced. Targeting completion
Late-24.
Boulcott Hospital (Wellington)Two new theatres, PACU expansion and conversion of
double rooms to singles
NZ$7.7NZ$0.0NZ$7.76.2%TBC
1
New ownership in place. Updated business case being awaited.
Procurement options being considered with ECI likely.
Ormiston Hospital Stage 1
(Auckland)
Stage 1 - 3 level expansion of existing hospitalNZ$37.9NZ$5.1NZ$32.85 .1 %Mid-24Early works commenced May-22 with long lead time
items purchased within budget allowance. Forecast
completion date remains at May 2024.
Grace Hospital Stage 1
(Tauranga)
Fitout of two theatres, new endoscopy room, additional 10
beds and redevelopment of existing clinical areas
NZ$31.7NZ$5.5NZ$26.25.3%Late-23Theatre fitout works completed along with alterations to the day surgery
unit. Main works design under review.
Royston Hospital Stage 2
(Hastings)
Fitout of two theatres and reconfiguration of pre and post
operative clinical areas
NZ$6.3NZ$2.4NZ$3.95.3%Late-22Minor demolition complete. Design work progressing.
Bowen Hospital OT5 (Wellington)Fitout of one theatre, new sterile stores and expansion of
consulting suites
NZ$6.3NZ$3.0NZ$3.35.3%Late-22Theatre fitout works complete. Balance of work to ward rooms and
seismic gap commenced.
Endoscopy Auckland (Auckland)4 dedicated endoscopy procedure rooms, 15 car parks,
reception/waiting areas
NZ$22.6NZ$0.3NZ$22.35 .1 %Late-23Resource consent extension underway. ECI procurement likely.
Total New Zealand DevelopmentsNZ$204.0NZ$45.4NZ$158.65.4%
Total Developments in NZ$NZ$293.2NZ$78.3NZ$214.95.8%
Campbelltown Stage 1New cancer centreA$54.4A$6.1A$48.34.3%
3
Early-24Construction commenced in July-22.
Tasman Medical CentreSpecialist Ambulatory Care/Private HospitalA$98.6A$9.5A$89.1~4.5%Late-24Terms agreed.
Total Australian Fund-through developmentsA$153.0A$15.6A$137.14.4%
Total Fund-through developments in $NZD
2
NZ$169.3NZ$17.2NZ$152.1
1
Subject to receipt of final business case
2
Developments where Vital is funding through the
development rather than acting as developer
3
Stabilised yield based on Genesis Care rent in Yr3
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2022
|
40
Acquisition of Hutt Valley Health Hub, Wellington, NZ
VITAL ACQUIRED A PREMIUM CO-LOCATED AMBULATORY CARE FACILITY TO COMPLEMENT EXISTING INVESTMENTS
~4.0%
Feb 2022
Sustainable features
$46.5m
~3,300sqm
~3,200sqm
~14.2 years
7 tenants
Key precinct
WALE
focused on primary care
and outpatient services
Co-located with Hutt Hospital and
Boulcott Hospital (also owned by Vital)
initial yield
settlement
Sustainable features include CLT timber construction
and seismic dampers incorporated into design.
acquisition price
net lettable area
Future expansion land
available for development
1
ACQUISITION SUMMARY
FUTURE DEVELOPMENT SUMMARY
1
Includes existing adjoining holding and development land expected to be settled shortlyVITAL HEALTHCARE PROPERTY TRUST | ANNUAL RESULTS 2022 | 41
Acquisition of The Tennyson Centre, Adelaide, SA
VITAL ACQUIRED ONE OF ADELAIDE’S LEADING “CANCER CENTRES OF EXCELLENCE”
4.8%~A$93m
1
12,700sqm
Oct 2021
1,900sqmA$2.75m
6,568sqm
3.5%–4%
Quality tenantsSeveral key leases
net lettable area
fixed annual rent reviews
Icon Cancer, GenesisCare, Nexus
Day Hospitals, Dr Jones & Partners
renewed since acquisition
Initial yieldacquisition price
site area
settlement
site areaacquisition price
ACQUISITION SUMMARY
DEVELOPMENT LAND SUMMARY
The Tennyson
Centre
Development
Land
1
Includes development acquisition cost listed below
VITAL HEALTHCARE PROPERTY TRUST | ANNUAL RESULTS 2022 | 42
BLINK TO FORMAT
Acquisition of land to expand The Hills Clinic, Sydney, NSW
VITAL ACQUIRED A STRATEGIC LAND HOLDING ADJOINING EXISTING PREMIUM ASSET FOR FACILITY EXPANSION
Feb 2022A$50m
4,340sqm
~5%
25 years
100%
settlementacquisition and estimated
development costs
site area
yield on cost
in line with existing lease
pre-committed to
Aurora Healthcare
ACQUISITION SUMMARY
The Hills
Clinic
~4,340sqm
MEMORIAL AVENUE
MCCAUSLAND PLACE
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2022
|
43
Acquisition of multi-stage development site in South West Sydney
VITAL ACQUIRED A PRE-COMMITTED GENESIS CARE CANCER CENTRE AND MULTI STAGE DEVELOPMENT SITE IN SYDNEY GROWTH CATCHMENT
~4.0%
2
Feb 2022A$52m
1
3%
40,000
sqm
UP TO
23,000sqmA$24.6m
2,713sqm
15 year
net lettable areaWALE
initial yield
for stage 1
settlementacquisition price &
development costs
annual rent reviews
additional GFA
site areaacquisition price
STAGE 1 – FUND-THROUGH DEVELOPMENT OVERVIEW
STAGES 2 & 3 – ADDITIONAL DEVELOPMENT SUMMARY
1
Excludes adjoining development land but includes fund-through construction costs for Stage 1
2
After deducting ground rent costs and allowing for benefit of stamp duty savings via fund-through structure
Camden Rd
Hurley St
Cancer Cancer
CentreCentre
Mental Mental
HealthHealth
Health Health
FacilityFacility
VITAL HEALTHCARE PROPERTY TRUST | ANNUAL RESULTS 2022 | 44
Arvida Retirement and
Aged Care Facility
(under construction)
Queenstown
Airport
The precinct strategically adjoins
NZX-listed Arvida's retirement
village and aged care facility
(under construction).
Childcare
Retail 2
Retail 1
Medical Centre
/ Pharmacy
Southern Cross
Hospital
Radiology
Centre of Medical
Excellence
Arvida Group
Country Club
Buildings to be on separate
titles which supports a higher
valuation than if combined
Kawarau Park
Health Precinct
The hospital is the only private hospital
in Queenstown and Central Otago and
the precinct benefits from Queenstown's
favourable demographics.
Acquisition of Kawarau Park Health Precinct, Queenstown
A newly developed health precinct
comprising six tenanted buildings
including Queenstown's only
private hospital operated in a joint
Venture between Southern Cross
Healthcare and Central Lakes Trust.
The hospital includes three operating
theatres and 13 inpatient rooms.
Other tenants include nationwide
providers such as NZX-listed Green
Cross Health and Pacific Radiology
(subsidiary of NZX-listed Infratil),
along with several surgical consulting
rooms, childcare and supporting
retail and commercial uses.
TENANTS
The precinct is situated on over 2.3ha of
land and has additional development
potential of at least 2,000sqm of land.
DEVELOPMENT POTENTIAL
FAVOURABLE DEMOGRAPHICS
1
Settlement occurred in late July 2022
2
Excludes development land of ~$4m
WALE underpinned by
hospital lease of 12 years
8.7 years
of leases (by income) increase by the
greater of market and CPI (uncapped)
~40%
fully let blended yield
~4.5%
2
purchase price
$95m
1
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2022
|
45
The facility sits on a large land
holding of ~15,000sqm and has
an existing planning height limit of
17m (4 levels compared with the
current single level building).
There is potential for future
redevelopment, including ~1,600sqm
of additional land that currently earns
income from parking but provides
an opportunity to enhance the
acquisition noting that this corner is
closest to Christchurch Hospital.
Acquisition price of $50.7m
(excludes transaction costs and
fit-out loan to CDHB which is
repayable over 10 years).
~30% of the facility is currently
available for lease and is subject to
a 24-month vendor rental underwrite.
The acquisition settled on 1 April 2022.
Acquisition of 68 Saint Asaph St, Christchurch
Existing tenants include a Canterbury
District Health Board (CDHB) maternity
care facility
1
and Syft Technologies
(~50% of the Syft tenancy is life
sciences laboratory space with the
balance used for offices).
TENANTS
DEVELOPMENT POTENTIAL
ACQUISITION
Metro sports facility
(in construction)
5.1%
April 2022
settlement
estimated NOI
2
yield excluding
fees and development land but
including a ~$7m fit-out loan
repayable over 10 years.
8.5 years
WALE (by income)
1
Lease commences 1 August 2022
2
Net Operating Income
Hospital and related
68 St Asaph St
CDHB multi deck
staff carpark
CDHB head office
Manawa Building
Public outpatient
clinic
Public hospital
energy centre
/boiler house
(in construction)
and existing labs
Public Hospital
VITAL HEALTHCARE PROPERTY TRUST | ANNUAL RESULTS 2022 | 46
Acquisition and expansion of Endoscopy AucklandAcquisition and expansion of Endoscopy Auckland
The property is leased to Evolution Healthcare
for 20 years with the hospital business owned
jointly by Healthcare Holdings and Evolution
Healthcare (respectively, New Zealand’s second
and third largest private hospital operators).
Vital has acquired land and
buildings at 148 Gillies Avenue and
22–24 Kipling Avenue, Epsom.
1
Currently, the properties comprise an
endoscopy facility and residential
units on ~4,000sqm of land.
PROPERTY
TENANTS
AGREED DEVELOPMENT
~4.75%
initial yield
~$21.6m
development costs
~5.1%
net yield on
development cost
$22.2m
1
purchase price
Gillies Property
Kipling Property
(site now predominantly
cleared for development)
1
Settlement for the majority of the land and buildings occurred in June 2022 with the balance awaiting Overseas Investment Office approval
Mercy Ascot
Hospital
Auckland Surgical
Centre (Southern Cross)
Gillies Hospital
(Southern Cross)
Brightside Hospital
(Southern Cross)
Ascot Hospital
(Vital Asset)
Endoscopy Auckland
Newmarket
Epsom
Mount Eden
Remuera
Terms have been agreed to
utilise the vacant land at 22
Kipling Ave and develop a new
day surgery and endoscopy
facility, with the existing facility
expanding surgery capacity.
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2022
|
47
Artist’s impression showing existing building on left and proposed extension set back on the right.
AGREED DEVELOPMENT
Expansion of Ormiston Hospital, Auckland
The property is leased to Ormiston
Surgical Endoscopy Limited which is
~50% owned by Southern Cross, New
Zealand’s largest private hospital operator.
On completion, the new facility will
be leased for 20 years with the lease
of the existing facility also extended to
20 years (an ~18.5 year extension).
Terms have been agreed to develop
a new ~4,500sqm, 3 level building
linked to the existing ~5,000sqm, 3
level building by an air bridge.
Vital has agreed terms for a
~$40m expansion of its existing
asset, Ormiston Hospital.
PROPERTY
TENANTS
~5.5%
net yield on
development cost
~$40m
development costs
1
Artist’s impressions
1
Includes allocation of land (already owned by Vital) and unrentalised development fees and remains subject to final pricing
Savory appointed as
lead contractor
Construction
commenced mid-2022
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2022
|
48
Additional portfolio
information
WESTERN
AUSTRALIA
NORTHERN
TERRITORY
SOUTH
AUSTRALIA
NEW
SOUTH
WALES
TASMANIA
VICTORIA
QUEENSLAND
4
3
6
6
12
Investment properties
1
~$3.3BN PORTFOLIO OF HEALTHCARE REAL ESTATE COMPRISING 47 INVESTMENT PROPERTIES AND 2,800+ BEDS
Vital also owns strategic land holdings for future development valued at ~$196m
AS AT 30 JUNE 2022
Western Australia (4)
Abbotsford Private Hospital
Hamersley Aged Care
Marian Centre
Rockingham Aged Care
South Australia (3)
Sportsmed Hospital, Clinic, Consulting
and Office
The Tennyson Centre
Playford Health Hub – Retail and Carpark
Queensland (6)
Baycrest Aged Care
Belmont Private Hospital
Eden Rehabilitation
Palm Beach Currumbin Clinic
Tantula Rise Aged Care
The Southport Private Hospital
New South Wales (12)
Clover Lea Aged Care
Darlington Aged Care
Fairfield Aged Care
Grafton Aged Care
Hirondelle Private Hospital
Hurstville Private Hospital
Lingard Day Centre
Lingard Private Hospital
Maitland Private Hospital
Mons Road Medical Clinic
The Hills Clinic
Toronto Private Hospital
Victoria (6)
Ekera Medical Centre
Epworth Eastern
Hospital & Medical Centre
120 Thames Street
Epworth Camberwell
Epworth Rehabilitation Hospital
South Eastern Private Hospital
Auckland (6)
Apollo Health and Wellness Centre
Ascot Central
Ascot Carparks
Ascot Hospital & Clinics
Ormiston Hospital
Endoscopy Auckland
Wellington (4)
Boulcott Hospital
Bowen Hospital
Wakefield Hospital
Hutt Valley Health Hub
Northland (1)
Kensington Hospital
Bay of Plenty (1)
Grace Hospital
Christchurch (1)
Saint Asaph Street
Hawke's Bay (2)
Napier Health Centre
Royston Hospital
Queenstown (1)
Kawarau Park Health
2
14
1
Number of properties include Kawarau Park Health Precinct, Queenstown, but excludes strategic assets. All other figures exclude Kawarau Park Health Precinct, QueenstownVITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2022
|
50
PRIVATE HOSPITALS – AUSTRALIA
17 hospitals (acute and specialty –
mental health, rehabilitation)
F our hospital operators
80% of AUS portfolio value;
79% of AUS rent
WALE: 19.1 years
6 assets, multiple tenants
1 4% of AUS portfolio value;
12% of AUS rent
WALE: 7.0 years
8 facilities (all in AUS)
2 operators
6% of AUS portfolio value;
9% of AUS rent
WALE: 9.9 years
AMBULATORY CARE – AUSTRALIA
AGED CARE – AUSTRALIA
~$2.4bn Australian portfolio overview
GEOGRAPHICALLY DISPERSED AUSTRALIAN PORTFOLIO CONTINUES TO PERFORM WELL
45%
35%
14 %
6%
H
O
S
P
I
T
A
L
8
0
%
O
T
H
E
R
2
0
%
AMBULATORY
CARE
SPECIALTY
HOSPITAL
AGED CARE
ACUTE
HOSPITAL
17.1 years
WALE
SUBSECTOR DIVERSITY (BY VALUE)
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2022
|
51
~$0.9bn New Zealand portfolio overview
KEY NEW ZEALAND MARKET PERFORMING STRONGLY
PRIVATE HOSPITALS – NEW ZEALAND
9 hospitals (all acute)
6 hospital operators
75% of NZ portfolio value;
75% of NZ rent
WALE: 21.6 years
6 assets, multiple tenants
25% of NZ portfolio value;
25% of NZ rent
WALE: 9.9 years
AMBULATORY CARE – NEW ZEALAND
18.7 years
WALE
75 %
25%
H
O
S
P
I
T
A
L
7
5
%
O
T
H
E
R
2
5
%
AMBULATORY
CARE
ACUTE
HOSPITAL
SUBSECTOR DIVERSITY (BY VALUE)
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2022
|
52
Lease expiry profile
LOW RISK EXPIRY PROFILE SUPPORTS SUSTAINABLE, PREDICTABLE AND DEFENSIVE CASH FLOWS
Lease expiries in FY23 primarily reflect smaller tenancies at multi-tenant properties
10-year average annual lease expiry of only 1.7% (as % of total portfolio income)
Jun-23
0%
2.5%
5.0%
7.5%
10%
Jun-24Jun-25Jun-26Jun-27Jun-28Jun-29Jun-30Jun-31Jun-32
Total expiry
Largest single rent expiring10 Year Average
1.7%
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2022
|
53
Rent reviews
HIGH PERCENTAGE OF TOTAL RENT IS REVIEWED ANNUALLY WITH STRUCTURED
1
REVIEW MECHANISMS
Rent reviews have
been completed for
110 leases in FY22
Structured reviews
represent 92%
1
of
leases by income
as at 30 June 2022
Significant uplift via
structured rent reviews
across Portfolio
1
Includes fixed percentage and CPI reviews
Rent reviews – FY22
(“LIKE-FOR-LIKE” EXCLUDES DEVELOPMENTS, ACQUISITIONS AND DISPOSALS)
#
Jun-21 Rent p.a.
(NZD)
Jun-22 Rent p.a.
(NZD)
Increase
(NZD)
Annualised Growth
(Stable currency)
AustraliaAUS5484,752,63387,830,9793,078,3463.6%
New ZealandNZ5632,466,16433, 733, 75 91,267,5953.9%
Total11 0117,218,797121,564,7384,345,9423.7%
#
Jun-21 Rent p.a.
(NZD)
Jun-22 Rent p.a.
(NZD)
Increase
(NZD)
Annualised Growth
(Stable currency)
CPICPI78103,256,277106,892,7793,636,5023.5%
FixedFixed2311, 742 , 27812,237,226494,9494.2%
MarketMarket81,254,7571,349,96695,2107.6%
TurnoverTurnover1965,4851,084,766119,28112.4%
Total11 0117,218,797121,564,7384,345,9423.7%
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2022
|
54
Core portfolio metrics
5 YEAR TRENDS HIGHLIGHT PORTFOLIO STRENGTH AND UNDERPIN LONG-TERM PERFORMANCE
OCCUPANCY
AVERAGE 10 YR LEASE EXPIRY
1
WALE
TOTAL INCOME SUBJECT TO
STRUCTURED RENT REVIEWS
~99%
occupancy
Long-term track record of maintaining
High degree of confidence that
future expiries will be renewed
or replaced with new tenants in
advance of expiry
1
Reflects the average % of total portfolio
income that expires over the next 10 years
95%
96%
97%
98%
99%
100%
2018
99.3
99.499.4
99.2
98.8
2019202020212022
15
16
17
18
19
2018
18.2
18.118.1
18.7
17.6
2019202020212022
0%
1%
2%
3%
4%
5%
6%
1.8
1.7
1.3
1.6
1.7
20182019202020212022
PERCENTAGE OF INCOME
0%
20%
40%
60%
80%
100%
85.8
90.0
94.0
95.0
92.3
20182019202020212022
PERCENTAGE OF INCOME
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2022
|
55
Additional financial
information
Adjusted funds from operations (AFFO)
CONSERVATIVE PAY-OUT RATIO
FY22F Y 21($) CHANGE(%) CHANGE
Operating profit before tax and other income
1
56,517 51,064 5,453 10.7
Add/(deduct):
Current tax expense(8,280) (7,858) (422) (5.4)
Incentive fee 15 , 914 12,402 3 , 512 28.3
Current tax on translation of foreign currency funding transactions 98 227 (129) (56.8)
Amortisation of borrowing costs 1, 270 878 392 44.6
Amortisation of leasing costs & tenant inducements 2 , 778 2,421 357 14 . 7
Strategic transaction expenses 283 - 283 -
IFRS 16 operating lease accounting(163) (144) (19) (13.2)
Funds from operations (FFO)
1
68,417 58,990 9,427 16.0
Add/(deduct): -
Actual capex & leasing from continuing operations(593) (1,533) 940 61 . 3
Adjusted funds from operations (AFFO) 67, 8 24 57,457 10,367 18.0
AFFO (cpu)11 . 9 2 c11.54c0.38c 3.3
Distribution per unit (cpu)9.63c8.88c0.75c 8.5
AFFO pay-out ratio81 %77%--
1
All values shown in NZ$000s
Units on issue (weighted average, 000s)569,104497,892
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2022
|
57
Interest rate hedging profile
COST OF DEBT WELL HEDGED, MANAGING RISK
1
Drawn debt (excludes line fees on undrawn facility)
HEDGING MATURITY PROFILE ($A)
NOTE: Fixed rates exclude line fees and margin
0.00%
0.50%
1.00%
1.50%
2.00%
2.50%
3.00%
0
50
100
150
200
250
300
350
400
450
Jun-22
Dec-22
Jun-23
Dec-23
Jun-24
Dec-24
Jun-25
Dec-25
Jun-26
Dec-26
Jun-27
Dec-27
Jun-28
Dec-28
Jun-29
VALUE ($M)
Maturity dateAverage interest rate
RATES30 JUNE
2022
30 JUNE
2021
Weighted average cost of debt
1
3. 73 %3.32%
"Weighted average fixed rate
(excl line and margin)"
2.89%2.94%
Weighted average fixed rate duration4.7 yrs5.5 yrs
% of drawn debt fixed45%49%
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2022
|
58
Net tangible assets (NTA)
NTA PER UNIT BRIDGE
REVALUATION GAINS SUPPORTED STRONG NTA GROWTH PER UNIT
Revaluation gain of $244m;
9.3% increase from June 2021
~77% of gain from Australian
portfolio and ~23% from
New Zealand
Revaluation gains include
~$100m from rental increases,
leasing activity and ~$10m of
development margins
$2.40
$2.50
$2.60
$2.70
$2.80
$2.90
$3.00
$ 3 .10
$3.20
$3.30
$3.40
$2.89
$3.34
$0.32
$0.06
$0.07
($0.02)
$0.02
FY2022property revaluationscurrency translationretained earningsnew units issuedinterest rate swapsFY2021
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2022
|
59
Movement in investment property
WELL-LEASED HEALTHCARE ASSETS CONTINUE TO EXPERIENCE CAP RATE COMPRESSION
INVESTMENT PROPERTY BRIDGE (FY22)
KEY POINTS
(NZ MILLIONS)
Continued activation of strong development
pipeline, contributing ~$100m to portfolio
over FY22
1 00% of Vital's Income Producing Properties
independently valued over FY22
R evaluation gains include ~$100m from
rental increases and leasing activity, ~$10m
of development margins and 30 basis points
cap rate compression since 30 June 2021
Maintained geographic balance
between Australia and New Zealand of
approximately two-thirds and one-third
respectively
1
$287m (excluding transaction costs) of acquisitions, including $94m for The Tennyson Centre, $52m for Saint Asaph St (Christchurch), $45m for Hutt
Valley Health Hub, $20m for Endoscopy Auckland and the balance for strategic / development sites. All asset values shown in NZ$, pre costs
2
Includes development expenditure and capitalised interest costs
3
Book value at sale date
4
Period end NZD/AUD exchange rate moved from 0.9309 at 30 June 2021 to 0.9037 at 30 June 2022
$0
$500
$1,000
$1,500
$2,000
$2,500
$3,000
$3,500
2,635
$1,934m
$701m
$2,391m
$948m
298
100
244
(13)
753,339
30-Jun-22Acquisitions
1
Capital
additions
2
Property
revaluations
Disposals
3
Foreign
exchange
4
30-Jun-21
AUS Assets
NZ Assets
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2022
|
60
Comparative returns
LONG-TERM OUTPERFORMANCE BY VITAL VS BENCHMARK ON A TOTAL RETURN
1
BASIS
TOTAL RETURN
1
TO 30 JUNE 20221YR
(%)
5YR (P.A.)
(%)
10YR (P.A.)
(%)
SINCE 2004
(P.A.)
2
(%)
Vital-10.27. 213 . 212 . 7
S&P/NZX All Real Estate Index-13.66.49.08 .1
S&P/NZX 50 Index-14.17. 412.37. 7
Vital’s performance vs NZX REIT3.50.94.24.6
Vital’s performance vs NZX 503.9-0.20.95.0
Outperformance against both the S&P/NZX All Real Estate Index
and S&P/NZX 50 Index since December 2004
L ong-term outperformance highlights the defensive nature of
healthcare real estate compared to other real estate classes
7 .9% outperformance versus NZX REIT benchmark over last 24
months and 5.2% outperformance versus NZX 50
Source: Forsyth Barr
1
Total returns measured by change in unit price plus post-tax distributions to 30 June 2022
2
S&P/NZX All Real Estate Index and S&P/NZX 50 Index data from 31 December 2004, being
the inception date of the NZX All Real Estate Index
VHP VS S&P NZX REAL ESTATE INDEX
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2022
|
61
Glossary
AFFO
Adjusted Funds From Operations is an alternate measure used for assessing distributable income. Essentially adjusts net profit
after tax for all non-cash items (i.e. NDI) then makes adjustments for items such as maintenance capex and lease incentives paid.
Cap Rate
Capitalisation Rate. Generally calculated as net operating income / current market value of investment property.
CPI
Consumer Price Index. An index that measures the change in the cost of a ‘basket’ of basic goods and services, showing how
the cost-of-living changes over time. The most widely accepted indicator of inflation.
FX
An abbreviation for ‘foreign exchange’ used where there is a transaction in a currency other than the local currency.
GFA
Gross floor area
NPI
Net Property Income.
NTA
Net Tangible Assets. The total assets of the Trust less total liabilities. NTA is normally divided by the number of units on issue and
expressed as an annual amount per unit.
WALE
Weighted Average Lease term to Expiry. The weighted average lease term remaining to expire across a portfolio, sometimes
also referred to as WALT.
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2022
|
62
Disclaimer
This document has been prepared by NorthWest Healthcare Properties Management Limited (the Manager) as manager of the Vital
Healthcare Property Trust (the Trust). This document provides general information only and is not intended as investment, legal, tax, financial
product or financial advice or recommendation to any person and must not be relied on as such. You should obtain independent professional
advice prior to making any decision relating to your investment or financial needs.
All references to $ are to New Zealand dollars unless otherwise indicated.
This document may contain forward-looking statements. Forward-looking statements can include words such as “expect”, “intend”, “plan”,
“believe”, “continue” or similar words in connection with discussions of future operating or financial performance or conditions. Any
indications of, or guidance or outlook on, future earnings or financial position or performance and future distributions are also forward-
looking statements. The forward-looking statements are based on management's and directors’ current expectations and assumptions
regarding the Trust’s business, assets and performance and other future conditions, circumstances and results. As with any projection or
forecast, forward-looking statements are inherently susceptible to uncertainty and to any changes in circumstances. The Trust’s actual results
may vary materially from those expressed or implied in the forward-looking statements. The Manager, the Trust, and its or their directors,
employees and/or shareholders have no liability whatsoever to any person for any loss arising from this document or any information
supplied in connection with it. The Manager and the Trust are under no obligation to update this document or the information contained in it
after it has been released. Past performance is no indication of future performance.
The information in this document is of general background and does not purport to be complete. It should be read in conjunction with Vital’s
market announcements lodged with NZX, which are available at www.nzx.com/companies/VHP.
11 August 2022
VITAL HEALTHCARE PROPERTY TRUST
|
ANNUAL RESULTS 2022
|
63
www.vhpt.co.nz
Thank you
Artist's impression of development of GenesisCare, Campbelltown
---
VITAL HEALTHCARE PROPERTY TRUST vhpt.co.nz
Managed by NorthWest Healthcare
Properties Management Limited
Page 1 of 1
MARKET RELEASE
11 August 2022
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.